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ABSTRACT 
Socioeconomic Status and the Progression of Heart Failure 
 
Randi E. Foraker 
(Under the direction of Wayne D. Rosamond) 
 
This dissertation explores the relationship between socioeconomic status and the 
progression of heart failure following an incident heart failure hospitalization, defined in 
three domains: rehospitalization, mortality and self-rated health.  Hospital admissions for 
heart failure are on the rise in the United States, and mortality remains high among heart 
failure patients.  Meanwhile, self-rated health is a potent predictor of future health, and its 
trajectory among heart failure patients is unknown.   
The first aim was to estimate the effect of neighborhood socioeconomic and Medicaid 
status on the time to first rehospitalization and the rehospitalization rate.  Participants who 
lived in low neighborhood socioeconomic areas at baseline who had multiple comorbidities 
during the incident heart failure hospitalization were rehospitalized faster and more often 
compared to participants living in high socioeconomic neighborhoods at baseline with 
multiple comorbidities.  Meanwhile, Medicaid recipients with a low level of comorbidity 
were rehospitalized faster and more often compared to non-Medicaid recipients.   
The second aim was to estimate the effect of neighborhood socioeconomic and Medicaid 
status on the time to and risk of mortality.  Participants who lived in low neighborhood 
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socioeconomic areas at baseline who had multiple comorbidities during the index heartfailure 
hospitalization experienced a shorter time to death compared to participants living in high 
socioeconomic neighborhoods at baseline with multiple comorbidities.  
A comparison of the trajectory of self-rated health across time was examined among  
participants as part of the third aim.  Predictors of a decline in self-rated health across time 
were assessed, and factors shown to contribute to poorer self-rated health regardless of 
incident disease status included advanced age, low educational attainment, current smoking 
and obesity.   
This dissertation brings to attention several areas for future research in cardiovascular 
disease epidemiology.  The first is a need to better understand the relationship of 
socioeconomic status and the progression of heart failure in terms of its out-of-hospital 
management.  The second is to explore the mechanisms underlying the relationship between 
poor socioeconomic status and increased mortality.  Lastly, interventions can be tested to 
help understand how to improve self-rated health, and the resulting health outcomes, among 
aging adults.
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I. INTRODUCTION 
The public health burden of heart failure (HF) is rising.  Hospital discharges for HF 
increased 157% from 1979 to 2002 (Heart Disease and Stroke Statistics - 2005 Update, 
2005), and continue to rise (D. Lloyd-Jones et al., 2010).  HF rehospitalizations, which are 
often preventable (MedPAC, 2007), tend to be higher among older patients, non-whites, and 
patients with prior hospitalizations and multiple primary care visits (Fang, Mensah, Croft, & 
Keenan, 2008; Ghali, Cooper, & Ford, 1990; Inouye et al., 2008; Schocken et al., 2008).  In 
addition to being recognized as a major cause of serious morbidity (Adams et al., 2005; 
Cowie et al., 2002; H. Eriksson, 1995; Hoyt & Bowling, 2001), HF mortality is high (Jong, 
Vowinckel, Liu, Gong, & Tu, 2002; M. S. Nieminen & Harjola, 2005).  From 1980 to 1995, 
the number of deaths in the US with an underlying cause of HF increased nearly 70% 
(Haldeman, Croft, Giles, & Rashidee, 1999).  It is estimated that HF is a primary or 
contributory cause of more than 300,000 deaths each year in the US (Hunt et al., 2001), and 
HF mortality rates increase sharply with age.  In addition, while HF survival has been shown 
to be worse than other cardiovascular diseases and cancers, with the exception of lung cancer 
(Simon Stewart, MacIntyre, Hole, Capewell, & McMurray, 2001), it remains unknown if 
trajectories in self-rated health (SRH) among HF patients show similar trends. 
In this work, we characterized the relationship between neighborhood socioeconomic 
status (SES) and HF progression among ARIC cohort participants.  Risk factors for HF and 
comorbid conditions tend to be more common among patients of low SES (Kaplan & Keil, 
 2
1993; McAlister, Stewart, Ferrua, & McMurray, 2004).  Low individual SES, measured by 
factors such as income, education and occupation, implies limited economic resources 
available to the individual.  While low neighborhood SES and individual SES are shown to 
have a negative effect on health outcomes (CDC, 2005; Chaix, Rosvall, & Merlo, 2007; 
Stjarne, Fritzell, Ponce de Leon, & Hallqvist, 2006; Suadicani, Hein, & Gyntelberg, 2001), 
their individual and joint effects on HF progression are not yet established.  Meanwhile, 
health insurance status may be associated with care-seeking behavior (Philbin & DiSalvo, 
1999) and subsequent disease outcomes (Ayanian, Kohler, Abe, & Epstein, 1993).  Medicaid, 
in particular, may exert effects on health outcomes which are independent of SES (Foraker et 
al., 2008; Ross & Mirowsky, 2000), as its receipt is determined by having certain diseases 
and disabilities or an income below the poverty line (Ku, 2005; Rosenbaum, 2002). 
Possible pathways linking lower neighborhood socioeconomic and Medicaid status to 
faster and more deleterious HF progression may include limited access to primary care, and 
inadequate management of HF symptoms out-of-hospital.  However, we further speculated 
that it was possible for low neighborhood SES to impart a larger influence, for example, 
among participants with a higher burden of comorbidity, resulting in a shorter time to 
readmission, higher mortality and a steeper decline in SRH among these HF patients.  
To the extent these findings are generalizable, they may lead to more effective 
management of HF patients, decreasing the burden of HF progression among patients with 
higher levels of comorbidity.  For example, in the event neighborhood SES operates via 
comorbid disease to further contribute to the progression of HF, interventions (O'Dwyer, 
Baum, Kavanagh, & Macdougall, 2007) could be targeted to address the needs of patients of 
low neighborhood SES who also have high comorbidity. 
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This dissertation explored three aspects of the public health burden of incident HF.  
First, we examined neighborhood socioeconomic and Medicaid status and their association 
with rehospitalization among patients with incident hospitalized HF.  Second, we explored 
the association of neighborhood socioeconomic and Medicaid status with mortality among 
patients with incident hospitalized HF.  Lastly, we captured the effect of neighborhood SES 
on the trajectory of SRH among participants with incident HF, and compared the trajectory to 
that of participants with other types of incident disease.
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II. SPECIFIC AIMS 
Aim 1: Estimate the effect of neighborhood socioeconomic and Medicaid status on 
rehospitalization among patients with an incident HF hospitalization. 
 
Aim 1a:   Determine whether the relationship is modified by the presence or absence of 
chronic conditions or by age, race/study community, gender or individual SES. 
 
We hypothesize that patients of lower neighborhood SES will have shorter times to 
readmission and more frequent hospitalizations, as will Medicaid recipients.  It is possible 
that both low neighborhood SES and receipt of Medicaid impart a larger influence among 
patients with a higher burden of comorbidity, resulting in a shorter time to rehospitalization 
and more frequent readmissions.  
 
Aim 2: Estimate the effect of neighborhood socioeconomic and Medicaid status on 
mortality among patients with an incident HF hospitalization.  
 
Aim 2a:  Determine whether the relationship is modified by the presence or absence of 
chronic conditions or by age, race/study community, gender or individual SES. 
 
We hypothesize that patients of lower neighborhood SES will have shorter times to death 
following an incident HF hospitalization, as will Medicaid recipients.  It is possible that both 
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low neighborhood SES and receipt of Medicaid impart a larger influence among patients 
with a higher burden of comorbidity, resulting in a shorter time to death among these 
patients. 
 
Aim 3: Describe and compare the trajectory of self-rated health among participants 
with different disease states, such as those who remain disease-free throughout follow-
up and those who experience incident HF, myocardial infarction,  stroke, lung cancer, 
or receive a cardiac procedure.  
 
Aim 3a: Describe and compare the trajectory of SRH among participants with HF to that of 
participants with different types of incident disease, such as those who remain disease-free 
throughout follow-up and those who experience myocardial infarction, stroke, lung cancer, or 
receive a cardiac procedure. 
 
Aim 3b:  Determine whether the relationship is modified by the presence or absence of 
chronic conditions or by age, race/study community, gender or individual SES. 
 
We hypothesize that participants of lower neighborhood SES will have a steeper slope of 
decline in SRH across time compared to participants of higher neighborhood SES.  It is 
possible the effect of low neighborhood SES will be modified by other sociodemographic or 
socioeconomic variables, resulting in more of a decline in SRH over time among these 
participants.
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III. BACKGROUND AND SIGNIFICANCE  
A. Epidemiology of Heart Failure 
HF is a complex medical syndrome that has major personal, public health and economic 
implications.  HF does not have a single pathophysiologic etiology (Mosterd & Hoes, 2007; 
Schocken et al., 2008).  The most common etiology in industrialized societies is ischemic 
heart disease (IHD).  Other potential causes include hypertension, valvular heart disease, 
arrhythmias such as atrial fibrillation, and alcohol abuse (Levy et al., 2002; Mosterd & Hoes, 
2007).   
The global diffusion of coronary heart disease (CHD), including HF, is likely a result of 
population aging and improved treatment and survival of patients with CHD (Schocken et al., 
2008).  In the United States (US), a growing burden of HF is anticipated as the population of 
persons 65 years and older is expected to exceed 70 million by the year 2030 (DHHS, 2007).  
The lifetime risk of HF is an estimated 20% for both men and women (D. M. Lloyd-Jones et 
al., 2002).  Approximately 5.2 million people in the US have HF (Thom, 2007), and CHD is 
the leading cause of hospitalization in the US (Popovic & Hall, 2001).  The American Heart 
Association estimates that more than $33 billion in medical expenditures were attributable to 
HF in 2007 (Rosamond et al., 2007), and that number is expected to increase with the 
increasing burden of the disease.   
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Four clinical stages of HF have been identified by the American Heart Association 
(AHA)/American College of Cardiology (ACC) (Figure 3.1) (Schocken et al., 2008).  As 
seen in Figure 3.1, Stage A represents preclinical disease, and includes CHD risk factors 
such as aging, hypertension, smoking, diabetes mellitus and obesity.   The accumulation of 
risk factors in Stage A leads to and exacerbates structural changes in the heart during Stage 
B.  The preclinical progression of HF from Stage A to Stage B may, for example, involve the 
occurrence of myocardial infarction (MI) which, on a cellular level, affects the efficiency of 
the heart via increased collagen synthesis (i.e., myocardial fibrosis) and decreased 
contractility of the myocardium.  Stage B captures the early stages of decompensation, in 
which the heart structure changes in order to adapt to consequences of CHD and ischemia 
and maintain cardiac output.  In Stages C and D, structural heart disease is accompanied by 
clinical signs and symptoms of ventricular dysfunction.   
Figure 3.1. Four clinical stages of heart failure, AHA/ACC 
 
 (Schocken et al., 2008) 
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Patients diagnosed with HF often have a high burden of clinical comorbidities.  Chronic 
conditions such as hypertension, MI, diabetes and obesity are risk factors for the 
development of HF (Schocken et al., 2008; Weir, McMurray, & Velazquez, 2006), and 
clinical HF is commonly accompanied by these factors (Heywood et al., 2007).  In a 
scientific statement, the AHA names precursors to HF (e.g., hypertension and CHD) as 
targets for HF prevention (Schocken et al., 2008).  Registry studies indicate that, of patients 
hospitalized for HF, more than 50% had coronary artery disease, 27-44% had type-2 
diabetes, nearly 75% had hypertension and 18-30% had renal insufficiency (Adams et al., 
2005; M. S. Nieminen & Harjola, 2005).  Further, risk factors for conditions comorbid with 
HF are more common among patients of low SES.  In a study of residents of Rome aged 75 
and older, Antonelli-Incalzi et al. found that decreasing neighborhood SES was associated 
with an increase in all-cause readmission rate, hospital length of stay and comorbidity, as 
defined by the Charlson index of comorbidity (Antonelli-Incalzi et al., 2007).  Data from the 
Behavioral Risk Factor Surveillance System, which were age-standardized to the year 2000 
US population, report the prevalence of CHD risk factors by level of education, income and 
employment status, and show an inverse relationship between the prevalence of CHD risk 
factors and individual-level SES (Table 3.1).   
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Table 3.1. Prevalence (%) of coronary heart disease risk factors* by sociodemographic 
characteristics, Behavioral Risk Factor Surveillance System, United States, 2003 
Characteristic % Characteristic % 
Age group (years)  Annual household income  
          35-49 34.6           <$10,000 52.5 
          50-64 51.1           $10,000-19,999 49.3 
          ≥65 56.4           $20,000-34,999 42.8 
Race/ethnicity            $35,000-49,999 37.0 
          White, non-Hispanic 35.5           ≥$50,000 28.8 
          Black, non-Hispanic 48.7 Employment status  
Sex            Employed 34.0 
          Men 37.8           Unemployed 43.4 
          Women 36.4           Homemaker 34.3 
Education            Retired 45.1 
          Less than high school 52.5           Unable to work 69.3 
          High school or equivalent 43.8   
          Some college 36.9   
          College graduate 25.9   
*Age-adjusted 
 (CDC, 2005) 
 
Low SES has been associated with higher HF incidence (He et al., 2001; Ingelsson, 
Lind, Arnlov, & Sundstrom, 2006; F. A. McAlister et al., 2004; Schaufelberger & 
Rosengren, 2007; S. Stewart et al., 2006).  In addition, there remain differences in HF 
morbidity and mortality which are unexplained by clinical features of the disease (Fonarow, 
2008), suggesting the need to explore other domains to understand the progression of HF.  
Identifying social and economic neighborhood forces which independently impact health 
would have important implications for the management and treatment of HF patients (Chaix 
et al., 2007; Stjarne et al., 2006).  It is likely that the neighborhood SES of an area determines 
the availability of health care resources in a community, such as the proximity of 
neighborhood health clinics.  Outpatient care in local health clinics is critical to the out-of-
hospital monitoring of HF patients, and if not available in low neighborhood SES areas, may 
adversely affect the prognosis of HF patients in that community (G. Lee & Carrington, 
2007).  It remains to be seen if living in a low neighborhood SES area imparts risk of poor 
HF prognosis above and beyond that influenced by individual SES and comorbid conditions.   
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B.  Heart Failure Progression 
The benefits of HF care, including pharmacologic therapies (Bohm, Maack, Wehrlen-
Grandjean, & Erdmann, 2003; Ferreira, Bettencourt, Cortez, Araujo, & M., 1997; 
Hjalmarson et al., 2000; Jamali, Tang, Khot, & Fowler, 2001; Packer et al., 1996; Packer et 
al., 2001; Pitt et al., 1999), diagnostic and invasive (Guru et al., 2007; Udell et al., 2007) 
procedures, likely extend to patients in the early stages of HF by treating risk factors and 
preventing or slowing progressive changes in heart structure and function.  The prescription 
of HF therapies such as angiotensin converting enzyme (ACE) inhibitors, beta (β)-blockers, 
diuretics and digoxin are supported by the AHA/ACC and European Society of Cardiology 
guidelines, as are certain diagnostic and invasive procedures (Hunt et al., 2001; Remme & 
Swedberg, 2002).  However, in the Initiation Management Predischarge process for 
Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) registry, in 30 US 
hospitals, 60-day death or rehospitalization exceeded 30%, despite the use of evidence-based 
therapies, such as ACE inhibitors, digoxin and β-blockers (O'Connor, Stough, Gallup, 
Hasselblad, & Gheorghiade, 2005).  Thus, there exists a need to exploe other factors which 
may influence the progression of HF, such as sociodemographic and SES variables.  
Mechanisms by which low SES may result in adverse health outcomes have been 
explored in the literature.  Lack of access to financial resources, for example, has been shown 
to decrease the ability of female diastolic HF patients to perform self-care practices, such as 
medication adherence and daily weighing, and increase their likelihood of negative clinical 
outcomes, including rehospitalization (Gary, 2006).  Meanwhile, higher education and HF 
symptom severity were positively correlated with self-care, and may influence medication 
adherence for comorbid conditions such as diabetes and hypertension (He et al., 2001; 
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Rockwell & Riegel, 2001).  Further research indicates that lacking a prescription benefit, 
having lower income, fewer assets and worse health status are associated with an inability to 
afford medications and may result in coping behaviors such as taking medication every other 
day instead of daily to make the prescription last longer (Saver, Doescher, Jackson, & 
Fishman, 2004).    
1. Rehospitalization 
HF accounts for 12 to 15 million physician visits and 6.5 million hospital days per year, 
and is the leading cause of hospitalization among patients 65 and older in the US (Goff, 
Pandey, Chan, Ortiz, & Nichaman, 2000; M. S. Nieminen & Harjola, 2005).  
Hospitalizations for HF in the US reached 1.1 million in 2004 (Rosamond et al., 2007), and 
National Hospital Discharge Survey (NHDS) data show that annual hospitalizations with HF 
listed as primary or secondary diagnoses are increasing over time (Blustein, Hanson, & Shea, 
1998; Haldeman et al., 1999) (Figure 3.2).  Fang et al. reported that hospitalizations with any 
mention of HF on NHDS records tripled from 1.3 to 3.9 million from 1979 to 2004 in the US 
(Fang et al., 2008).  It is estimated that more than 75% of the $10 billion spent to manage HF 
each year is used to cover the cost of hospitalization (Polanczyk, Newton, Dec, & Di Salvo, 
2001; Zannad, Adamopolous, Mebazaa, & Gheorghiade, 2006). 
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Figure 3.2. Prevalence of hospitalization of patients with heart failure in the US (per 
1,000 persons) as a principal (first-listed) or any listed diagnosis, by year and age group 
 
 (Haldeman et al., 1999) 
 
In a review of 31 research reports from 1986 to 2004, one-third of HF patients were 
rehospitalized three to six months after discharge (Anderson et al., 2006).  Rehospitalization 
rates are shown to be higher among older patients, non-Whites, and patients with prior 
hospitalizations and multiple primary care visits (Fang et al., 2008; Ghali et al., 1990; Inouye 
et al., 2008; Schocken et al., 2008).  Several studies have reported a combined endpoint of 
rehospitalization or mortality.  In those analyses, prevalence of rehospitalization or death at 
60 days was 31-35% (Felker et al., 2004; O'Connor et al., 2005), and 81% (Zannad et al., 
1999) at one year. 
Repeat hospitalizations following a diagnosis of HF are common, are due to a worsening 
of HF symptoms or other clinical comorbidities, and are a burden on the health care system 
(MedPAC, 2007).  A high number of repeat hospitalizations for HF and a short interval of 
time between subsequent hospital readmissions may be indicators of poor patient health and 
more severe disease.  High readmission rates may also be an indication of limited outpatient 
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treatment options in the community or the treatment received during a hospital admission not 
resulting in sustained, adequate out-of-hospital management of HF symptoms (Adams et al., 
2005; Cuffe et al., 2002; Krumholz et al., 1997). 
Hospital discharges for HF have increased 157% from 1979 to 2002 (Heart Disease and 
Stroke Statistics - 2005 Update, 2005), and many rehospitalizations for HF are likely 
preventable (MedPAC, 2007).  Repeat hospitalizations among patients with HF may account 
for the growing burden of hospitalized HF cases, with up to 40% of patients being readmitted 
within six months (Hoyt & Bowling, 2001).  Due to limited follow-up, extant research has 
not adequately described the burden of repeat hospitalizations among HF cases.       
 Studies conducted to date are rich in clinical data, however, they are limited by short-
term follow-up analyses of HF progression.  Longer follow-up is needed to adequately 
capture the rehospitalization experience for the majority of patients diagnosed with this 
chronic disease.  Since HF is a chronic disease, it is important to allow for adequate follow-
up in order to describe the clinical course of HF progression.  In addition, rehospitalization is 
often treated as a secondary aim in clinical trials or a composite endpoint with mortality.  
Rates of rehospitalization are measured in these studies as calculated from the time of 
randomization, not the date of the incident HF event.  Patients in clinical trials are also 
healthier than patients not enrolled in clinical trials, with fewer comorbidities.  As a result, 
60- to 90-day rehospitalization rates reported in these trials are likely an underestimate with 
respect to the general population of patients with HF. 
The proposed research is not limited to a clinical trial design, and will address the 
aforementioned limitations by describing the rehospitalization experience of HF patients 
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independent of mortality.  In addition, incident hospitalized HF will be a clearly delineated 
starting point from which patients will be followed over many years for repeat hospital 
admissions.  Further, HF patients will not be excluded from the analysis due to a high burden 
of comorbidity, rather, the extent of comorbidity will be considered during data analysis in 
order to make the findings generalizable to a broader population of HF patients.  
2. Mortality 
In addition to being recognized as a major cause of serious morbidity (Adams et al., 
2005; Cowie et al., 2002; H. Eriksson, 1995; Hoyt & Bowling, 2001), HF mortality is high 
(Jong et al., 2002; M. S. Nieminen & Harjola, 2005).  It is estimated that more than 300,000 
deaths are attributed to HF as a primary or contributory cause each year in the US, regardless 
of advances in treatment (Hunt et al., 2001).  HF mortality rates increase sharply with age.  In 
1995, HF mortality rates per 100,000 US population were 633.5 for persons aged greater than 
or equal to 85 years, 130.8 for persons aged 75-84 years, and 32.2 for persons aged 65-74 
years (Haldeman et al., 1999).  In a study of five-year mortality in Scotland, HF was 
associated with the poorest survival, with the exception of lung cancer, with which it shared a 
similar number of lost life-years (Simon Stewart et al., 2001).  
From 1980 to 1995, the number of deaths in the US with an underlying cause of HF 
increased nearly 70% (Haldeman et al., 1999).  While mortality rates for HF remain 
relatively high during in-hospital, 30-day, one-year and five-year periods, age-adjusted 
mortality rates appear to be declining slightly over time (John G. F. Cleland, Gemmell, 
Khand, & Boddy, 1999; Haldeman et al., 1999; MacIntyre et al., 2000; Roger et al., 2004).  
Jong et al. noted that 30-day and one-year mortality rates among unselected patients 
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hospitalized for incident HF were higher than those reported in clinical trials, except for the 
youngest patients with a low level of comorbidity (Jong et al., 2002).  As such, the decline 
witnessed in HF mortality tends to be more dramatic among patients in clinical trials 
compared to community trials, and in men compared to women (Roger et al., 2004; 
Schocken, Arrieta, Leaverton, & Ross, 1992). 
In-hospital HF mortality ranges from 3-18% (Adams et al., 2005; J.G.F Cleland et al., 
2003; Cowie et al., 2002; Gheorghiade et al., 2006; Khand, Gemmell, Rankin, & Cleland, 
2001; Markku S. Nieminen et al., 2006; M. S. Nieminen & Harjola, 2005; O'Connor et al., 
2005; Reitsma et al., 1997).  Meanwhile, 30-day mortality is approximately 20% (Cowie et 
al., 2002; MacIntyre et al., 2000), while one-year mortality ranges from 30-50% (Jong et al., 
2002; MacIntyre et al., 2000; Packer et al., 2001; S. Stewart et al., 2002) and five-year 
mortality often exceeds 50% - and has approached 80% (Gomberg-Maitland, Baran, & 
Fuster, 2001; Ho, Anderson, Kannel, Grossman, & Levy, 1993; MacIntyre et al., 2000; Owan 
et al., 2006; Shahar et al., 2004).  Previously published data from the Atherosclerosis Risk in 
Communities (ARIC) study (1987-2002), show that 30-day mortality among cohort members 
was 10%, while one- and five-year mortality was 22% and 42%, respectively (Loehr, 
Rosamond, Chang, Folsom, & Chambless, 2008). 
The definition of HF between studies differs considerably, whether based on HF signs 
and symptoms or diagnoses received in-hospital.  The varied definitions of HF would likely 
be reflected in different mortality outcome measurments.  It is also possible that the wide 
range of mortality estimates is due to an inconsistent measure of the timing of the incident 
HF event.  For example, while cohort studies are often able to calculate mortality from a first 
diagnosis of HF during a clinic visit or hospitalization, many registry-based or clinical trials 
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report mortality rates measured from the time of enrollment rather than the time of initial 
diagnosis.        
3. Self-rated Health 
SRH is thought to reflect both mental and physical health domains, and is assessed by 
asking individuals to objectively describe their health status on a four- to eight-point Likert 
scale (e.g., excellent, good, fair or poor)(Singh-Manoux et al., 2007).  Questions posed to 
study participants may refer to “general health status” or “health”, or may differ by whether 
or not they ask for SRH in comparison to others one’s age, yet different measures tend to 
produce similar responses (I. Eriksson, Unden, & Elofsson, 2001).  SRH responses are 
typically stable until age 50 (McCullough & Laurenceau, 2004), and decline with 
age(McFadden et al., 2008).  Researchers hypothesize that responders of younger ages tend 
to be relatively free of illness and disability, whereas during later years, lower SRH reflects 
an uncertainty or even pessimism regarding one’s health status, or lower SRH may even be a 
response to other major life events, such as retirement (McCullough & Laurenceau, 2004).  
McCullough and Laurenceau conducted a multilevel analysis of annual measures of SRH 
among 1,411 men and women aged 20-94 years in the Terman Life Cycle Study of Children 
with High Ability, and graphed the curvilinear natural history of SRH.  They found that men 
reported higher SRH compared to women prior to age 50, and that SRH declined steeply for 
both sexes after age 50 (McCullough & Laurenceau, 2004) (Figure 3.3). 
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Figure 3.3. Trajectory of SRH across adulthood: Terman Life Cycle Study of Children 
with High Ability, 1940-1999 
 
 (McCullough & Laurenceau, 2004) 
 
 
SRH has been found to be associated with adverse health outcomes, such as repeated 
hospitalizations (Kennedy, Kasl, & Vaccarino, 2001), and mortality (Wolinsky et al., 2008).  
Among adults aged 65 years and older, high self-efficacy and favorable perception of 
neighborhood conditions was associated with better SRH status (Bowling, Barber, Morris, & 
Ebrahim, 2006).  Kennedy et al. investigated the effect of a single baseline measurement of 
SRH on future hospitalizations, and found that a good SRH was associated with a decreased 
risk of a first HF hospitalization as well as first and second hospitalizations for any cause 
(Kennedy et al., 2001).  Additionally, Diehr and colleagues found that SRH declined 
gradually among participants in the Cardiovascular Health Study, who had a mean age of 73 
at baseline, until a year before death, and then droped sharply (P. Diehr, Williamson, Patrick, 
Bild, & Burke, 2001).  Thus, it is hypothesized that a report of poor SRH may be able to 
predict adverse health outcomes. 
Many studies have investigated factors associated with current SRH (Daponte-Codina et 
al., 2008; McFadden et al., 2008; Wight et al., 2008) or a change in SRH from baseline 
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(Wolinsky et al., 2008), yet few studies have reported the trajectory of repeated measures of 
SRH across some specified time period in order to describe the progression of disease (P. 
Diehr et al., 2001).  Studies by Wight et al., McFadden et al. and Daponte-Condina et al. 
dichotomized SRH into fair or poor (vs. good or excellent), poor or moderate (vs. good or 
excellent) and less than good (vs. good) health, respectively (Daponte-Codina et al., 2008; 
McFadden et al., 2008; Wight et al., 2008).  The analytic technique of collapsing the SRH 
categories is likely to obscure important differences between persons with excellent 
compared to good, and fair compared to poor health.       
 Meanwhile, Wolinsky et al. (Wolinsky et al., 2008) reported on changes in SRH among 
African Americans over a four-year period.  Participants were classified into one of three 
categories: improved, declined and no change in SRH since baseline.  Participants with HF at 
baseline were more likely to report improved SRH, compared with no change in SRH, over 
the four years of follow-up (Wolinsky et al., 2008).  However, Wolinsky et al. censored 
participants from the analysis upon their death, so while participants with HF were more 
likely to improve their SRH status, they may have also been more likely to die during follow-
up, thus biasing the results with responses from healthy survivors (Wolinsky et al., 2008). 
C. Socioeconomic Status 
Mechanisms by which low SES may result in adverse health outcomes have been 
explored in the literature.  Lack of access to financial resources, for example, has been shown 
to decrease the ability of female diastolic HF patients to perform self-care practices, such as 
checking and recording blood pressure and pulse information each day, and increase their 
likelihood of negative clinical outcomes, including rehospitalization (Gary, 2006).  
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Meanwhile, education and HF symptom severity were positively correlated with self-care, 
and may influence medication adherence for comorbid conditions such as diabetes and 
hypertension (He et al., 2001; Rockwell & Riegel, 2001).  Further research indicates that 
lacking a prescription benefit, having lower income, fewer assets and worse health status are 
associated with an inability to afford medications and may result in coping behaviors such as 
taking medication every other day instead of daily to make the prescription last longer (Saver 
et al., 2004).  
1. Neighborhood Socioeconomic Status  
Health outcomes among persons living in low neighborhood SES areas are often 
compared to persons living in high neighborhood SES areas.  Low neighborhood SES, also 
referred to as high socioeconomic deprivation in the literature, is commonly associated with 
poor health outcomes.  Specifically, living in socioeconomically disadvantaged 
neighborhoods has been shown to increase the risk of MI as well as the prevalence of and 
mortality due to CHD (Stjarne et al., 2006).  Chaix et al. (2007) found neighborhood SES to 
be inversely associated with the incidence of and mortality from IHD, after controlling for 
individual socioeconomic factors (Chaix et al., 2007).  To date, few studies have 
incorporated measures of neighborhood SES in their analyses of HF outcomes. 
Neighborhood SES is characterized by indicators of the economic resources available in 
the community, and is helpful for monitoring socioeconomic disparities in health.  It may be 
defined by criteria such as the average income or educational attainment of the neighborhood 
residents, or by the percent of owner-occupied housing in the community.  For example, 
median household income of all residents in a geographically defined neighborhood may be 
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used to represent the amount of collective economic resources for that area (Stjarne et al., 
2006).   
An alternative viewpoint among researchers regarding the utility of neighborhood SES 
for monitoring socioeconomic disparities is one of convenience.  Many researchers who 
utilize measures of neighborhood SES do so because they do not have access to measures of 
individual SES.  For example, patient address data are commonly available from the medical 
record, while individual SES measures (e.g., education, income and occupation) are not.  In 
the current work, measures of neighborhood SES are not intended to be proxies of individual 
SES.  The economic environment of the neighborhood directly and indirectly impacts health 
via social networks, access to care and to what extent the culture of the neighborhood fosters 
health promoting behaviors.  While neighborhood SES and individual SES may be related in 
terms of the neighborhood an individual can afford to live in, for example, the location or 
structure of the neighborhood may benefit or impede its residents with regard to accessing 
preventive care, healthy foods or recreation regardless of their level of individual SES.      
2. Neighborhood Socioeconomic Status and Heart Failure Progression 
Low SES is associated with higher HF incidence (He et al., 2001; Ingelsson et al., 2006; 
F. A. McAlister et al., 2004; Schaufelberger & Rosengren, 2007; S. Stewart et al., 2006), 
rehospitalization and survival (Philbin, Dec, Jenkins, & DiSalvo, 2001; Rathore et al., 2006; 
S. Stewart et al., 2002; Simon Stewart et al., 2001; Wen & Christakis, 2005).  Researchers 
have found that neighborhood SES has an effect on a patient’s health independent of 
individual SES (Pickett & Pearl, 2001; Robert, 1999; Yen & Kaplan, 1999).  Social 
environment characteristics, such as those imparted by neighborhood SES, have been shown 
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to be associated with all-cause mortality after adjustment for individual socioeconomic and 
demographic factors (Yen & Kaplan, 1999).  The independent influence of neighborhoods 
may be due to issues of access to care, structural social support, and the built environment.  
Others suggest the influence of neighborhood SES on health is determined by material and 
infrastructure resources available in the community which serves to strengthen the effects of 
social stratification (Chaix et al., 2007; Stjarne et al., 2006).    
The influence of social neighborhood context on the progression of HF is one domain 
that has been understudied.  Evidence suggests that social and environmental contexts play 
an important role in health outcomes (Nancy Krieger et al., 2002; Marmot, 2003).  However, 
low individual SES is also associated with poor health outcomes when neighborhood SES is 
not taken into account.  For example, less than 12 years of education, a marker of low 
individual SES, was found to be associated with a higher burden of CVD and related risk 
factors (Mensah, Mokdad, Ford, Greenlund, & Croft, 2005) and an increased number of 
hospitalizations among ambulatory HF patients (Sui, Gheorghiade, Zannad, Young, & 
Ahmed, 2007).  An additional study in Japan found the odds of rehospitalization increased 
among patients with no occupation and poor follow-up care (Tsuchihashi et al., 2001).  To 
date, the influence of neighborhood socioeconomic factors on HF progression have not been 
assessed in the context of both individual SES and demographic factors. 
i. Neighborhood Socioeconomic Status and Rehospitalization 
Blair (2002) reviewed eight published manuscripts on the relationship between area-
level measures of social deprivation and rehospitalization rates for HF.  It was concluded that 
hospital admission rates increase with increased social deprivation (Blair, Lloyd-Williams, & 
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Mair, 2002).  McAlister (2004) reported follow-up rates with primary care physicians were 
lowest among patients of high socioeconomic deprivation, as measured at the neighborhood 
level (F. A. McAlister et al., 2004).  Fewer primary care visits may be an indication for 
higher hospital utilization rates among patients of low neighborhood SES.   
Neighborhood SES may affect susceptibility to readmission among patients with HF 
(Pickett & Pearl, 2001; Robert, 1999; Yen & Kaplan, 1999).  Higher rates of hospital 
readmission have been observed among socially deprived groups (Antonelli-Incalzi et al., 
2007; Blair et al., 2002; F. A. McAlister et al., 2004; Philbin et al., 2001; Rathore et al., 
2006; Wen & Christakis, 2005).  In contrast, high neighborhood SES patients have a lower 
frequency of rehospitalization and a higher likelihood of survival after an incident 
hospitalization, after adjusting for other patient characteristics (Philbin et al., 2001; Rathore 
et al., 2006; S. Stewart et al., 2002; Simon Stewart et al., 2001; Wen & Christakis, 2005).    
The influence of the neighborhood context on a variety of CHD outcomes has been 
demonstrated in previous neighborhood SES research conducted in ARIC community 
surveillance (Foraker et al., 2008; K. M. Rose et al., 2007).  Public health interventions on a 
neighborhood scale have the potential of reaching a large number of patients in need.  For 
example, if neighborhood of residence is shown to play a role in the patterns of 
rehospitalizations among HF patients, community-level interventions, such as providing 
transportation to local health clinics or mobile health units for the monitoring of HF patients 
can be employed.    
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ii. Neighborhood Socioeconomic Status and Mortality 
In a nationwide US study of all-cause and cause-specific mortality, Jemal et al. (2008) 
estimated that 48% of deaths among men and 38% of deaths among women aged 25-64 years 
would not have occurred if all adults, regardless of educational attainment, had experienced 
the death rates of college graduates (Jemal et al., 2008).  In the literature, the association 
between SES and HF mortality is inconsistent, and there exist a paucity of data regarding 
estimates of mortality arising from an incident HF diagnosis.  In a review of eight clinical 
studies, lower SES was associated with increased mortality among HF patients (Blair et al., 
2002).  In particular, one-year mortality due to CHD is associated with neighborhood-level 
SES.  Winkleby et al. (2007) found an increased likelihood of one-year CHD mortality 
among 130,024 women and men in Sweden living in low neighborhood SES compared to 
high neighborhood SES areas (Winkleby, Sundquist, & Cubbin, 2007).  This relationship 
remained significant after controlling for age, marital status, family income, educational 
attainment, immigration status, time lived in neighborhood, and urban/rural status (Winkleby, 
Sundquist, & Cubbin, 2007). 
Meanwhile, in a registry of 12,220 incident HF cases in the United Kingdom, 30-day, 
one-year and five-year survival were not influenced by neighborhood SES, as measured by 
quintiles at the postcode level (Blackledge, Newton, & Squire, 2003).  In a smaller study 
conducted in London, neighborhood SES, as measured by the Jarman index at the postcode 
level, was not found to be associated with one-year mortality (Cowie et al., 2002).   While 
the aforementioned studies have reported an inverse association between neighborhood-level 
SES and mortality, these studies from the United Kingdom have not.  The disparate findings 
may have to do with the level of aggregation of neighborhood-level SES provided by the 
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postcode.  For example, in the United Kingdom, the postcode is unique to 15 or 20 
households (Danesh et al., 1999) and is conceptualized as a useful marker of individual SES 
since it applies to so few households.  Thus, the interpretation of neighborhood-level effects 
while using postcode as the level of aggregation may not be valid. 
In a study of 10,557 Medicare beneficiaries in Chicago (1993-1999), higher SES was 
associated with longer survival post-hospitalization for five clinical conditions (Wen & 
Christakis, 2005).  Wen and colleagues reported a statistical interaction between 
neighborhood SES (zip-code level data) and individual SES (poverty status), indicating that 
high neighborhood SES particularly benefited patients with high individual SES, especially 
among MI patients (Wen & Christakis, 2005).  With regard to individual SES, Brazilian HF 
patients receiving public health system (vs. private insurance) care experienced greater 
mortality (de Campos Lopes, Yamada, Araujo, Pereira Barreto, & Mansur, 2006).  In 
addition, individual SES, as measured by educational attainment and financial distress, was 
significantly associated with all-cause mortality and the endpoint of death or 
rehospitalization in the Studies of Left Ventricular Dysfunction trial (Dries et al., 1999).  
Similar to studies of rehospitalization, studies of the neighborhood SES-HF association 
typically do not include measures of individual SES, precluding inferences regarding the 
robustness in predictive power of neighborhood SES and its associated constructs.   
An additional consideration in the study of HF mortality is that combining new-onset 
and worsening HF in order to assess mortality serves to confound the effects of new versus 
recurrent disease on mortality (Rudiger et al., 2005).  The existing literature not only lacks 
consistency regarding an adequate quantification of incident HF and related mortality rates, 
but many studies are also constrained by short follow-up time. 
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iii. Neighborhood Socioeconomic Status and Self-rated Health 
Cross-sectional analyses among elderly persons consistently demonstrate that living in 
disadvantaged neighborhoods, having low education and low household wealth increase the 
odds of reporting poor health (Daponte-Codina et al., 2008; Kunst et al., 2005; Power, 
Rodgers, & Hope, 1998; Wight et al., 2008).  In a study of the relation between 
neighborhood SES (percent of residents living below poverty) and SRH among rural women 
without a history of breast cancer in North Carolina, individual SES (family income) was 
found to be an effect measure modifier (Kobetz, Daniel, & Earp, 2003).  As a result, women 
from high-poverty neighborhoods experienced 35% greater odds of low SRH compared to 
women from low-poverty neighborhoods, and within low-poverty neighborhoods, low-
income women had 40% higher odds of low SRH than high-income women.  In other 
studies, the association between neighborhood SES and SRH appears to persist after taking 
individual SES into account (Wight et al., 2008). 
Proposed mechanisms of the neighborhood SES-SRH relationship include an increase in 
allostatic load due to the stressors of low SES, and few resources available to persons from 
low neighborhood SES areas in order to deal with such stress (Wight et al., 2008).  Few 
studies utilize longitudinal data to explore changes in SRH (Paula Diehr, Johnson, Patrick, & 
Psaty, 2005; Paula Diehr & Patrick, 2003; P. Diehr et al., 2001), and no research has been 
done to date to quantify the trajectory of repeated measures of SRH among HF patients by 
neighborhood SES.  Information regarding SRH trajectories that differ by SES may be used 
to develop interventions which prevent the loss of well-being associated with an incident 
diagnosis of HF and which may delay subsequent adverse health events, such as 
rehospitalizations or mortality.     
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3. Medicaid Status 
Medicaid enrollment is often used as a surrogate for low individual SES in studies of 
hospital claims data (Croft et al., 1999).  A study of Medicaid recipients from four US states 
(Arkansas, California, Indiana and New Jersey) indicated that Medicaid enrollees are most 
likely to be aged 64 years or less, white and female (Esposito, Bagchi, Verdier, Bencio, & 
Kim, 2009).  However, in a US-wide review of 1.2 million hospital Medicare claims for HF 
in 1986, black patients were three times as likely as whites, and females twice as likely as 
males, to be eligible for Medicaid (Croft et al., 1999).  Thus, the demographic distribution of 
Medicaid recipients differ by region.  
Health insurance status may be associated with care-seeking behavior (Philbin & 
DiSalvo, 1999) and subsequent disease outcomes (Ayanian et al., 1993).  Medicaid, in 
particular, may exert effects on health outcomes which are independent of neighborhood-
level SES (Foraker et al., 2008; Ross & Mirowsky, 2000), as its receipt is determined by 
having certain diseases and disabilities or an income below the poverty line (Ku, 2005; 
Rosenbaum, 2002).  Thus, in in the absence of other individual-level SES information, 
Medicaid coverage is a reasonable surrogate for low SES.  
 The Center for Medicaid and Medicare Services has targeted HF for cost-saving 
measures, as HF is the most common cause of hospitalization among older US adults 
(Mehrotra, McNeil, & Landon, 2007).  During the last decade, chronic disease management 
programs have addressed patient self-care and provider guideline adherence in order to keep 
HF patients out of the hospital and to reduce health care costs for both HF and diabetes (Katz 
et al., 2009; Mehrotra et al., 2007).  One such chronic disease management program 
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implemented in Indiana resulted in a decrease in claims paid for Medicaid recipients with HF 
(Katz et al., 2009).  Based on a survey of 120 health plans following a mandate for chronic 
disease management programs, the authors concluded that the success of such programs to 
decrease health care costs among HF patients depends upon the engagement of health care 
providers in guideline-based care (Mehrotra et al., 2007).    
4. Medicaid Status and Heart Failure Progression 
Evidence suggests that social and environmental contexts play an important role in 
health outcomes (Ana V Diez Roux, Borrell, Haan, Jackson, & Schultz, 2004; Nancy Krieger 
et al., 2002; Marmot, 2003).  Although health insurance is one facet of the social context, 
research to date has not assessed the influence of Medicaid enrollment on the risk of 
rehospitalization or mortality among HF patients in the context of individual socioeconomic, 
demographic and comorbid factors.    
i. Medicaid Status and Rehospitalization 
Compared to patients hospitalized for HF with other types of insurance coverage, 
Medicaid patients experienced the longest length of stay, greatest amount of hospital charges 
and the highest readmission rate for HF in New York state in 1995 (Philbin & DiSalvo, 
1998).  An additional finding in this study was that discharge code 428 was found in the 
principal diagnosis position for 87% of all patients, and the presence of this code was equally 
common among insurance groups (Philbin & DiSalvo, 1998).  Therefore, there does not 
appear to be a discharge code usage preference by insurance type in capturing HF as the 
reason for hospital admission. 
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Meanwhile, medication adherence appears to influence readmission rates among 
Medicaid recipients.  In a study of Medicaid beneficiaries with HF from four US states, 
nearly 30% of Medicaid beneficiaries from four states had coexisting coronary artery disease 
or diabetes, and those who were adherent to HF medications experienced fewer 
hospitalizations and were less likely to visit the emergency department compared to those 
who were nonadherent (Esposito et al., 2009).    
ii. Medicaid Status and Mortality 
In a study of managed care patients hospitalized for HF in New York state in 1995, 
Medicaid patients did not experience an increased risk of mortality during the index HF 
hospitalization compared to patients with other types of insurance coverage (Philbin & 
DiSalvo, 1998).  Similar findings of no difference in in-hospital mortality rates among 
Medicaid recipients were reported from a study of managed care in Oregon during the same 
year (Ni, Nauman, & Hershberger, 1998).  Meanwhile, a paucity of data exists which takes 
into account a longer period of follow-up to determine if Medicaid enrollees experience an 
increased risk of mortality post-discharge. 
Differences in the rates of rehospitalization or death among Medicaid recipients may 
exist by race and comorbidity burden.  Croft and colleagues (1999) identified 170,239 
Medicare patients who were hospitalized for HF after being free of HF during the previous 
two years.  An increased six-year risk of death was seen among black, but not white, 
Medicaid enrollees (Croft et al., 1999).  In addition, HF patients with comorbid diabetes had 
a higher risk of death compared to patients without diabetes listed as a concurrent condition 
during the index hospitalized HF event (Croft et al., 1999). 
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5. Potential Role of Comorbid Conditions 
Chronic comorbid conditions likely play an important role in the pathophysiology and 
progression of HF.  For example, chronic kidney disease (CKD) manifests in elevated or 
worsening blood pressure, which may in turn reduce cardiac output due to vascular 
restriction.  CKD may also create an excess of fluid due to reduced excretion (i.e., preload) 
resulting in cardiac remodeling (Kottgen et al., 2007).  In turn, hypertension is a risk factor 
for Stage A HF according to the AHA/ACC guidelines (Figure 3.1), and cardiac adaptations 
to volume overload allow for preclinical progression through Stage B to the clinical 
symptoms of stages C and D. 
It is estimated that CHD is the most common cause of left ventricular systolic 
dysfunction (LVSD) leading to HF in industrialized societies (John G F Cleland, John, 
Dhawan, & Clark, 2001; Hunt et al., 2001), and Cowie et al. (2002) found that patients 
developing HF in the context of MI had a worse prognosis compared to patients with other 
etiologies (Cowie et al., 2002).  A two- to four-fold increase in in-hospital mortality has been 
shown in patients with HF occurring after acute MI (Weir et al., 2006), and both 30-day and 
one-year mortality following a first HF diagnosis increases in the highest comorbidity-laden 
groups (Jong et al., 2002; Simon Stewart et al., 2001). 
Research from the Acute Decompensated Heart Failure National Registry (ADHERE) 
reported 21% of patients had serum creatinine levels greater than 2 mg/dL(Adams et al., 
2005).  Worsening renal failure is associated with poor HF outcomes.  A commonly utilized 
measure of kidney function, glomerular filtration rate (GFR), is estimated using a patient’s 
serum creatinine level.  In the literature, there exists an inverse association between GFR and 
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mortality (Hillege et al., 2000; Jong et al., 2002; Smith et al., 2005).  The ADHERE has 
identified creatinine level as a strong predictor of in-hospital mortality among HF patients 
(Marie Galvao et al., 2006), and Heywood et al. (2007) hypothesize that GFR is more 
predictive of mortality than LVSD in patients with HF (Heywood et al., 2007).  Anderson et 
al. (2006), in a review of 31 research articles of HF readmission, concluded that conditions 
such as diabetes and renal failure may rapidly advance HF and contribute to more severe 
disease (Anderson et al., 2006; Go et al., 2006; Khand et al., 2001; Remme & Swedberg, 
2002).       
 ACC/AHA guidelines suggest that the evaluation and management of comorbid disease, 
such as diabetes and kidney disease, in HF patients may be as critical as the treatment of HF 
itself (Hunt et al., 2001).  Although comorbid conditions appear to be important in the 
progression of HF, many studies omit the study of selected comorbidities (Blackledge et al., 
2003; B. H. Greenberg et al., 2007) or patients with significant comorbidity from analyses 
entirely (Felker et al., 2004; Heywood et al., 2007; Rathore et al., 2006). 
Comorbid conditions are important to consider in the context of HF progression.  
Multiple or severe comorbidity may lead to increased rehospitalization, higher mortality or 
an accelerated decline in SRH, especially in the context of low neighborhood SES.  Overall, 
neighborhood-level SES has been found to be negatively associated with the metabolic 
syndrome (Ana V. Diez Roux, Jacobs, & Kiefe, 2002) and diabetes (Barker, Gardner, & 
Power, 1982; Green, Hoppa, Young, & Blanchard, 2003), as well as CHD (Ana V. Diez-
Roux et al., 2001; Diez-Roux et al., 1997) and obesity (Boardman, Saint Onge, Rogers, & 
Denney, 2005).  For the aforementioned conditions, low neighborhood SES remained 
statistically significantly associated with an increase in negative health outcomes, even with 
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statistical adjustment for individual SES (Daniel, Moore, & Kestens, 2008).  The proposed 
mechanisms allowing neighborhood SES to influence the development of cardiometabolic 
diseases include maladaptive biologic responses to, and the conscious perception of, chronic 
and acute stressors (Daniel et al., 2008). 
According to published research, it is likely that patients of low neighborhood SES carry 
a higher burden of comorbidity than patients of high neighborhood SES.  Since a higher 
burden of comorbidity is more common among patients of low SES (Antonelli-Incalzi et al., 
2007), it is possible that HF patients of low neighborhood SES with a high level of 
comorbidity, for example, are at greater risk of mortality within one year compared to HF 
patients of low SES with a low level of comorbidity.  Patients of low neighborhood SES 
often do not have the neighborhood structural resources (e.g., decreased proximity to local 
health clinics, pharmacies or access to transportation) or adequate social support (e.g., reside 
alone, are of older age, do not live among neighbors of high health literacy) to obtain 
adequate out-of-hospital management of their comorbidities.  
 Results from studies based on highly selected patient groups cannot speak to the breadth 
of the burden of HF, and may be underestimating both rehospitalization and mortality rates 
while only capturing the quality of life/SRH experience of the healthiest patients.  As a 
result, registry studies and clinical trials which exclude patients with a high burden of 
comorbidity may be omitting a segment of the HF population who would benefit most from 
public health intervention.   
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i. Charlson Index of Comorbidity 
The Charlson index of comorbidity (Table 3.2) has been validated and is used to 
quantify the burden of comorbidity in several studies of mortality and adverse health 
outcomes (Charlson, Pompei, Ales, & MacKenzie, 1987).  In its use with HF outcomes, a 
“modified” Charlson index excludes chronic heart failure from the conditions used to 
compute the comorbidity score (Senni et al., 2006).  Overall, mortality (Charlson et al., 1987; 
Deyo, Cherkin, & Ciol, 1992; Jong et al., 2002) and rehospitalization (Philbin & DiSalvo, 
1999) increases with increasing comorbidity index values.  However, when applied to 
Medicare data in Arkansas, the comorbidity index did not predict short-term mortality as well 
as it predicted long-term mortality (Cleves, Sanchez, & Draheim, 1997).  The Charlson-Deyo 
index of comorbidity applied International Classification of Diseases, Version 9, Clinical 
Modification (ICD-9-CM) codes to the components of the Charlson index (Deyo et al., 
1992).  Utilizing a scale of zero, one, two or three or more for the Charlson index, Charlson 
et al. (1987) concluded that each stepwise increase in the comorbidity index added a similar 
magnitude of mortality risk as did a decade increase in age (Charlson et al., 1987).   
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Table 3.2. Charlson comorbidity index, associated discharge codes and point values 
Comorbidity category ICD-9-CM Description Value 
Myocardial Infarction 410-410.9 
412 
Acute myocardial infarction 
Old myocardial infarction 
1 
Peripheral Vascular 
Disease 
443.9 
441-441.9 
785.4 
V43.4 
38.48 
Peripheral vascular disease, intermittent claudication 
Aortic aneurysm 
Gangrene 
Blood vessel replaced by prosthesis 
Resection and replacement of lower limb arteries 
1 
Cerebrovascular Disease 430-438 Cerebrovascular disease 1 
Dementia 290-290.9 Senile dementia 
Presenile dementia 
1 
Chronic Pulmonary 
Disease 
490-496 
500-505 
506.4 
Chronic obstructive pulmonary disease 
Pneumoconioses 
Chronic respiratory conditions due to fumes and 
vapors 
1 
Rheumatologic disease 710.0 
710.1 
710.4 
714.0-2 
714.81 
725 
Systemic lupus erythematosus 
Systemic sclerosis 
Polymyositis 
Adult rheumatoid arthritis 
Rheumatoid lung 
Polymyalgia rheumatica 
1 
Mild Liver Disease 571.2 
571.5 
571.6 
571.40-49 
Alcoholic cirrhosis 
Cirrhosis without mention of alcohol 
Biliary cirrhosis 
Chronic hepatitis 
1 
Diabetes 250-250.3 
250.7 
Diabetes with or without acute metabolic disturbances 
Diabetes with peripheral circulatory disorders 
1 
Moderate or Severe Liver 
Disease 
572.572.8 
 
Hepatic coma, portal hypertension, other sequelae of 
chronic liver disease, esophageal varices 
3 
Diabetes with Chronic 
Complications 
250.4-250.6 Diabetes with renal, ophthalmic or neurological 
manifestations 
2 
Hemiplegia or Paraplegia 344.1 
342-342.9 
Paraplegia 
Hemiplegia 
2 
Renal Disease 582-582.9 
583-583.7 
585 
586 
588-588.9 
Chronic glomerulonephritis 
Nephritis and nephropathy 
Chronic renal failure 
Renal failure, unspecified 
Disorders resulting from impaired renal function 
2 
 (Charlson et al., 1987; Deyo et al., 1992) 
 
 
Diabetes, a factor in the Charlson comorbidity index, has been shown to increase in-
hospital, one-year and five-year mortality and all-cause rehospitalization within 60- and 90-
days (B. Greenberg et al., 2006; Ho et al., 1993).  Diseases comorbid with HF which are 
captured in the Charlson index of comorbidity, such as diabetes, may modify the 
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neighborhood SES-HF progression relationship.  For example, if a patient from a low 
neighborhood SES area also has diabetes, the pathophysiologic consequences of diabetes 
may lead to more severe disease and a higher likelihood of HF morbidity and mortality 
compared to patients from low neighborhood SES areas without diabetes, especially 
considering the importance of having the resources to manage a chronic disease.  Suggested 
mechanisms of this process may include a susceptibility among diabetics to obesity, 
endothelial dysfunction and LVH (Schocken et al., 2008).    
As discussed previously, it is a common practice to exclude patients with selected 
comorbidities from study, as patients with certain comorbidities may be at greater risk of 
poor health outcomes.  However, since HF is a chronic disease which is often accompanied 
by comorbid conditions, it is possible that the presence or absence of comorbid disease may 
affect HF progression.  In addition, it remains unknown whether patients of low 
neighborhood SES who carry a higher burden of comorbidity fare worse compared to 
patients of low neighborhood SES who carry a relatively lower burden of comorbidity.  The 
investigation of possible effect measure modification of the neighborhood SES-HF 
progression relationship by comorbidity score does not yet exist in the literature.  If it is the 
case that the Charlson index comorbidity score modifies the neighborhood SES-HF 
progression relationship, public health interventions to prevent adverse HF outcomes can be 
further targeted to patients of selected neighborhood SES and comorbidity strata.    
ii. Hypertension 
A series of NHANES reports document hypertension as an independent risk factor for 
the development of HF (He et al., 2001), and there is additional evidence that the prevalence 
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of hypertension among HF patients is increasing over time (Owan et al., 2006).  Systemic or 
pulmonary hypertension can cause cardiac dysfunction due to increased afterload (Schocken 
et al., 2008).  Although hypertension is believed to contribute to ventricular remodeling and 
the clinical onset of HF, there is a discrepancy in the literature between hypertension as a risk 
factor for incident HF as compared to HF survival. 
In the Organized Program to Initiate Life-saving Treatment In Hospitalized Patients with 
Heart Failure (OPTIMIZED-HF), patients with lower systolic blood pressure (SBP) upon 
admission experienced higher in-hospital and 30- to 90-day post-discharge mortality rates 
(Gheorghiade et al., 2006).  Similarly, in a multicenter study of predictors of post-
hospitalization mortality (the Finnish Acute Heart Failure Study), three-month, six-month 
and one-year all-cause mortality decreased with each ten mmHg increase in SBP measured at 
hospital admission (Siirila-Waris et al., 2006).  
Mosterd and Hoes (2007) acknowledge the protective effect of hypertension in their 
review of the clinical epidemiology of HF, and propose that the unexpected finding may be 
due to hypotension, or “pump failure”, being more unfavorable with respect to HF survival 
compared to hypertension (Mosterd & Hoes, 2007).  It is also possible that the better short-
term survival seen among patients with higher SBP upon hospital admission is a result of 
survivor bias.  For example, patients who do not have a life-sustaining SBP may not arrive to 
the hospital in time to be treated, whereas patients with high SBP may be more likely to be 
admitted to the hospital alive and receive timely treatment due to their elevated SBP. 
Furthermore, in studies of HF, blood pressure data may be limited to that which is 
collected at the time of hospital admission.  It is possible that the SBP reading recorded in the 
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medical record upon admission is not representative of the patients’ typical hypertensive 
status.  Nevertheless, as a result of these apparently conflicting data, an investigation into 
hypertension as an effect measure modifier of the neighborhood SES-HF progression 
relationship is warranted. 
iii. Overweight and Obesity 
Overweight and obesity are well-recognized risk factors for the development of HF (He 
et al., 2001; Loehr et al., 2008; Loehr et al., 2009; Schocken et al., 2008), however, the 
existence of overweight/obesity can obscure HF symptoms and may lead to inaccuracies in 
diagnosing HF (Swedberg et al., 2005).  Nonetheless, the physiologic basis for the 
relationship between overweight/obesity and incident HF is well-defined, and involves an 
accelerated atherosclerotic process, increased inflammatory response and a predisposition to 
other chronic diseases (e.g., hypertension, diabetes) which may lead to or exacerbate existing 
HF (Fonarow, Heywood, Heidenreich, Lopatin, & Yancy, 2007). 
Regardless of the suggested pathology linking overweight/obesity with incident HF, in 
the ADHERE, higher body mass index (BMI) was associated with lower risk of in-hospital 
and long-term mortality, adjusting for other clinical variables (G. C. Fonarow, J. T. Heywood 
et al., 2007).  The seemingly protective effect overweight/obesity has on HF survival has 
been termed the “obesity paradox”.  In addition to the finding that hypertension benefits HF 
survival, obesity may also be protective in the study of HF survival (Mosterd & Hoes, 2007).  
These findings suggest that patients with cardiac cachexia, a disease process in which HF 
patients lose significant non-edematous body mass, are not robust to cardiac events (von 
Haehling, Lainscak, Springer, & Anker), while patients with excess body weight are not 
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succeptible to this process.  As with comorbid hypertension, no research to date has explored 
if comorbid obesity modifies the relationship between neighborhood SES and HF 
progression.     
D.  Conclusion 
As the US population ages, HF will likely continue to be an increasing burden on the 
individual patient as well as the health care system.  The proposed research aims to 
investigate HF progression in three areas: (1) rehospitalization; (2) mortality and (3) SRH.  
Specifically of interest is the association between neighborhood SES and HF progression.  A 
conceptual model of the relationship between neighborhood SES and HF progression is 
shown in Figure 3.4.   
Demographic characteristics of the patient (age, race / study community and gender) are 
shown to influence: neighborhood SES, individual SES, presence of clinical comorbidities, 
health behaviors and HF progression (Figure 3.4).  Demographic characteristics will be 
considered in these analyses, but are not the focus of the research, as these factors are not 
modifiable.  Meanwhile, neighborhood SES is shown to influence individual SES, perhaps 
via educational and occupational opportunities available in the neighborhood, as well as HF 
progression (Figure 3.4).  Individual SES is shown to also be associated with neighborhood 
SES, as individual-level income, for example, may affect the neighborhood in which one can 
afford to buy or rent a home. 
Both neighborhood SES and HF progression are shown to have a reciprocal association 
with clinical comorbidities and health behaviors, such as hypertension and smoking.  Clinical 
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comorbidities are not only influenced by ones neighborhood of residence, for example, by 
the accessibility of healthy foods (Borrell, Diez-Roux, Rose, Catellier, & Clark, 2004), but 
also may influence whether a person is healthy enough to be employed and can afford to live 
in a higher SES area (Figure 3.4).  In addition, there exists evidence that not only can clinical 
comorbidities exacerbate HF progression, but HF progression may also intensify the severity 
of clinical comorbidities.  
Of particular interest to the current research is the concept of the mechanism of 
neighborhood SES operating differently on the progression of HF – characterized by 
rehospitalization, mortality and SRH – among patients with a higher burden of comorbidity.  
Thus, understanding the role of clinical and social factors in the context of increasing 
hospitalizations, high mortality rates and declining SRH may help clinicians more optimally 
treat and manage HF patients and assist public health professionals, communities (O'Dwyer 
et al., 2007) and organizations to improve prevention efforts and access to care among 
patients of all levels of neighborhood SES. 
Successful interventions to date which have reduced mortality and rehospitalization rates 
have been multidisciplinary and have included educational modules directed by nurses and 
other healthcare providers (Hoskins, Walton-Moss, Clark, Schroeder, & Thiel, 1999; Finlay 
A. McAlister et al., 2004; McDonald et al., 2001; O'Connell, Crawford, & Abrams, 2001; 
Rich et al., 1995).  In a meta-analysis of eight randomized trials, Gwardry-Sridhar (2004) and 
colleagues found that educational interventions emphasizing medication compliance and 
lifestyle changes were effective at reducing both mortality and rehospitalization rates, yet 
acknowledged that existing studies did not provide sufficient follow-up time to quantify the 
long-term effects of the interventions (Gwadry-Sridhar, Flintoft, Lee, Lee, & Guyatt, 2004).  
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An additional study of 29 randomized trials concluded that patient self-care, follow-up care 
and access to specialty HF clinics yielded short-term mortality and rehospitalization benefits, 
but the long-term benefits of such programs remain unknown (Finlay A. McAlister et al., 
2004).  Moreover, the effects of healthcare interventions may only have benefits in select 
patient groups.  For example, in analyses of ADHERE data (M. Galvao & ADHERE 
Scientific Advisory Committee (SAC) Investigators, 2005; Marie Galvao et al., 2006), 
researchers found that while male and female patients had similar in-hospital mortality rates, 
female patients did not receive the same discharge instructions as men, which may impact 
longer-term rehospitalization and mortality rates. 
Future research, as a response to the current work, may include an assessment of 
prevention programs and interventions targeted at select neighborhoods based on the 
neighborhood SES of the area.  No published data are available which address whether the 
neighborhood SES - HF progression relationship differs between patients with and without a 
high comorbidity burden.  If differences in the neighborhood SES - HF progression 
relationship exist by presence or absence of other chronic diseases, public health 
professionals may be able to further tailor their prevention messages and interventions to 
reach the segments of the population at greatest risk of the negative consequences of HF.  If 
certain neighborhoods or patients receiving Medicaid are limited by poor health care quality 
and access, public health policymakers can play a role in improving HF awareness and 
standards of care in neighborhood health clinics and providing public access to these 
outpatient clinics.  Also, there may be methodologic implications for future research 
regarding the refinement of the SRH rubric.  Although poor SRH has been shown to be 
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correlated with poor health outcomes, as a result of this research, neighborhood SES 
information may be investigated as an addition SRH to add to its predictive power. 
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Figure 3.4.  Conceptual models 
A. Specific Aims 1 and 2: Rehospitalization or Death. 
 
B. Specific Aim 3: Self-Rated Health. 
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IV.  METHODS 
A. Introduction 
The objectives of this dissertation were to examine the influence of neighborhood SES 
and receipt of Medicaid on the progression of HF.  The elements of HF progression, 
rehospitalization, mortality and SRH, represent both incident (death) and repeated 
(rehospitalization and SRH) outcomes.  Also, participants were clustered geographically at 
the level of the main exposure, the neighborhood.  Therefore, the methods for this 
dissertation required several different approaches for the analysis of multi-level data.  The 
current project involves the analysis of extant data.  As such, this section provides a 
description of the data and the analytic procedures.   
B. Atherosclerosis Risk in Communities Study   
The ARIC cohort study was designed to investigate the etiology and natural history of 
atherosclerosis and atherosclerotic disease, and to quantify variation in atherosclerotic risk 
factors by race, gender, study community, and time.  A random selection of approximately 
4,000 participants aged 45-64 were recruited from four US communities.  At baseline, the 
ARIC study cohort consisted of 15,792 participants from the following US communities: 
Forsyth County, North Carolina (NC); Jackson, Mississippi (MS); northwest suburbs of 
Minneapolis, Minnesota (MN) and Washington County, Maryland (MD).  The Jackson, MS 
sample is comprised solely of African Americans, while the other study communities were 
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sampled from the entire population of their respective communities (The Atherosclerosis 
Risk in Communities (ARIC) study: design and objectives, 1989), resulting in an 
oversampling of blacks in Forsyth County, NC. 
The initial visit was conducted in 1987-1989, and re-examinations occurred in 1990-
1992 (Visit 2), 1993-1995 (Visit 3), and 1996-1998 (Visit 4).  Telephone follow-up is 
conducted yearly, and used in order to update address, hospitalization, diagnosis, surgery, 
symptom and medication information.  The relationship between visit years, calendar years 
and telephone contact years (CY) are shown in Table 4.1.  The shaded cells indicate when 
in-person visits occurred for each year of enrollment.  Medical records are obtained via 
ARIC surveillance for all hospitalizations occurring after the baseline visit.  Discharge 
diagnoses and cardiovascular event information are recorded by ARIC study abstractors.  
The cohort is closed, so no additional recruitment or enrollment occurred since baseline. 
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Table 4.1. Contact years (CY) by year of baseline visit and calendar year, The ARIC 
study 
   Year of Baseline Visit 
Clinic Exam Calendar Year 1987 1988 1989 
1987 CY 1   
1988 CY 2 CY 1  Visit 1 
1989 CY 3 CY 2 CY 1 
1990 CY 4 CY 3 CY 2 
1991 CY 5 CY 4 CY 3 Visit 2 
1992 CY 6 CY 5 CY 4 
1993 CY 7 CY 6 CY 5 
1994 CY 8 CY 7 CY 6 Visit 3 
1995 CY 9 CY 8 CY 7 
1996 CY 10 CY 9 CY 8 
1997 CY 11 CY 10 CY 9 Visit 4 
1998 CY 12 CY 11 CY 10 
 1999 CY 13 CY 12 CY 11 
 2000 CY 14 CY 13 CY 12 
 2001 CY 15 CY 14 CY 13 
 2002 CY 16 CY 15 CY 14 
 2003 CY 17 CY 16 CY 15 
 2004 CY 18 CY 17 CY 16 
 2005 CY 19 CY 18 CY 17 
 2006 CY 20 CY 19 CY 18 
 2007 CY 21 CY 20 CY 19 
 
 
Approximately 1,500 incident hospital admissions for HF occurred among ARIC cohort 
participants since the baseline examination through December 31, 2004.  The current 
analyses are restricted to African American and Caucasian men and women, aged 45-64 at 
baseline, with incident hospitalized HF in the ARIC cohort (excluding patients with prevalent 
HF at baseline, indicated by taking medications for HF in the previous two weeks; or having 
two of these three symptoms: orthopnea, paroxysmal nocturnal dyspnea or edema in addition 
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to taking digoxin or diuretics).  We considered their respective subsequent hospitalizations, 
vital status and annual measures of SRH occurring since their incident hospitalized HF event. 
1. Socioeconomic Status 
US Bureau of the Census data are often used in epidemiologic studies when individual 
sociodemographic information is unavailable from the medical record (Nancy Krieger et al., 
2002).  Zip code boundaries are drawn to optimize efficient mail delivery by the US Postal 
Service.  In contrast, census tracts are designed to be socially homogenous (Wen & 
Christakis, 2005) and are believed to be more representative of the neighborhood context 
than zip codes (Nancy Krieger et al., 2002).  Limitations of the extant research which does 
include neighborhood SES are: a reliance on zip code boundaries (Rathore et al., 2006) to 
define neighborhoods, and a lack of access to measures of individual SES in order to 
determine the independent effect of neighborhood SES on health outcomes.   
Neighborhood Socioeconomic Status 
Although many researchers use zip code aggregation of neighborhood SES, this practice 
is mainly one of convenience, as the zip code area may not accurately represent the 
neighborhood in which an individual resides and conducts activities of daily living.  The 
assignment of geographic areas to zip code boundaries allow for efficient delivery of US 
mail, while census tracts have an average population size of 4,000 persons and, in contrast to 
zip codes, are thought to respect political and economic boundaries (Nancy Krieger et al., 
2002).  Thus, this study utilized neighborhood socioeconomic data assigned to the level of 
the census tract.   
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The area-level (neighborhood SES) measure selected for study from the 1990 US Census 
was median household income (nINC).  The 1990 census most closely approximated the 
timing of the baseline visits for the cohort (1987-1989).  In previous work, the use of a 
single-variable neighborhood SES measure produced results of similar magnitude and 
precision when compared to a more complex composite index measure of neighborhood SES 
(Kathryn M. Rose et al., 2009).  Participants’ addresses obtained at the baseline visit were 
assigned to the level of the census tract by a vendor with high geocoding accuracy (Whitsel 
et al., 2004).  A previous analysis of mortality in the ARIC cohort reported over 95% of 
participant addresses at baseline were successfully geocoded to the level of the census tract 
(Pollitt et al., 2007).   
We categorized nINC into community-wide tertiles based upon participants' place of 
residence at baseline, during the period 1987-1989: low (<$24,777), medium ($24,777≤-
<36,071) and high (≥$36,071).  All residents living in the study areas during the 1990 US 
Census contributed to the construction of tertiles of median household income for the current 
study in order to place the participants' neighborhood income in context with reference to all 
other residents of the study communities.  Each participant in the study sample was assigned 
the nINC of the census tract in which they resided at baseline.  We did not take into account 
whether or not cohort members changed their address from baseline, as the study population 
was relatively stable.  Unpublished data from the cohort indicate that of participants with 
complete address information through visit three, 84% had lived in the same census tract 
since baseline, and even if they changed place of residence, 92% of participants remained in 
the same nINC tertile throughout follow-up.    
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Individual Socioeconomic Status 
Occupation, income and education are commonly used measures to represent individual 
SES.  ARIC study cohort participants at baseline provided their current or most recent 
occupation, family income and educational attainment (in years).  Current or most recent 
occupation at baseline was classified into 1980 US Census occupational categories: (1) 
managerial and professional specialty; (2) technical, sales and administrative support; (3) 
service; (4) farming, forestry and fishing; (5) precision production, craft and repair; and (6) 
operators, fabricators and laborers.  However, using these categories, 16% of black women 
and 25% of white women were excluded from an analysis of the relationship between 
individual SES and atherosclerosis in the ARIC cohort, since their occupation, “homemaker”, 
precluded assignment to a censual category (Diez-Roux, Nieto, Tyroler, Crum, & Szklo, 
1995).  Since the categorizations of current or most recent occupation are not appropriate for 
a large number of women in the ARIC cohort, occupation was not used in the current 
analyses as an individual-level SES variable. 
Meanwhile, the classification of annual family income (US dollars) at baseline was as 
follows: (1) <8,000; (2) 8,000-11,999; (3) 12,000-15,999; (4) 16,000-24,999; (5) 25,000-
34,999 and (6) ≥35,000.  Income data were missing for 10% or more of black participants, 
and approximately 5% of white participants at baseline (Diez-Roux et al., 1995).  Further, 
current research suggests that individual-level income is not a preferred indicator of adult 
SES, since poor health in adulthood may influence one’s income potential (Dray-Spira, Gary, 
& Brancati, 2008).  As a result of these findings, we did not use annual family income as an 
individual-level SES variable in the current analyses.  
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In contrast, educational attainment data, assessed at baseline among ARIC cohort 
participants, are complete (Diez-Roux et al., 1995).  Educational attainment is categorized 
among members of the ARIC cohort as: <8th grade; 8th – 11th grade; high school or general 
equivalence diploma (GED); some vocational school; 1 – 3 years of college; 4 years of 
college completed and some graduate or professional school (Borrell et al., 2004).  In the 
current study, we characterized education as (1) less than high school; (2) high school or 
GED or (3) greater than high school.  According to previous research done in the ARIC 
cohort, these three educational levels appear to warrant their own categories, and should not 
be dichotomized, for example, at the level of high school education (Diez-Roux et al., 1995), 
as approximately 40% of participants had less than a high school education and 35% were 
high school graduates or had their GED at study baseline.   
Several investigators use insurance status as a surrogate for individual SES (Ayanian et 
al., 1993; Harnick, Cohen, Schechter, Fuster, & Smith, 1998; Shen, Wan, & Perlin, 2001), 
although the validity of this approach is unknown.  Insurance status is available in ARIC 
from the incident HF hospitalization medical record, and is defined as follows: Prepaid health 
insurance (health maintenance organization [HMO] or private insurance), Medicare, 
Medicaid, and other types of insurance (e.g., governmental insurance or workers’ 
compensation).  Receipt of Medicaid (yes/no) was used in this analysis, as indicated in the 
medical record.  Medicaid coverage may be a reasonable proxy for low individual SES, as 
the majority of Medicaid beneficiaries also have incomes below the poverty line (Ku, 2005).  
Previous work in ARIC surveillance indicates that receipt of Medicaid may influence care-
seeking behavior (Foraker et al., 2008). 
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2. Incident Hospitalized Heart Failure 
Hospitalization data in the ARIC cohort are collected via the Cohort Event Eligibility 
(CEL) form (ARIC, 2007a).  A CEL form is completed for a cohort participant by ARIC 
study personnel if a hospitalization is identified: (1) during the annual follow-up (AFU) 
telephone contact; (2) via ongoing ARIC community surveillance; or (3) while investigating 
an unrelated hospital admission of the cohort participant.  The target date for AFU contacts is 
the one-year anniversary of the first clinic visit for each participant.  Cohort participants are 
followed-up each year thereafter by telephone in order to maintain correct address 
information, and to document vital status and medical events (e.g., hospitalizations, 
surgeries, medications) occurring since the last contact. 
Trained staff conduct telephone interviews and complete an AFU form (ARIC, 2008) for 
each participant.  Participants are contacted yearly, regardless of whether or not they 
continue to reside within ARIC study boundaries.  Since the inception of ARIC, information 
regarding overnight (i.e., inpatient) hospital stays has been collected as part of the AFU.  
Recent versions of the AFU (specifically, forms L and M) also ascertained outpatient hospital 
admissions, however, those data were not yet available at the time of this investigation and 
thus were not incorporated into the current analyses.  Administratively, the AFU and CEL 
forms must be linked in order to make certain all overnight hospitalizations ascertained via 
the AFU are investigated. 
Inpatient hospitalization data is abstracted from the medical record and recorded on the 
CEL if the hospital is within the ARIC study boundaries and the records are complete, or if 
the hospital is located outside of the catchment area and the medical record can be obtained.  
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Thus, the CEL form can be used to track each hospitalization for every cohort member since 
baseline.  Data contained in the CEL form include, but are not limited to, the date of 
discharge or death and ICD-9-CM discharge codes recorded in the order listed on the hospital 
discharge index.  
All-cause hospitalizations are identified during annual follow-up or during routine ARIC 
surveillance (White et al., 1996).  For the purpose of this study, cardiovascular disease 
(CVD)-related hospitalizations were further identified from all-cause hospitalizations using 
ICD-9-CM discharge codes 402, 410-414, 427, 428, 430-436 or 518.4; while a HF-related 
hospitalization was defined as that with an ICD-9-CM discharge code 428 (ARIC, 2007a). 
 If the ICD-9-CM discharge codes or terms used in the discharge summary reference a 
CVD-, stroke, or HF-related hospitalization, then an appropriate hospital data abstraction 
form is completed for that hospitalization (ARIC, 2007d).  Hospital data abstraction forms 
contain information on co-occurring illnesses and clinical comorbidities, as well as 
procedures performed during the hospital stay. 
3. Progression of Heart Failure 
For the purposes of this work, progression of HF following an incident hospitalized 
event was defined in three domains:  rehospitalization, mortality and SRH. 
i. Rehospitalizations 
Hospitalizations are routinely assessed in ARIC as previously described.  Briefly, as part 
of annual follow-up, information regarding inpatient hospital stays is collected, and 
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hospitalization data are abstracted from the medical record regardless of the location of the 
hospital.  All-cause hospitalizations, in addition to CVD- and HF-related hospitalizations, 
were ascertained for members of the cohort following their incident hospitalized HF event. 
ii. Mortality 
Mortality data in the ARIC cohort are collected via the CEL form and AFU.  Mortality 
data contained in the CEL form come from death certificates and provide the date, cause of 
death, and whether the death occurs in-hospital.  For the purpose of these analyses, cause of 
death will not be used due to a primary interest in all-cause mortality and the anticipated 
limitations of cause of death data.  In ARIC, CEL and AFU mortality data are supplemented 
by informant interview, witness reports, physician questionnaires and autopsy reports, if 
applicable.  In addition, National Death Index searches are conducted annually to account for 
any cohort members whose vital status is not known through the AFU contact attempt. 
Mortality was measured by ascertainment of deaths occurring within 30-, 60-, and 90 
days, and one year and five years, respectively, of the incident hospitalized HF event.  The 
date of all deaths were located in CEL data and were classified as within 30-, 60-, or 90 days, 
one year or five years of the incident hospitalized HF event (yes/no).  Approximately half of 
all ARIC cohort participants with incident hospitalized HF were deceased by December 31, 
2004.  
iii. Self-rated Health 
SRH is thought to reflect both mental and physical health domains, and is assessed by 
asking individuals to objectively describe their health status.  SRH is associated with disease 
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incidence and subsequent mortality.  SRH was measured at baseline and at each AFU with 
the question, "Over the past year, compared to other people your age, would you say that 
your health has been excellent, good, fair or poor?"  To get an accurate picture of SRH, 
however, it is important to take death into consideration in analyses.  For example, if only 
live participants are considered during follow-up, SRH may be shown to improve after a 
sentinel health event, since the sickest patients (i.e., those with fair or poor SRH) have died 
(Paula Diehr & Patrick, 2003). 
Figure 4.1 shows reported SRH across all contact years of follow-up among members of 
the ARIC cohort.  In increasing follow-up years, we see a steady decline in the percent of 
participants reporting excellent health while the proportion of participants reporting good 
health remains relatively consistent over time.  Meanwhile, the percent of participants 
reporting fair health increases slightly over time, while the proportion of participants 
reporting poor health does not vary over time.  It is of note that ascertainment of the SRH 
measure is nearly complete for early follow-up years, however, the results shown in Figure 
4.1 are based on fewer cohort members as follow-up progresses and the amount of missing 
data due to death and – nearly negligible – loss to follow-up increases over time.   
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Figure 4.1. Reported self-rated health across all contact years, The ARIC study 
 
A SRH response set is not precisely ordinal, therefore, we transformed the SRH 
responses according to Diehr et al. (Paula Diehr et al., 2005): 95 for excellent, 80 for good, 
30 for fair, 15 for poor, and 0 for death.  This transformation represents the estimated 
probability of persons being healthy two years later, as developed from several data sources, 
including the Cardiovascular Health Study (Paula Diehr & Patrick, 2003; P. Diehr et al., 
2001).  In addition, the ARIC cohort had experienced little loss to follow-up, therefore, were 
able to estimate (i.e., interpolate) missing SRH data, with the exception of data missing due 
to death, from data collected before and after the missing SRH assessment.  If a cohort 
member died during follow-up and was not contacted for annual follow-up the year of their 
death, they were assigned a SRH value of zero for that year and each year thereafter.      
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4. Covariates  
All statistical modeling approaches involved the assessment of confounding and effect 
measure modification.  Effect measure modification (EMM) was investigated using a p<0.2 
level of significance for the outcomes of rehospitalization or death.  Meanwhile, a <0.05 
level of significance for EMM was used for the outcome of SRH, as the large sample size 
due to yearly measures of SRH provided more power to detect effect measure modification.  
For all analyses, a variable must have been statistically significantly (p<0.05) associated with 
both the exposure and the outcome to be considered a potential confounder.  Confounding 
was assessed using a 10% change in estimate strategy (McNamee, 2003).  Variables 
appearing in Table 4.2 were first assessed using a Directed Acyclic Graph (DAG) to 
determine whether these potential confounders met the following confounding criteria: (1) 
the covariate was associated with HF progression; (2) the covariate was associated with 
neighborhood SES and (3) the covariate was not affected by neighborhood SES (Rothman, 
2002).  
Table 4.2. Selected covariates and the assessment of effect measure modification and 
confounding, The ARIC study 
Exposure: nSES Outcome: HF Progression 
Tertiles (low-, medium-, high-) of US  Rehospitalization and death 
census-tract median household income Self-rated health 
Potential Confounders* Potential EMMs 
Age Comorbidity score 
Race / study community Hypertension 
Gender Overweight / obesity 
Education Smoking status 
Medicaid status Alcohol use 
*Potential confounders will first be explored as potential effect modifiers 
 
Plausible causal relationships were indicated in the DAGs (Figure 4.2) by unidirectional 
arrows.  Acyclic relationships are one feature which differentiates the DAGs shown in 
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Figure 4.2  from the conceptual model shown in Figure 3.4.  When constructing a DAG, it 
was up to the researcher to decide, based on extant literature and biologic plausibility, 
whether, for example, neighborhood SES was more likely to “cause” clinical comorbidity, or 
if clinical comorbidity was more likely to “cause” neighborhood SES.  In the current study, 
the exposure preceded the diagnosis of HF and the subsequent progression of the disease.  
Thus, it was unlikely that the disease, or even precursors to the disease, affected the 
neighborhood in which the participants resided at baseline.  Therefore, the unidirectional 
arrow originates from neighborhood SES and points toward clinical comorbidity (Figure 
4.2). 
Figure 4.2. Directed acyclic graphs with all unidirectional arrows 
A. Specific Aims 1 and 2: Rehospitalization or Death. 
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B. Specific Aim 3: Self-Rated Health. 
 
 
In order to fulfill the criteria as a potential confounder, variables in the DAG must: (1) 
have an arrow pointing in either direction between them and HF progression; and (2) have an 
arrow pointing from them to neighborhood SES.  Variables such as clinical comorbidity and 
health behaviors have arrows pointing to them from neighborhood SES, and thus have the 
potential to be on the causal pathway between neighborhood SES and HF progression.  
Caution should be taken before adjusting for variables along the causal pathway, as doing so 
may create bias (Jager, Zoccali, MacLeod, & Dekker, 2007).  All potential confounders of 
the neighborhood SES and HF progression relationship were first considered as effect 
measure modifiers and then as potential confounders. 
As Figure 4.3 shows, once the arrows pointing from the exposure, neighborhood SES, 
are removed, unblocked backdoor paths exist via demographic variables and individual SES.  
Thus, demographic variables and individual SES are potential confounders, and according to 
the DAG shown in Figure 4.3, once they are controlled for in the analysis, the paths from 
  57
neighborhood SES to HF progression leading through clinical comorbidities and health 
behaviors are blocked.  
Figure 4.3. Directed acyclic graphs without unidirectional arrows eminating from 
exposure 
 
A. Specific Aims 1 and 2: Rehospitalization or Death. 
 
 
B. Specific Aim 3: Self-Rated Health. 
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Covariates included race/study community, gender, age and selected socioeconomic, 
clinical and behavioral characteristics.   
Sociodemographic Characteristics 
In the study of rehospitalization and mortality, we determined participants' age on the 
date of the incident HF hospitalization.  For the SRH analyses, we incorporated age at the 
time of the AFU contact.  In order to conserve power, we treated age as a continuous 
variable, centered at the mean.  The analyses included males and females, and we constructed 
composite variables for self-reported race (black/white) and ARIC study community [Forsyth 
County (Co.), NC; Jackson, MS; northwest suburbs of Minneapolis, MN; and Washington 
Co., MD] into the following categories: black/Forsyth, white/Forsyth Co., black/Jackson, 
white/Minneapolis, white/Washington Co.  
Socioeconomic Characteristics 
Occupation, income and education are commonly used measures to represent individual 
SES.  ARIC study cohort participants at baseline provided their current or most recent 
occupation, family income and educational attainment (in years).  Educational attainment 
was assessed at baseline (less than 11 years, high school graduate, and greater than high 
school), as was health insurance status at the time of the index HF hospitalization (receipt of 
Medicaid, yes/no). 
Clinical and Behavioral Characteristics 
 Blood pressure was measured at study visits one through four with random-zero 
mercury manometers per ARIC study protocol (ARIC, 1988).  Hypertension was defined at 
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baseline  by either a (1) systolic blood pressure ≥140 mmHg; (2) diastolic blood pressure ≥90 
mmHg or (3) recent history of antihypertensive medication use.  For the purpose of these 
analyses, the highest of the blood pressure measures or an indication of antihypertensive 
medication taken at the time of the baseline visit was used to represent the participant’s 
hypertensive status.  Loehr et al. report a hypertension prevalence of 52% at baseline among 
incident HF participants ascertained through 2004 in the ARIC cohort (Loehr et al., 2008). 
 Height and weight were measured at each clinic visit by technicians per ARIC study 
protocol (ARIC, 1988).  Briefly, height and weight were measured with participants in scrub 
attire following an overnight fast.  Height was measured using a wall mounted ruler, and 
weight was measured on a scale which was zeroed and calibrated per study protocol (Loehr 
et al., 2009).  We calculated BMI (weight in kilograms [kg]/height in meters squared [m2]) 
from these data points.  For the purpose of these analyses, the highest of the measures taken 
at baseline were used to represent the participant’s BMI.  BMI was categorized as normal 
weight (<25 kg/m2), overweight (≥25 to <30 kg/m2), or obese (≥30 kg/m2) (Loehr et al., 
2008; NIH, 1998).  According to baseline data from ARIC through 2004, participants with 
incident HF averaged a BMI of 29.7 kg/m2 (standard deviation 6.2 kg/m2) (Loehr et al., 
2008).  
Current smoking and current drinking (yes/no) were assessed at study baseline.    
Comorbidity Index Score 
Patients diagnosed with HF often have coexisting clinical comorbidities.  Chronic 
conditions such as hypertension, CHD, diabetes and obesity are risk factors for the 
development of HF (Schocken et al., 2008; Weir et al., 2006), and clinical HF is commonly 
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accompanied by one or more of these factors (Heywood et al., 2007).  In general, the burden 
of mortality (Charlson et al., 1987; Deyo et al., 1992; Jong et al., 2002) and rehospitalization 
(Philbin & DiSalvo, 1999) increases with increasing comorbidity.  
The effect of neighborhood SES may act through risk factors for CVD, as certain 
conditions are believed to be more common in low neighborhood SES areas (Stjarne et al., 
2006).  Therefore, there exists evidence that comorbid conditions are on the causal pathway 
between neighborhood SES and HF progression (Figure 4.3).  
The Charlson index of comorbidity was originally developed using comorbid conditions 
present among breast cancer patients and validated on a sample of consecutive New York 
Medical Center patients (Charlson et al., 1987).  Charlson et al. (1987) first assessed the 
effect of an absolute number of comorbid illnesses on mortality, and then transformed the list 
of comorbid illnesses to include a numeric score which accounted for the seriousness of each 
comorbid illness.  Deyo et al. translated the Charlson index into a list of ICD-9-CM 
discharge codes for use with administrative databases (Deyo et al., 1992).  In general, each 
one-point increase in index score results in a dose-response increase in mortality, length of 
stay, surgical complications and hospital charges (Charlson et al., 1987; Deyo et al., 1992). 
For the rehospitalization and mortality analyses, we ascertained the prevalence of 
common underlying conditions at the time of the index HF hospitalization using ICD-9-CM 
discharge codes.  The Charlson index, a clinical comorbidity algorithm (Deyo et al., 1992), 
was derived from these data (Table 3.2).   
The sum of all of the discharge-code related score values (Table 3.2) results in a total 
index score for each patient.  A cutpoint of three points has been previously used in the 
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literature to define those with a high burden of comorbidity (three or more points) from those 
with a low burden of comorbidity (two or fewer points) (Charlson et al., 1987; Deyo et al., 
1992).  In its use with HF outcomes, a “modified” Charlson index excludes chronic HF from 
the conditions included in the computation of the comorbidity score (Senni et al., 2006).  
Consistent with previous studies including participants with chronic HF, we defined a high 
burden of comorbidity as a sum of two or more points on the Charlson index scale, whereas a 
low burden of comorbidity was defined with a total of less than two points. 
C. Aim 1: Analyses   
After excluding 245 participants with prevalent HF at baseline, 1,415 participants had 
an incident hospitalized HF event during follow-up (1987-2004).  An additional 70 
participants were excluded due to missing data on neighborhood SES, and 3 were excluded 
because they were not white or black, or were blacks living in Minnesota or Maryland, 
resulting in a final sample size of 1,342 participants. 
Time to first hospital readmission (all-cause, CVD- and HF-related rehospitalization) 
was an outcome of interest for this analysis.  We also examined the rate of readmission (total 
number of rehospitalizations over person-time of follow-up) for all-cause, CVD-related and 
HF rehospitalizations.  We conducted both time-to-event analyses as well as logistic 
regression to assess the risk of 30-day, 1-year and 5-year rehospitalization.   
Crude nINC-rehospitalization analyses were conducted, the influence of covariates in a 
full model were tested, and effect modification (pinteraction<0.05) of the nINC-rehospitalization 
relationship was assessed by age, race/study community, gender, hypertension, BMI, 
smoking, drinking and comorbidity index score. 
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1. Time to Rehospitalization 
We measured time to readmission over the course of follow-up since the incident 
hospitalized HF event by the product-limit (Kaplan-Meier) method (Cox, 1972; Symons & 
Moore, 2002).  An assumption of survival analysis is that the distribution of survival free of 
hospitalization for those who are censored (i.e., who died or were lost to follow-up) would 
have been the same as the non-censored had they not been censored.  Also, the model 
assumes that events are independent.  The model produced survival curves depicting survival 
free of readmission.  The proportional hazards (PH) assumption was examined for every 
variable in the model, both graphically using survival probability and log (-log) survival plots 
(Figure 4.4) and with hypothesis tests evaluating time interaction terms.  In both types of 
plots, parallel lines indicate the PH assumption is not violated.  The PH model is non-
parametric, and thus allows for flexibility of assumptions. 
Figure 4.4. Survival probability and log (-log) survival plots of current smoking 
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PH regression was conducted to quantify time elapsed between the incident HF 
hospitalization and the first rehospitalization.  Hazard ratios were estimated comparing 
categorical levels of neighborhood SES in crude and multivariable models.  In the 
multivariable models, ties were handled with the Efron method.  Incident HF hospitalizations 
which resulted in death were censored at the time of death, as those patients were no longer 
eligible for rehospitalization at that time.  Multivariate Cox proportional hazard models 
estimated the risk of rehospitalization using death during follow-up as a censoring variable.  
All participants were censored at the end of 2004.  
2. Rehospitalization Rate 
We used SAS software (SAS Institute, Cary, NC) with the procedure PHREG and the 
repeated events option to model rehospitalization rates, accounting for the clustering of 
events within patients and patients within geographic area while investigating all-cause, 
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CVD-related and HF-related hospitalization rates, respectively.  Time at risk for 
rehospitalization was the time elapsed between the incident HF hospitalization admission 
date until rehospitalization, death, loss to follow-up or the end of 2004, whichever came first.  
The rate was calculated as the number of hospitalizations per participant over the person-time 
at risk for the participant.  The hospitalization count was modeled with the logarithm of 
person-days at risk as the offset.   
All-cause hospitalizations were identified during annual follow-up or during routine 
ARIC community surveillance (White et al., 1996).  For the purpose of this study, CVD-
related hospitalizations were further identified from all-cause hospitalizations using ICD-9-
CM discharge codes 402, 410-414, 427, 428, 430-436 or 518.4; while a HF-related 
hospitalization was defined as that with an ICD-9-CM discharge code 428 (ARIC, 2007a). 
We used generalized linear Poisson mixed models to estimate rehospitalization rate 
ratios, comparing the rehospitalization rates of participants from low nINC to high nINC and 
from medium nINC to high nINC, along with 95% confidence intervals (RR, 95% CI).  The 
assumptions of the Poisson model are that events are independent and the probability of an 
event occurring within an interval is proportional to the length of the interval.  Standard 
Poisson variance assumptions were verified by testing for over-dispersion (Dallal, 2008; Rao 
& Scott, 1999), and we calculated robust variance estimates accordingly.    
Over-dispersion 
We used Poisson regression to model the natural log of the expected count of 
hospitalizations per unit time post-incident HF event, using the natural logarithm of the 
follow-up time as the offset.  A potential limitation of the Poisson distribution is that it may 
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not be able to predict the underlying distribution of count data per unit time in the source 
population.  When the data are more variable than the distribution assumed by the Poisson 
model, the data are said to be overdispersed. 
In the case of our rehospitalization data, it was possible that more patients than expected 
were not rehospitalized, that is, experienced a count of zero for the number of 
rehospitalizations per unit time.  There are several statistical techniques used to assess over-
dispersion in a Poisson distribution.  We fitted a Poisson regression model to the data, as 
previously described, using the natural logarithm of person-time as the offset.  We consulted 
the deviance statistic (Dallal, 2008) to determine if the ratio was close to one.  Over-
dispersion is indicated by the deviance statistic (divided by its degrees of freedom) if the 
ratio is greater than one. 
Given a deviance statistic greater than one, we fitted negative binomial regression to the 
rehospitalization data, using the natural logarithm of person-time as the offset.  Again, the 
deviance statistic was consulted.  If the negative binomial regression model fit the underlying 
data distribution more effectively, the deviance statistic would be closer to one.  In the 
comparison of the Poisson and negative binomial models, we expected to find similar effect 
estimates from both models, however, due to a review of the literature comparing the two 
modeling strategies, we anticipated the width of the 95% CIs would be larger when using the 
negative binomial model (Dallal, 2008), as the model estimates derived from overdispersed 
data are not as precise as the Poisson model may indicate. 
 In our data, the Poisson models yielded a deviance statistic of close to four.  Thus, 
over-dispersion was suggested.  In response, we fit negative binomial models to the data and 
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observed deviance statistics just below 1.2.  As expected, the point estimates of the rate ratios 
did not change.  However, the 95% CIs widened considerably with the application of the 
negative binomial model.  The imprecision of the estimates reflect the effect over-dispersion 
has on these data.  Estimates and 95% CIs from the negative binomial models are shown in 
the Appendix.  Although the estimates were less precise, the supplemental analyses 
accounting for over-dispersion did not change our interpretation of the results.   
3. Risk of Rehospitalization 
We performed logistic regression to estimate the risk of 30-day, one-year and five-year 
rehospitalization.  Neighborhood SES and other covariates were assessed for linearity in the 
logit.  Logistic regression (PROC LOGISTIC, SAS Version 9.1, Cary, NC) was used to 
assess the influence of neighborhood SES on 30-day, one-year and five-year rehospitalization 
among HF patients in crude and multivariable models.   
D. Aim 2: Analyses   
Time to death was an outcome of interest for this analysis.  We conducted time-to-event 
analyses as well as logistic regression to assess the risk of 30-day, one-year and five-year 
mortality.  Crude nINC-mortality analyses were conducted, the influence of covariates in a 
full model were tested, and effect modification (pinteraction<0.05) of the nINC-mortality 
relationship was assessed by age, race/study community, gender, hypertension, BMI, 
smoking, drinking and comorbidity index score. 
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1. Time to Death 
We measured time to death over the course of follow-up since the incident hospitalized 
HF event by the product-limit (Kaplan-Meier) method (Cox, 1972; Symons & Moore, 2002).  
An assumption of survival analysis is that the distribution of survival for those who are 
censored (i.e., who died or were lost to follow-up) would have been the same as the non-
censored had they not been censored.  Also, the model assumes that events (deaths) are 
independent.  The model produced survival curves depicting survival since the incident HF 
hospitalization.  The proportional hazards (PH) assumption was examined for every variable 
in the model, both graphically using log (-log) survival plots (Figure 4.4) and with 
hypothesis tests evaluating time interaction terms.  The PH model is non-parametric, and thus 
allows for flexibility of assumptions. 
 PH regression was conducted to quantify time elapsed between the incident HF 
hospitalization and mortality.  Hazard ratios were estimated comparing categorical levels of 
neighborhood SES in crude and multivariable models.  In the multivariable models, ties were 
handled with the Efron method.  Multivariate Cox proportional hazard models estimated the 
risk of death during follow-up without competing risk.  All participants were censored at the 
end of 2004. 
i. Combined Endpoint: Rehospitalization or Death 
A combined endpoint of rehospitalization or death was also explored in these analyses.  
We conducted time-to-event analyses for rehospitalization or death, whichever came first, as 
well as logistic regression to assess the risk of 30-day, 1-year and 5-year rehospitalization or 
death.  Crude nINC-rehospitalization/mortality analyses were conducted, the influence of 
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covariates in a full model were tested, and effect modification (pinteraction<0.05) of the nINC-
rehospitalization/mortality relationship was assessed by age, race/study community, gender, 
hypertension, BMI, smoking, drinking and comorbidity index score.   
2. Risk of Death 
The date of all deaths were located from annual follow-up (AFU) data and were 
classified as within 30 days, one-year or five years of the incident hospitalized HF event 
(yes/no).  Neighborhood SES and other covariates were assessed for linearity in the logit.  
Logistic regression (PROC LOGISTIC, SAS Version 9.1, Cary, NC) was used to assess the 
influence of neighborhood SES on 30-day, one-year and five-year mortality among HF 
patients in crude and multivariable models.  Low SES-to high SES and medium SES-to high 
SES risk ratios for mortality were estimated using logistic regression.   
E. Aim 3: Analyses   
ARIC study staff conducts annual follow-up by telephone to update address and contact 
information, and to assess overnight hospitalizations and changes in health status occurring 
since the last annual contact.  SRH was measured among 15,792 black and white men and 
women at baseline and at each annual follow-up (1987-2006) for a median of 17.6 (range 1-
19) years using the question, "Over the past year, compared to other people your age, would 
you say that your health has been excellent, good, fair or poor?"   We transformed these 
responses to represent the estimated probability of being healthy in the future based on their 
current response (Paula Diehr et al., 2005): 95 for excellent, 80 for good, 30 for fair, 15 for 
poor, and 0 for death.  
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Participants' baseline place of residence (1987-1989) was geocoded to the level of the 
census tract by a vendor with demonstrated accuracy, as described elsewhere (Whitsel et al., 
2004).  Neighborhood-level median household income (nINC) was obtained from the 1990 
US Census and averaged across all ARIC study communities.  Participants were assigned a 
tertile of nINC [low (<$24,777), medium ($24,777≤-<36,071) or high (≥$36,071)] based 
upon their address at baseline. 
There were 276,200 total SRH observations for members of the cohort, of which 9,552 
(3.4%) were missing.  If an observation was missing, and there were complete SRH values 
for both the previous and subsequent year of follow-up, we imputed the missing observation 
by averaging the values from the previous and subsequent years.  As a result, over half 
(N=5,140) of the missing observations were imputed.  We assigned a zero for the missing 
value if it occurred during the year in which the cohort member died.  In order to capture the 
SRH of the entire cohort across time, and not just that of the survivors, we included 
observations through contact year 19 for members lost to follow-up or who were deceased, 
and assigned a zero for each follow-up year which occurred after the cohort members' death.   
 Of the original 15,792 cohort members, 754 were excluded due to missing nINC 
(N=13,030 SRH observations), resulting in 263,170 SRH observations available for these 
analyses.  We analyzed mean SRH at discrete time points and trajectories of SRH across time 
among participants who were disease-free at baseline and disease-free throughout follow-up 
(N=11,188), as well as among those receiving a diagnosis of incident myocardial infarction 
(MI; N=1,071), any stroke (N=809), heart failure (HF; N=1,592) or lung cancer (N=433), 
and those undergoing cardiac revascularization procedures (N=1,340) during follow-up.  
Cardiac procedures were defined as operations on the vessels of the heart, including bypass 
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and revascularization (ICD-9-CM 36.0, 36.1 and 36.2).  We assessed SRH data through the 
end of 2006, and incident events through the end of 2005, in order to give each cohort 
member at least one year of follow-up post-event.       
For comparison purposes, each member of the disease-free group was assigned a random 
“event” date (P. Diehr et al., 2001).  As a result, the pre-event and post-event trajectories 
from the incident disease groups could be compared to those of the group which remained 
healthy throughout follow-up, to determine if the SRH trajectories among the diseased differ 
from the trajectory of SRH that would be expected due to disease-free aging.  With regard to 
differences by incident disease status, HF survival has been shown to be worse than other 
cardiovascular diseases and cancers, with the exception of lung cancer (Simon Stewart et al., 
2001), and it remains unknown if SRH trajectories show similar trends.    
Factors influencing pre- and post-event trajectories were of interest, as well as covariates 
which played a role in the decline of SRH over the follow-up period.  Age (centered at 65 
years) and age squared at the time of the annual follow-up contact were included in statistical 
models.  Gender and race/study community were the additional demographic variables of 
interest.  Health status and behavior variables assessed at baseline included body mass index 
(BMI), classified into normal (referent, <25 kg/m2), overweight (25-<29.9 kg/m2) or obese 
(≥29.9 kg/m2); hypertension, present if systolic blood pressure ≥140 mmHg, diastolic blood 
pressure ≥90 mmHg, or if taking hypertensive medication within the previous two weeks; 
current drinker and current smoker.  Educational attainment was assessed at baseline and 
categorized as less than 11 years, high school graduate, and greater than high school 
(referent).  We accounted for period effects [1987-1992 (referent), 1993-1999 and 2000-
2006] at each annual follow-up contact in order to capture secular trends (Rice, Lang, 
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Henley, & Melzer, 2010) which may influence the nINC-SRH relationship, such as changes 
in health behaviors and disease treatments occurring in the ARIC communities over time.      
Repeated assessments of SRH were accounted for using individual quadratic growth 
models.  McCullough and Laurenceau used a similar modeling strategy in their analysis of 
the natural history of SRH (McCullough & Laurenceau, 2004).  Specifically, SRH for each 
participant was regressed on age for pre-event, post-event, entire follow-up, and at each time 
point of interest (e.g., three, two and one year prior, as well as the event year and one, two, 
three, four and five years after the event).  The y-intercept was then the mean (centered at 65) 
age of participants at the time of the AFU contact.  The standard equation assumed a linear 
pattern of growth or decline.  As such, we also computed a quadratic model and a cubic 
model to assess for the best fit to the data. 
After choosing a quadratic model by way of comparing deviance statistics, we regressed 
individual differences in estimated SRH on between-participant differences in neighborhood 
SES, gender and race/study community, health behavior and clinical variables collected at 
baseline (McCullough & Laurenceau, 2004).  The main relationship of interest in these 
analyses was that between levels of neighborhood SES and SRH.  We expected to see a 
steeper decline in mean SRH among participants living in low neighborhood SES areas 
compared to high neighborhood SES areas.  
We also regressed incident disease-specific SRH at each time point of interest (e.g., 
baseline; three, two, and one year prior to the event; event year; and one, two, three, four and 
five years post-event) on study covariates to generate estimated adjusted SRH values and 
standard errors (PROC GLM, SAS 9.1.3, Cary, NC).  We used the change in adjusted SRH 
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between the year of event and one year later to calculate how much of the decline in SRH 
post-event was due to death for each incident disease group.  For example, we calculated the 
mean adjusted decline in SRH among participants who were alive one-year post event and 
divided that value by the mean adjusted decline in SRH among all participants (regardless of 
vital status).  The proportion of decline in SRH post-event due to deaths was then one minus 
the aforementioned value. 
If a relationship between nINC and SRH exists, it is feasible that nINC may influence 
the slope of decline in SRH over time depending on the type of incident health condition.  
Thus, we fit individual quadratic growth models separately to data by incident disease group, 
accounting for repeated measures of SRH (PROC MIXED, SAS 9.1.3, Cary, NC).  Effect 
measure modification of the nINC-SRH relationship was assessed (disease-free: 
pinteraction<0.01; other disease: pinteraction<0.05) by demographic, medical history and health 
behavior variables. 
1. Alternative Approach 
In 2001, the procedure “TRAJ” was developed by Jones et al. for SAS statistical 
software in order to analyze developmental trajectories (Clark, Jones, Wood, & Cornelius, 
2006; Jones & Nagin, 2007).  We explored its potential for analyzing trajectories of SRH 
over time among members of the ARIC cohort.   Its appeal was the incorporation of both 
mixed and latent growth curve modeling.  Thus, this technique accounts for repeated 
measures of SRH among participants, and is designed to allow for individual variations in 
trajectories over time.  Specifically, the censored normal (CNORM) model had previously 
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been used with psychometric measure data (Jones & Nagin, 2007), and had the potential to 
be applied to our continuous SRH data. 
Our repeated measures SRH data were structured in a long format, with rows of 
observations representing each contact year within participants.  For use with the TRAJ 
procedure, the data were transformed to the wide format, with one row of observations per 
participant and columns representing each contact year.  We downloaded the TRAJ module 
compatible with SAS Version 9.x, which is available from the developer's website (Jones, 
2010).  The TRAJ procedure identifies different parameter values in the data and utilizes the 
information to group the data into a specified number of groups. 
The TRAJ procedure does not allow the researcher to specify the type of groups or the 
parameters by which the groups should be created.  It is the purpose the TRAJ procedure to 
identify salient groups from the data given.  Therefore, the TRAJ procedure is beneficial to 
researchers who wish to identify distinct groupings within their data.  For example, the TRAJ 
procedure can identify distinct subpopulations, or components of the data which can in turn 
predict group membership.  Another benefit of the TRAJ procedure, in addition to its ability 
to handle repeated measures data, is that it can accommodate time-varying covariates.   
The goal of our work was to define the groupings for our data a priori.  For example, an 
aim of the current work was to determine if the trajectories of SRH over time differed by 
neighborhood SES in the ARIC cohort.  The TRAJ procedure would not group the data using 
the parameter “neighborhood SES” unless it was found to be a significant discriminatory 
parameter for the data.  As a result of these analyses, group membership was influenced by 
low neighborhood SES, hypertensive status, age and education.  The data were grouped into 
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three categories of membership as specified, yet there was no method available using the 
TRAJ procedure to define groupings by neighborhood SES (e.g., low, medium and high) a 
priori.  Therefore, we opted to model these longitudinal data using individual growth models, 
with neighborhood SES as a main exposure, and determine if there were statistical 
interactions between neighborhood SES and other covariates which influenced a change in 
slope for the SRH trajectories. 
F. Strengths and Limitations 
1. Strengths 
A strength of the ARIC data is that they include 19 years of annual follow-up contacts 
(median 17.6) for assessing SRH and a median of 4.2 years of follow-up for 
rehospitalizations and mortality among participants with an incident hospitalized HF event.  
Many clinical trials and registry studies do not capture the clinical course of HF subsequent 
to discharge (Adams et al., 2005; G. C. Fonarow, J. T. Heywood et al., 2007; Fonarow, 
Srikanthan, Cintron, & Lopatin, 2007; M. Galvao & ADHERE Scientific Advisory 
Committee (SAC) Investigators, 2005; Marie Galvao et al., 2006; Heywood et al., 2007) or 
otherwise short-term follow-up (Felker et al., 2004; Gregg C. Fonarow et al., 2007; 
Gheorghiade et al., 2006; B. H. Greenberg et al., 2007).  An additional limitation of clinical 
trials is that they do not typically enroll a representative sample of HF patients.  For example, 
data from clinical trials indicate that women represent approximately one-third of patients 
(Marie Galvao et al., 2006).  Conversely, among studies utilizing registry data, 
approximately half of all HF patients are women.  Similarly, women make up nearly half of 
incident HF cases in the ARIC cohort (Loehr et al., 2008).  
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An additional strength of these data for investigating time until rehospitalization or death 
is the continuous monitoring of cohort participants for rehospitalizations occurring for any 
reason at any time during follow-up.  We utilized data provided by annual follow-up in order 
to conduct time-to-event analyses, which tracked participants after an incident HF 
hospitalization until they experienced a rehospitalization or death or were censored.  The 
ARIC study design allowed for thorough ascertainment of rehospitalizations, deaths and 
dates of last contact.  We also utilized an alternative method for analyzing these 
rehospitalization and death data in order to make the results comparable to studies which 
have limited follow-up time, or that only assess whether participants have been 
rehospitalized at discrete time points (e.g., 30 days post-discharge).  
These data were also ideal for use with regard to SRH.  We were able to transform the 
SRH scale per Diehr et al (Paula Diehr & Patrick, 2003).  This transformation is superior to 
the use of ordinal values, since it takes into consideration the non-linear relationship between 
excellent, good, fair and poor.  Researchers have also grouped measures of SRH, such as 
excellent/good and fair/poor together for analyses (Daponte-Codina et al., 2008; McFadden 
et al., 2008; Wight et al., 2008).  This technique is intended to dichotomize good and poor 
health, yet also over-simplifies the relationship, and may obscure true gradients in SRH 
between levels.  Another advantage with regard to the transformation of SRH values is that 
the transformation adequately accounts for death, and allows for meaningful interpolation of 
SRH values if a participant is missing a SRH value from an interim AFU. 
Further, Kreiger et al. provided preliminary data in support of the use of US census tract 
variables based on economic indicators (e.g., income, poverty) for the study of neighborhood 
SES and adverse health outcomes (N. Krieger et al., 2003).  Results from the Public Health 
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Geocoding Disparities Project (N. Krieger et al., 2003) suggested that individual 
neighborhood SES measures captured the neighborhood economic environment as well as 
more complex composite indexes.  Previous research in ARIC community surveillance also 
supports our selection of a single US census tract variable, median household income, to 
represent neighborhood SES for these analyses.  In a comparison of three single-variable 
measures (median household income, percent below poverty and percent of households 
headed by women) and one composite index (A. V. Diez-Roux et al., 2001), relationships 
between neighborhood SES and incident hospitalized MI were consistent across 
neighborhood SES measures (Abstracts of the 41st Annual Meeting of the Society for 
Epidemiologic Research June 24-27, 2008, 2008).  In a study of incident hospitalized MI 
rates across all four ARIC study communities, the association with neighborhood SES were 
consistent using either overall (community-wide), community-specific or race-specific 
cutpoints for median household income (Kathryn M. Rose et al., 2009).  For the purpose of 
this study, we used community-wide cutpoints to capture the influence of median household 
income, since overall cutpoints better represent the income distribution of the study 
population from which the cohort was sampled. 
When we included a tract-level neighborhood SES measure in the statistical models, we 
accounted for the dependence of observations among participants from the same census tract 
of residence.  Otherwise, the standard error of the estimates would have been underestimated.  
Multilevel modeling adjusts the standard error of the estimates to allow for the dependence of 
observations within the same cluster.  We were able to include participant characteristics as 
the first level of analysis clustered within census tracts as second-level units.  We reported 
the presence or absence of an association between neighborhood SES and HF progression, 
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and did not attempt to make a direct causal inference due to the hierarchical structure of the 
analysis (Greenland, 2002; Greenland & Brumback, 2002; Oakes, 2004).  Failing to account 
for the clustering of participants in census tracts may obscure some important neighborhood 
effects.  For example, in the National Heart Care Project, one-year mortality was found to be 
greater in whites than blacks among Medicare enrollees with incident HF developing chronic 
kidney disease during follow-up.  However, upon adjusting for state and hospital cluster, 
racial differences disappeared, indicating a greater influence of geography in the analyses 
(Smith et al., 2005).  The use of generalized estimation equations also accounted for the 
clustering of hospitalizations within patients, as some of the analyses involved repeated 
measures data. 
Cause of death data are difficult to quantify with respect to HF, since HF is rarely listed 
as an underlying cause of death (Murdoch et al., 1998).  According to guidelines for 
completing death certificates (CDC, 2003, 2004), congestive HF is a broad differential 
diagnosis and cannot be listed as an underlying cause of death, since its etiology should 
always follow its mention on the death certificate (Figure 4.5).  Figure 4.5 shows two 
examples of how HF may be validly recorded on a death certificate – either as a significant 
condition contributing to death or as an immediate cause of death, with named underlying 
etiology.  Often death certificates neglect to mention HF, and are insensitive to capturing a 
prior history of HF (Anthony et al., 2009).  As a result, the number of persons dying with HF 
is likely to be underestimated if using death certificate data. 
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Figure 4.5. Two examples of heart failure recorded correctly on death certificates 
 
HF as a significant condition contributing to death 
 
 
 
HF as an immediate cause of death, with named underlying etiology 
 
 
 (CDC, 2003) 
 
 
However, a focus of the current research is all-cause mortality among participants with 
HF.  Our inclusion criteria specify that participants develop incident hospitalized HF over the 
course of follow-up.  Therefore, the analyses presented in this work do not rely on death 
certificate information regarding cause of death, nor were death certificates used to determine 
if participants had HF.  Thus, readers can assume that if the death certificates were completed 
accurately for these individuals, HF would be listed as a significant condition contributing to 
death or as an immediate cause of death. 
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As completeness of SRH data depend upon multiple measures pre- and post-event 
diagnosis, low loss to follow-up is important.  In the ARIC cohort, according to ARIC 
coordinating center communication, approximately 93% of living participants were contacted 
in year 19 of the study and did not refuse to participate.  Therefore, in reference to AFU data 
used in the current study, only 7% of ARIC cohort participants have been lost to follow-up. 
With regard to our assessment of clinical variables, hypertension and overweight/obesity 
data were collected at baseline, prior to the incident HF admission.  An advantage of utilizing 
baseline values instead of medical record data is that the presenting level of blood pressure 
may not be indicative of typical blood pressure levels, and overweight or obesity upon 
hospital admission may be due to fluid retention/edema.  Furthermore, burden of 
comorbidity, as determined by the modified Charlson index (Senni et al., 2006) which 
excludes the point value for congestive HF, was assessed for the current study by searching 
hospital discharge codes from the incident HF hospitalization.  It is well-documented that 
hospital discharge data provide limited information regarding conditions other than those 
involving the principle diagnosis (J.G.F Cleland et al., 2003; D. S. Lee et al., 2005).  As a 
result, many studies utilizing the Charlson index have included comorbidities from all 
hospital admissions associated with a particular condition (Cleves et al., 1997), or during the 
one year (Deyo et al., 1992) or five years (Blackledge et al., 2003; S. Stewart et al., 2002) 
prior to the hospitalization of interest.  A strength of our study is that we were able to 
construct the modified Charlson index utilizing information from hospitalizations up to five 
years’ prior to the incident HF hospitalization to see how the distribution of comorbidity in 
our sample changed (Table 4.3).  Data from the index hospitalized HF event was used 
because all patients had those data available.  If data from prior years were used, the subset 
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of patients with prior hospitalizations would have had more opportunities to have 
comorbidities listed in the discharge summary, yet may not have truly had a higher burden of 
comorbidity than those patients first identified during the index HF hospitalization. 
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Table 4.3. Prevalence (%) of Charlson comorbidity index components during the index and prior to the index heart failure 
hospitalization, The ARIC study (1987-2004) 
  Incident HF 
hospitalization 1 year prior 2 years prior 3 years prior 4 years prior 5 years prior 
  N=1,342 N=512 N=674 N=793 N=877 N=917 
Myocardial infarction Y 
N 
12.7 
87.3 
17.0 
83.0 
16.6 
83.4 
15.6 
84.4 
16.5 
83.5 
16.6 
83.4 
Peripheral vascular disease Y 
N 
7.8 
92.2 
5.7 
94.3 
5.0 
95.0 
5.0 
95.0 
4.7 
95.3 
4.7 
95.3 
Cerebrovascular disease Y 
N 
9.0 
91.0 
7.8 
92.2 
7.6 
92.4 
6.3 
93.7 
6.4 
93.6 
7.0 
93.0 
Dementia Y 
N 
0.6 
99.4 
0.2 
99.8 
0.5 
99.5 
0.3 
99.7 
0.2 
99.8 
0.2 
99.8 
Chronic pulmonary disease Y 
N 
27.4 
72.6 
13.7 
86.3 
11.1 
88.9 
11.4 
88.6 
11.3 
88.7 
11.3 
88.7 
Rheumatologic disease Y 
N 
2.5 
97.5 
2.2 
97.8 
1.6 
98.4 
1.3 
98.7 
1.3 
98.7 
1.2 
98.8 
Mild liver disease Y 
N 
0.8 
99.2 
0.4 
99.6 
0.3 
99.7 
0.3 
99.7 
0.2 
99.8 
0.2 
99.8 
Diabetes Y 
N 
21.8 
78.2 
21.1 
78.9 
20.4 
79.6 
19.2 
80.8 
20.0 
80.0 
19.2 
80.8 
Diabetes with end organ 
damage 
Y 
N 
4.1 
95.9 
2.9 
97.1 
2.1 
97.9 
1.5 
98.5 
1.3 
98.7 
0.1 
99.9 
Hemiplegia or paraplegia Y 
N 
1.5 
98.5 
1.4 
98.6 
0.7 
99.3 
0.5 
99.5 
0.8 
99.2 
0.9 
99.1 
Moderate or severe kidney 
disease 
Y 
N 
2.8 
97.2 
1.2 
98.8 
0.5 
99.5 
0 
100 
0.1 
99.9 
0.2 
99.8 
Moderate or severe liver 
disease 
Y 
N 
0.6 
99.4 
0.2 
99.8 
0 
100 
0.1 
99.9 
0.1 
99.9 
0 
100 
Index score of ≥2+ Y 
N 
23.4 
76.6 
18.6 
81.4 
15.6 
84.4 
13.9 
86.1 
14.4 
85.6 
14.0 
86.0 
Index score 0 35.3 60.9 62.9 64.8 64.1 63.9 
 1 41.3 20.5 21.5 21.3 21.6 22.1 
 2 16.0 11.1 11.1 10.3 10.8 10.6 
 3 3.5 5.3 3.1 2.8 2.6 2.6 
 4 2.9 1.2 1.0 0.4 0.6 0.7 
 5 0.9 1.0 0.3 0.4 0.4 0.7 
 6 0.1 - - - 0.1 0.1 
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2. Limitations 
Annual follow-up and ongoing surveillance of the ARIC cohort participants allowed for 
the identification of hospitalized incident HF cases occurring since baseline.  It is 
hypothesized that the prognosis for hospitalized HF patients is worse than for patients 
diagnosed in the community (Blackledge et al., 2003).  Although data is currently collected 
on out-of-hospital management of HF in the ARIC cohort, acquisition of these data has only 
recently begun, and were not available for this analysis.  Therefore, the results of these 
analyses are most generalizable to those HF events occurring in-hospital, and may not be 
representative of cases occurring in the community outpatient setting. 
In the ARIC cohort, incident hospitalized HF is identified by a HF diagnostic code 
428.0-428.9 in any position in the hospital discharge record, and is not validated by physician 
adjudication.  Abstractors are instructed to record discharge codes as they appear in the 
hospital record, yet no particular order of codes is specified in the instructions for the 
abstractors (ARIC, 2007b).  Therefore, the position of the discharge code (e.g., first or 
second position) may not be reliable in ARIC.  A limitation of these data, then, is an inability 
to determine how salient the HF diagnosis was to the hospitalization in question.  
Alternatives to the use of discharge codes in the diagnosis of HF are physical exams or 
physician review of hospital records to validate the diagnosis.  Physical exams were 
conducted in the ARIC cohort at baseline (1987-1989) and at three in-person visits thereafter.  
However, the last visit was held in 1998, and there are no physical exam data for the ARIC 
cohort after that time.  In general, methods for diagnosing HF via physical exam are varied 
(Fonseca, 2006; van Kraaij et al., 2002) and depend on clinical findings not easily identified 
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nor commonly looked for during a physical exam (Kirkpatrick & Lang, 2008; Young & 
Worthley, 2004).  Physician adjudication of HF events in the ARIC cohort is currently 
underway for discharge records abstracted since 2007 (ARIC, 2007c).  Physician review of 
medical records requires availability of trained study personnel and is an added expense to 
monitor.   
According to Goff et al. (2000), the ICD-9-CM code 428 in the first or second discharge 
diagnosis position among hospitalized MI patients in the Corpus Christi Heart Project was 
associated with 63% sensitivity, 95% specificity, 84% positive predictive value and 87% 
negative predictive value.  In comparison with an algorithm including both 428 and 402 
codes (67% sensitivity, 93% specificity, 77% positive predictive value and 88% negative 
predictive value), the use of code 428 to identify HF resulted in a 25% underestimate of HF-
related hospitalizations (vs. 13%).  However, Shahar et al. (2004) found 85% of 
hospitalizations coded as HF (ICD-9-CM 428) met the majority of HF definitions per 
published criteria (Shahar et al., 2004).  Further, in a community-based cohort study, Roger 
et al. found that the ICD-9-CM code 428 identified 80% of the HF cases, and 82% of these 
cases also met Framingham criteria for HF.  In comparison, other ICD-9-CM HF codes that 
were not used in conjunction with a 428 code met Framingham criteria for HF in only 14-
30% of the cases (Roger et al., 2004).  
Inaccuracies in identifying HF hospitalizations with the use of ICD-9-CM codes have 
implications with regard to this project.  Specifically, it is concerning that the use of the 
discharge diagnosis code 428 may not adequately capture the hospitalized burden of HF 
among ARIC cohort members.  However, heart failure signs and symptoms were not 
assessed during physical examinations of participants over the course of the ARIC study, so a 
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gold standard definition of HF as used in other studies (Goff et al., 2000) is not applicable to 
the proposed project.  Data are currently being collected on outpatient diagnosis of heart 
failure among ARIC cohort members.  In the future it will be possible to assess, as these 
outpatient data become available, whether participants identified with HF on an outpatient 
basis have also been identified with HF as an inpatient according to hospital records. 
Although there is concern regarding correctly identifying incident hospitalized HF in the 
study population using ICD-9-CM discharge codes, data which also accurately capture 
subsequent hospitalizations are necessary.  While it is probable that incident hospitalized HF 
events were underestimated in the ARIC cohort, the assessment of repeat hospitalizations is 
likely biased in the other direction.  Repeat hospitalizations for HF are undoubtedly a burden 
on the health care system, however, it is likely that more hospitalizations are attributed to HF 
than are actually due to the condition.  An important limitation of utilizing hospital record 
data is that once an individual receives a diagnosis code for HF on their hospital discharge 
report, the HF diagnosis code is often reassigned, or carried over, to subsequent 
hospitalizations at that hospital, even if the primary reason for the rehospitalization is not HF.  
Therefore, the current study assesses all-cause, CVD- and HF-related rehospitalizations, 
respectively, in order to represent a range of plausible values for rehospitalization rates 
among participants with an incident hospitalized diagnosis of HF. 
G. IRB/ Human Subjects 
Approval for this project was obtained through the Institutional Review Board of the 
University of North Carolina Gillings School of Global Public Health.  No additional contact 
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was made with study participants, as all analyses were of secondary data.   The ARIC study 
coordinators at each clinic site obtained approval for data collection.   
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V. Socioeconomic Status, Medicaid Coverage, Clinical Comorbidity and 
Rehospitalization or Death following an Incident Heart Failure Hospitalization: 
ARIC Cohort (1987-2004) 
The first manuscript prepared and submitted to a peer-reviewed journal incorporated two 
aspects of HF progression: rehospitalization and mortality.  With respect to the dissertation 
outline, this manuscript presents the results and discusses the implications of Aims 1 and 2. 
The concepts of rehospitalization and mortality work well together as a body of work, 
since both outcomes are a result of severe or decompensated HF.  This manuscript adds to 
the literature, since existing studies of morbidity and mortality are limited by short-term 
follow-up.  In addition, reports based on clinical trials often explore rehospitalization or 
mortality as a composite endpoint, yet rehospitalization and mortality represent distinct 
entities, and warrant individual evaluation. 
A. ABSTRACT 
Repeat hospitalizations among persons with heart failure (HF) are often due to a 
worsening of HF symptoms and are a burden on the health care system.  A short time to 
rehospitalization or death among HF patients may be a marker of severe disease, inadequate 
outpatient management of HF symptoms, or both. We compared the association of 
neighborhood median household income (nINC) and receipt of Medicaid with 
rehospitalization or death among Atherosclerosis Risk in Communities cohort study 
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participants following an incident HF hospitalization (1987-2004). We categorized 1990 US 
Census tract-level nINC into tertiles based upon participants' place of residence at baseline, 
and used generalized linear Poisson mixed models to estimate rehospitalization rate ratios 
and 95% confidence intervals (RR, 95% CI), accounting for clustering within census tracts. 
We used Cox regression to estimate hazard ratios (HR, 95% CI) of rehospitalization or death.  
We assessed for effect measure modification by sociodemographic and clinical variables, and 
comorbidity burden significantly modified the nINC-rehospitalization/mortality relationship. 
Of 1,342 incident HF patients, 89% were rehospitalized, 47% died, and 91% were 
rehospitalized or died by the end of 2004.  In models controlling for race/study community, 
gender, age at HF diagnosis, body mass index, hypertension, educational attainment, alcohol 
use and smoking, persons with a high burden of comorbidity who were living in low nINC 
areas at baseline had an elevated hazard for all-cause rehospitalization (1.40, 1.10-1.77), 
death (1.36, 1.02 -1.80), rehospitalization or death (1.36, 1.08-1.70) – as well as increased 
rates of all-cause and cardiovascular disease-related hospitalizations – compared to those 
with a high burden of comorbidity living in high nINC areas.  Meanwhile, Medicaid 
recipients with a low level of comorbidity had an increased hazard of all-cause 
rehospitalization (1.19, 1.05 -1.36) and rehospitalization or death (1.21, 1.07-1.37), and a 
higher rate of repeat hospitalizations compared to non-Medicaid recipients.  In summary, 
participants from low nINC areas with a high burden of comorbidity were at greater risk for 
rehospitalization or death following a HF diagnosis, while Medicaid recipients with a low 
comorbidity burden were rehospitalized more often.  Comorbidity burden appears to 
influence the association between nINC, Medicaid status and rehospitalization and death 
among HF patients. 
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B. INTRODUCTION 
Hospital discharges for heart failure (HF) increased 157% from 1979 to 2002 (Heart 
Disease and Stroke Statistics - 2005 Update, 2005), and continue to rise (D. Lloyd-Jones et 
al., 2010).  HF rehospitalizations, which are often preventable (MedPAC, 2007), tend to be 
higher among older patients, non-whites, and patients with prior hospitalizations and multiple 
primary care visits (Fang et al., 2008; Ghali et al., 1990; Inouye et al., 2008; Schocken et al., 
2008).  In addition to being recognized as a major cause of serious morbidity (Adams et al., 
2005; Cowie et al., 2002; H. Eriksson, 1995; Hoyt & Bowling, 2001), HF mortality is high 
(Jong et al., 2002; M. S. Nieminen & Harjola, 2005).  From 1980 to 1995, the number of 
deaths in the US with an underlying cause of HF increased nearly 70% (Haldeman et al., 
1999).  HF is a primary or contributory cause of more than 300,000 deaths each year in the 
US (Hunt et al., 2001), and HF mortality rates increase sharply with age. 
Among Atherosclerosis Risk in Communities (ARIC) study (1987-2002) cohort 
members with incident HF, 30-day mortality was 10%, while one- and five-year mortality 
was 22% and 42%, respectively (Loehr et al., 2008).  Several studies with a combined 
endpoint of rehospitalization or mortality report a prevalence of rehospitalization or death of 
31-35% at 60 days (Felker et al., 2004; O'Connor et al., 2005), and 81% (Zannad et al., 1999) 
at one year. 
A shorter interval of time between initial hospitalization for HF and readmission or death 
may be an indicator of poor patient health and more severe disease.  Patients diagnosed with 
HF often have coexisting clinical comorbidities.  Chronic conditions such as hypertension, 
coronary heart disease (CHD), diabetes and obesity are risk factors for the development of 
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HF (Schocken et al., 2008; Weir et al., 2006), and clinical HF is commonly accompanied by 
one or more of these factors (Heywood et al., 2007).  In general, the burden of mortality 
(Charlson et al., 1987; Deyo et al., 1992; Jong et al., 2002) and rehospitalization (Philbin & 
DiSalvo, 1999) increases with increasing comorbidity.  However, in populations, variations 
in HF morbidity and mortality are not completely explained by clinical features of the disease 
(Fonarow, 2008), suggesting the need to explore understudied domains, such as the influence 
of the socioeconomic context. 
Low socioeconomic status is associated with higher HF incidence (He et al., 2001; 
Ingelsson et al., 2006; F. A. McAlister et al., 2004; Schaufelberger & Rosengren, 2007; S. 
Stewart et al., 2006), rehospitalization and survival (Philbin et al., 2001; Rathore et al., 2006; 
S. Stewart et al., 2002; Simon Stewart et al., 2001; Wen & Christakis, 2005).  Meanwhile, 
health insurance status is associated with care-seeking behavior (Go et al., 2006; Philbin & 
DiSalvo, 1999) and subsequent disease outcomes (Ayanian et al., 1993).  Medicaid, in 
particular, may exert effects on health outcomes which are independent of socioeconomic 
status (Foraker et al., 2008; Ross & Mirowsky, 2000), as its receipt is determined by having 
certain diseases and disabilities or an income below the poverty line (Ku, 2005; Rosenbaum, 
2002).  Evidence suggests that social and environmental contexts play an important role in 
health outcomes (Ana V Diez Roux et al., 2004; Nancy Krieger et al., 2002; Marmot, 2003), 
however, research to date has not assessed the influence of neighborhood socioeconomic 
status or receipt of Medicaid on the risk of rehospitalization or mortality among HF patients 
in the context of individual socioeconomic, demographic and comorbid factors.  We 
examined the role of neighborhood SES in rehospitalization or death after initial HF events in 
the ARIC study. 
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C. MATERIALS AND METHODS 
ARIC cohort participants (N=15,792) were enrolled from 1987-1989 from the following 
four US communities: Forsyth County, North Carolina; Washington County, Maryland; 
suburbs of Minneapolis, Minnesota and Jackson, Mississippi (The Atherosclerosis Risk in 
Communities (ARIC) study: design and objectives, 1989).  Cohort members are contacted 
yearly, regardless of whether or not they continue to reside within the study boundaries.  As 
part of annual follow-up, information regarding inpatient hospital stays is collected, and 
hospitalization data are abstracted from the medical record.   
All-cause hospitalizations are identified during annual follow-up or during routine ARIC 
community surveillance (White et al., 1996).  For the current study, cardiovascular disease 
(CVD)-related hospitalizations were further identified from all-cause hospitalizations using 
International Classification of Diseases, Version 9 (ICD-9) discharge codes 402, 410-414, 
427, 428, 430-436 or 518.4; while a HF-related hospitalization was defined as that with an 
ICD-9 discharge code 428 (ARIC, 2007a). 
Participants’ addresses obtained at baseline were assigned to the level of the census tract 
by a vendor with high geocoding accuracy (Whitsel et al., 2004).  The 1990 US census tract-
level neighborhood-level socioeconomic measure selected for study was median household 
income (nINC).  In previous work, the use of the single-variable nINC measure produced 
results of similar magnitude and precision when compared to a more complex composite 
index measure of neighborhood SES (Kathryn M. Rose et al., 2009).  We categorized nINC 
into community-wide tertiles based upon participants' place of residence at baseline, during 
the period 1987-1989: low (<$24,777), medium ($24,777≤-<36,071) and high (≥$36,071).  
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We did not take into account whether or not cohort members changed their address from 
baseline, as the study population was relatively stable.  Unpublished data indicate that of 
participants with complete address information through visit three, 84% had lived in the same 
census tract since baseline, and even if they changed place of residence, 92% of participants 
remained in the same nINC tertile throughout follow-up. 
After excluding 245 participants with prevalent HF at baseline, 1,415 participants had an 
incident hospitalized HF event through 2004.  An additional 70 participants were excluded 
due to missing data on neighborhood socioeconomic status, and 3 were excluded because 
they were not white or black, or were blacks living in Minnesota or Maryland, resulting in a 
final sample size of 1,342 participants. 
Covariates included race/study community, gender, age at incident HF hospitalization 
and selected socioeconomic, clinical and behavioral characteristics.  Educational attainment 
was assessed at baseline (less than 11 years, high school graduate, and greater than high 
school), as was health insurance status at the time of the index HF hospitalization (receipt of 
Medicaid, yes/no).  Participants' body mass index (BMI) was assessed at baseline and 
classified as normal (<25 kg/m2), overweight (25-<29.9 kg/m2) or obese (≥29.9 kg/m2).  
Hypertensive status at baseline was identified as systolic blood pressure ≥140 mmHg, 
diastolic blood pressure ≥90 mmHg, or taking hypertensive medication within the previous 
two weeks.  Teaching status of the hospital during the index admission (teaching vs. non-
teaching), was based upon whether or not the hospital has an internal medicine residency 
training program.   
  
 92
We ascertained the prevalence of common underlying conditions at the time of the index 
HF hospitalization using ICD-9 discharge codes.  The Charlson Index, a clinical comorbidity 
algorithm (Deyo et al., 1992), was derived from these data (Table 2).  The Charlson Index is 
a validated measure used to quantify the burden of comorbidity in several studies of mortality 
and adverse health outcomes (Charlson et al., 1987; Deyo et al., 1992).  In its use with HF 
outcomes, a “modified” Charlson Index excludes chronic HF from the conditions included in 
the computation of the comorbidity score (Senni et al., 2006).  Consistent with previous 
studies, we defined a high burden of comorbidity as a sum of two or more points on the 
Charlson Index scale, whereas a low burden of comorbidity was defined with a total of zero 
to one points. 
We used generalized linear Poisson mixed models to estimate all-cause, CVD-related 
and HF-related rehospitalization rate ratios, comparing the rates of participants from low 
nINC to high nINC, medium nINC to high nINC and Medicaid recipients to non-Medicaid 
recipients, along with 95% confidence intervals (RR, 95% CI).  This modelling strategy 
accounted for repeat hospitalizations among patients as well as the clustering of patients 
within census tracts.  Time at risk for rehospitalization was the time elapsed between the 
incident HF hospitalization admission date and death, loss to follow-up or the end of 2004, 
whichever came first.  We assessed for over-dispersion by consulting the deviance statistic of 
the Poisson model, and conducted supplementary analyses using negative binomial 
regression when the deviance statistic exceeded one (Dallal, 2008; Rao & Scott, 1999). 
The product-limit (Kaplan-Meier) method was used to measure time to readmission, 
death, or readmission or death over the course of follow-up.  Multivariate Cox proportional 
hazard models estimated the risk of death or rehospitalization or death, and rehospitalization 
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alone using death during follow-up as the censoring variable.  The model produced survival 
curves depicting survival free of readmission or death, and the proportional hazards 
assumption was assessed.  All participants were censored at the end of 2004. 
Crude nINC-rehospitalization/mortality analyses were conducted, the influence of 
covariates in a full model were tested, and effect modification (pinteraction<0.05) of the nINC-
rehospitalization/mortality relationship was assessed by age, race/study community, gender, 
hypertension, BMI and comorbidity index score.   
D. RESULTS 
Among participants with an incident HF hospitalization, approximately half (46%) were 
female, one-third (33%) were black and the average age at the time of the index event was 67 
years.  As shown in Table 5.1, a greater proportion (55%) of participants from low nINC 
areas had attained 11 or fewer years of education, as compared to participants in medium 
(35%) and high (19%) nINC areas.  Twenty percent of participants living in low nINC areas 
were Medicaid recipients, in contrast to 3% of those living in medium and high nINC areas 
(Table 5.1). 
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Table 5.1. Characteristics of participants with an incident hospitalized heart failure 
event (n=1,342), The ARIC study (1987-2004) 
 Medicaid Recipient Median Household Income (nINC) 
 Yes 
N=135 
No 
N=1,207 
Low 
N=553 
Medium   
N=454 
High  
N=335 
 N % N % N % N % N % 
Characteristics at Baseline       
Median Household Income, mean 17,897 29,456 16,519 31,799 42,979 
Gender    
Female
Male
97 
38 
71.9 
28.1 
513 
694 
42.5 
57.5 
309 
244 
55.9 
44.1 
173 
281 
38.1 
61.9 
128 
207 
38.2 
61.8 
Race/Study Community           
Black/Forsyth
Black/Jackson
White/Forsyth County
White/Washington County
White/Minneapolis
5 
97 
9 
20 
4 
3.7 
71.9 
6.6 
14.8 
3.0 
40 
300 
264 
363 
240 
3.3 
24.8 
21.9 
30.1 
19.9 
26 
369 
42 
103 
13 
4.7 
66.7 
7.6 
18.6 
2.4 
17 
6 
141 
232 
58 
3.7 
1.3 
31.1 
51.1 
12.8 
2 
22 
90 
48 
173 
0.6 
6.6 
26.9 
14.3 
51.6 
Hypertensivea           
Yes
No
Missing
112 
57 
- 
66.3 
33.7 
- 
598 
564 
11 
51.0 
48.1 
0.9 
349 
200 
4 
63.1 
36.2 
0.7 
200 
251 
3 
44.1 
55.3 
0.7 
161 
170 
4 
48.1 
50.8 
1.1 
Body Mass Index (BMI)b           
Obese
Overweight
Normal
Missing
75 
37 
23 
- 
55.6 
27.4 
17.0 
- 
503 
447 
255 
2 
41.7 
37.0 
21.1 
0.2 
273 
186 
93 
1 
49.4 
33.6 
16.8 
0.2 
172 
173 
109 
- 
37.9 
38.1 
24.0 
- 
133 
125 
76 
1 
39.7 
37.3 
22.7 
0.3 
Current Drinker           
Yes
No
32 
103 
23.7 
76.3 
589 
618 
48.8 
51.2 
168 
385 
30.4 
69.6 
237 
217 
52.2 
47.8 
216 
119 
64.5 
35.5 
Current Smoker           
Yes
No
56 
79 
41.5 
58.5 
417 
790 
34.5 
65.5 
204 
349 
36.9 
63.1 
161 
293 
35.5 
64.5 
108 
227 
32.2 
67.8 
Educational Attainment (years)           
 Advanced (17-21)
Intermediate (12-16)
 Basic (≤11)
Missing
12 
26 
96 
1 
8.9 
19.3 
71.1 
0.7 
307 
472 
425 
3 
25.4 
39.1 
35.2 
0.3 
79 
169 
302 
3 
14.3 
30.6 
54.6 
0.5 
106 
190 
157 
1 
23.4 
41.9 
34.5 
0.2 
134 
139 
62 
- 
40.0 
41.5 
18.5 
- 
Characteristics at Index Hospitalization        
Age, mean (SD) 67.5 (6.1) 66.9 (6.9) 66.0 (6.8) 67.9 (6.6) 67.5 (6.9) 
Charlson Comorbidity Index Scorec        
≥2
<2
37 
98 
27.4 
72.6 
277 
930 
23.0 
77.0 
126 
427 
22.8 
77.2 
118 
336 
26.0 
74.0 
70 
265 
20.9 
79.1 
Medicaid Recipientd           
Yes
No
- 
- 
- 
- 
- 
- 
- 
- 
111 
442 
20.1 
79.9 
15 
439 
3.3 
96.7 
9 
326 
2.7 
97.3 
aSystolic blood pressure ≥140mmHg or diastolic blood pressure ≥90mmHg, or blood pressure medication in the   
last two weeks. 
bNormal BMI: <25kg/m2; overweight: 25-<29.5kg/m2; and obese: ≥29.5kg/m2 
cAdapted for use with ICD-9 discharge codes 
dAs indicated in medical record 
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By the end of 2004, 89% of participants with an incident HF hospitalization had been 
rehospitalized at least once (mean: 3.6; range: 0-47), 47% died, and 91% had been 
rehospitalized or had died.  Figure 5.1 shows life table trends of rehospitalization, death and 
rehospitalization or death by person-time elapsed since the incident hospitalized HF event.  
At 30 days, 19% had been rehospitalized, while at 6 months 13% had died, and at one year, 
62% had been rehospitalized or had died (Figure 5.1). 
Figure 5.1. Cumulative proportion of participants with an incident heart failure 
hospitalization experiencing rehospitalization, death and rehospitalization or death, 
The ARIC study (1987-2004) 
 
 
Almost one-quarter of participants had a comorbidity index score of two or greater 
(Table 1).  Charlson comorbidity index components and their associated point values are 
shown in Table 3.2.  The most common comorbidities identified at the index hospitalization 
were chronic pulmonary disease (27%), diabetes (22%) and myocardial infarction (13%).  
Figure 5.2 shows the prevalence of each of the comorbidity index components at the index 
hospitalization.  The comorbidity index score modified the nINC-rehospitalization/mortality 
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relationship in Cox proportional hazards (time-to-event) and Poisson (rate) analyses.  
Therefore, subsequent results are presented stratified by level of the comorbidity score (≥2 
vs. <2). 
Figure 5.2. Number of participants with prevalent comorbid disease during the incident 
HF hospitalization, Charlson index of comorbidity: The ARIC study (1987-2004) 
 
 
Time-to-event analyses 
 
Crude median rehospitalization- and mortality-free survival times, in days, varied by 
comorbidity index score (high vs. low) among participants in each nINC tertile [low nINC 
(107 vs. 283), medium nINC (118 vs. 128) and high nINC (161 vs. 229)] as well as by 
receipt of Medicaid [recipients (60 vs. 168), those not receiving Medicaid (133 vs. 217)].  
Participants with a high burden of comorbidity experienced shorter times to rehospitalization 
and death compared to participants with a low burden of comorbidity across nINC and 
Medicaid groups.  Figure 5.3 shows survival curves adjusted for age, race/study community, 
and gender, and stratified by comorbidity index score and level of nINC.  Among participants 
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with a high burden of comorbidity, those living in high nINC areas experienced the longest 
rehospitalization- and mortality-free survival, while those living in low nINC areas 
experienced the shortest.  The observed nINC gradient did not persist among participants 
with a low burden of comorbidity (Figure 5.3).  However, survival was most favorable for 
participants with a low burden of comorbidity who were not Medicaid recipients, and least 
favorable for participants with a high burden of comorbidity who were Medicaid recipients 
(data not shown). 
Figure 5.3. Survival curve depicting time elapsed from the incident hospitalized heart 
failure event until rehospitalization or death, by nINC and comorbidity, The ARIC 
study (1987-2004) 
 
 
The nINC/Medicaid-rehospitalization/mortality survival relationships (HR, 95% CI) are 
shown in Table 5.2.  In models controlling for race/study community, gender, age at HF 
diagnosis, body mass index, hypertension, educational attainment, alcohol use and smoking, 
persons with a high burden of comorbidity who were living in low nINC areas at baseline 
had an elevated risk for all-cause rehospitalization (1.40, 1.10-1.77), death (1.36, 1.02 -1.80) 
and rehospitalization or death (1.36, 1.08-1.70) compared to those with a high burden of 
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comorbidity living in high nINC areas.  In contrast, participants with a low burden of 
comorbidity who were living in low nINC areas at baseline did not experience an increased 
risk for death.  Medicaid recipients with a low level of comorbidity had an increased risk of 
all-cause rehospitalization (1.19, 1.05 -1.36) and rehospitalization or death (1.21, 1.07 -1.37) 
compared to non-Medicaid recipients with a low level of comorbidity.  A significantly lower 
hazard of death was seen among those with a higher burden of comorbidity living in medium 
nINC areas compared to those living in high nINC areas  (0.74, 0.59-0.93).      
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Table 5.2. Hazard ratios and 95% confidence intervals for rehospitalization, death or 
rehospitalization or death among participants with an incident hospitalized heart 
failure event, The ARIC study (1987-2004) 
 Charlson Index Score ≥2 Charlson Index Score <2 
 Model 1a Model 2b Model 1a Model 2b 
All-cause 
Rehospitalization 
    
nINC     
     Low  1.23 (1.00, 1.51) 1.40 (1.10, 1.77) 1.13 (1.01, 1.26) 1.16 (1.04, 1.30) 
     Medium 1.07 (0.91, 1.27) 1.14 (0.95, 1.36) 1.26 (1.15, 1.39) 1.28 (1.16, 1.41) 
     High 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
Medicaid Recipient      
     Yes 1.18 (0.95, 1.46) 1.12 (0.89, 1.40) 1.17 (1.03, 1.32) 1.19 (1.05, 1.36) 
     No 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
Death     
nINC     
     Low  1.34 (1.04, 1.72) 1.36 (1.02, 1.80) 1.12 (0.97, 1.30) 1.09 (0.94, 1.26) 
     Medium 0.75 (0.61, 0.93) 0.74 (0.59, 0.93) 0.91 (0.79, 1.03) 0.90 (0.78, 1.02) 
     High 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
Medicaid Recipient      
     Yes 0.99 (0.76, 1.30) 0.95 (0.72, 1.25) 1.03 (0.87, 1.23) 0.96 (0.80, 1.14) 
     No 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
All-cause 
Rehospitalization or 
Death 
    
nINC     
     Low  1.23 (1.01, 1.50) 1.36 (1.08, 1.70) 1.09 (0.98, 1.21) 1.13 (1.02, 1.26) 
     Medium 1.00 (0.85, 1.17) 1.04 (0.87, 1.23) 1.24 (1.13, 1.36) 1.27 (1.15, 1.39) 
     High 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
Medicaid Recipient      
     Yes 1.23 (1.00, 1.51) 1.17 (0.95, 1.45) 1.17 (1.04, 1.32) 1.21 (1.07, 1.37) 
     No 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
anINC and Medicaid status plus race/study community, gender and age at index event 
bModel 1 plus hypertension, body mass index, current smoker, current drinker and educational attainment 
 
 
Of 1,342 participants with an incident HF hospitalization, 255 (19%) were not 
rehospitalized for any cause, while 318 (24%) were not rehospitalized for a CVD-related 
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cause and 590 (44%) were not rehospitalized for HF.  All-cause rehospitalization rates per 
100 person-years (95% CI) were 71.3 (63.3-80.4) for low nINC, 71.9 (64.5-80.2) for medium 
nINC, and 54.3 (47.7-61.7) for high nINC. 
In models controlling for race/study community, gender, age at HF diagnosis, BMI, 
hypertension, educational attainment, receipt of Medicaid, alcohol use and smoking, 
participants with a higher burden of comorbidity living in low nINC areas had a higher risk 
of all-cause (1.67, 1.01-2.76) and CVD-related (1.82, 1.08-3.07) – but not HF-related (1.65, 
0.81-3.34) – hospitalizations, compared to those with a high burden of comorbidity living in 
high nINC areas.  Participants living in medium nINC areas at baseline did not have an 
elevated risk compared to participants living in high nINC areas, nor was there an nINC 
differential among participants with a low burden of comorbidity.  Similar results were seen 
for CVD-related hospitalizations; however, no nINC effect in either strata of comorbidity 
burden was seen for HF-related hospitalizations, possibly due to relatively few events 
meeting the criteria for HF-related hospitalizations.  Among participants with a low 
comorbidity burden, Medicaid recipients were at increased risk for all-cause hospitalizations.  
The observed results persisted for Medicaid recipients with a low comorbidity burden in 
analyses for CVD- and HF-related hospitalizations (Figure 5.4). 
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Figure 5.4. Rate ratios and 95% confidence intervals for rehospitalization among 
participants with an incident hospitalized heart failure event by type of 
rehospitalization, The ARIC study (1987-2004) 
All-cause Rehospitalizations CVD-related Rehospitalizations 
  
HF-related Rehospitalizations 
 
 
 
 
In our data, the Poisson models used for estimating rehospitalization rate ratios yielded a 
deviance statistic of close to four.  Thus, over-dispersion was suggested.  In response, we fit 
negative binomial models to the data.  As expected, the point estimates of the rate ratios did 
not change, however, the confidence intervals widened with the application of the negative 
binomial model, reflecting the effect over-dispersion had on these data.  Although the 
negative binomial estimates were less precise, the analyses accounting for over-dispersion 
did not change our interpretation of the results (data not shown). 
In summary, accounting for all potential covariates, participants living in low nINC 
areas at baseline with a high burden of comorbidity were at greater risk for both 
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rehospitalization and death, as well as a higher rate of repeat hospitalizations, following an 
in-hospital HF diagnosis.  Meanwhile, Medicaid recipients with fewer comorbidities had a 
significantly higher rate of repeat hospitalizations than participants in the same comorbidity 
category who were not Medicaid recipients.  Additional adjustment for hospital type 
(teaching vs. non-teaching) did not change the results. 
E. DISCUSSION 
In this study, incident HF hospitalizations were more common among ARIC cohort 
participants of low and medium nINC compared to those living in high nINC areas at 
baseline.  Further, low nINC participants with an elevated comorbidity index score at the 
time of the incident hospitalized HF event were rehospitalized at a higher rate than high 
nINC participants in the same comorbidity category.  These findings were consistent with a 
review concluding that hospital admission rates increase with increased social deprivation 
(Blair et al., 2002).  In addition, we found that participants had an increased hazard of 
rehospitalization, death and rehospitalization or death if they lived in a low nINC area at 
baseline and had a higher burden of comorbidity, compared to participants living in high 
nINC areas at baseline with a similar level of comorbidity.   
Patients with limited neighborhood socioeconomic resources may not have adequate 
social support or access to primary care facilities necessary to manage HF out-of-hospital.  
Persons living in economically deprived areas may be less likely to have a primary care 
physician, and thus may seek care in-hospital for conditions commonly managed out-of-
hospital.  McAlister (2004) reported follow-up rates with primary care physicians were 
lowest among patients with high neighborhood socioeconomic deprivation (F. A. McAlister 
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et al., 2004).  Fewer primary care visits may be an indication of higher hospital utilization 
rates among patients of lower nINC.  A limitation of our study is that we are unable to take 
into account out-of-hospital management of HF, as outpatient records were not available for 
the time period under study.  Future investigations in ARIC will, however, attempt to 
monitor the outpatient events related to HF. 
Medicaid recipients without a high burden of comorbidity tended to have a higher hazard 
of first rehospitalization, and were rehospitalized more often than participants not receiving 
Medicaid.  It is possible that the Medicaid recipients in this study with greater comorbidity 
were more likely to seek or be referred to care for symptom managment out-of-hospital and 
as a result did not require more frequent hospitalizations than non-Medicaid recipients with a 
high comorbidity burden.  Conversely, the Medicaid recipients with fewer comorbidities in 
this study may not have been as aggressively managed in- or out-of- hospital, leading to a 
higher hazard of first rehospitalization following the index HF hospitalization. 
Shorter median times from the index event to readmission among those living in low 
nINC areas appeared to be a strong influence on the combined rehospitalization/mortality 
endpoint, as low nINC was not a predictor for HF survival across levels of comorbidity in the 
ARIC study population.  In particular, rehospitalization occurs more often and more quickly 
among participants living in low nINC areas, especially among those with more 
comorbidities identified during the incident hospitalized event.  In general, patients with 
more comorbidity may require a greater number of treatments because they are sicker, more 
susceptible to severe HF, or experience acute exacerbations of the disease.  Requiring more 
medical attention due to a high burden of comorbidity may serve to highlight the limited 
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resources available in low nINC areas, either for adequate self-care (Booth & Hux, 2003) or 
out-of-hospital management of disease.   
Strengths of this study include a racially diverse population of men and women who 
were free of HF at baseline and followed from 1987 to 2004 in order to capture an incident 
HF hospitalization, subsequent hospitalizations and fatal events.  Longer follow-up more 
adequately depicts the survival experience and clinical course of HF progression for the 
majority of patients diagnosed with this chronic disease.  The index HF hospitalization was 
defined as the first mention of a 428 ICD-9 discharge code in the medical record, a technique 
used in extant studies of HF (Loehr et al., 2008).  We acknowledge limitations inherent to 
this method of event identification, such as an inability to distinguish between acute and 
chronic HF events as well as not being able to determine the etiology of the incident 
hospitalized event.  Although the identification of incident events via ICD-9 discharge codes 
does not capture outpatient events that may have occurred prior the incident hospitalized 
event, the distribution of hospitalizations among ARIC participants with incident hospitalized 
HF were similar to a recently published community-based report which ascertained incident 
HF cases from both outpatient and inpatient records (Dunlay et al., 2009).   
 In the context of increasing hospital discharges for HF and a consistently high rate of 
mortality from the syndrome, it is critical to identify social and economic neighborhood 
forces which impact HF rehospitalization or death in the presence of individual 
socioeconomic, demographic and comorbid factors.   Differences by nINC in survival free 
from readmission or death post-incident HF hospitalization may have important implications 
for the management and treatment of HF patients (Chaix et al., 2007; Stjarne et al., 2006).  It 
is likely that nINC in part determines the availability of health care resources in a 
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community, such as the proximity of neighborhood health clinics.  Outpatient care is critical 
to the out-of-hospital monitoring of HF patients, and if less available in low nINC areas, may 
adversely affect the progression of HF among patients in these communities (G. Lee & 
Carrington, 2007).  In this study, Medicaid recipients with a low burden of comorbidity were 
more likely to be admitted to the hospital following an incident hospitalized HF event.  
Whether or not these patients are adequately monitored on an outpatient basis remains 
unclear.  Regardless, comorbidity burden appears to influence the association between nINC, 
Medicaid status and rehospitalization and death among HF patients. 
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VI. Socioeconomic Status and the Trajectory of Self-rated Health 
A. ABSTRACT 
Self-rated health (SRH) is thought to reflect both mental and physical health domains, 
and is assessed by asking individuals to objectively describe their health status.  SRH is 
associated with disease incidence and subsequent mortality.  Changes in SRH across an 
extended period of time in persons with different incident diseases are uncharacterized.  SRH 
was assessed in the Atherosclerosis Risk in Communities (ARIC) study during annual 
telephone interviews over a median of 17.6 years of follow-up, and differences in SRH were 
determined by neighborhood median household income (nINC), which was derived from the 
1990 US Census from participant addresses at study baseline (1987-1989).  Individual 
quadratic growth models were used for repeated measures of SRH in persons who remained 
disease-free during follow-up (N=11,188), as well as among those who were diagnosed with 
myocardial infarction (MI; N=1,071), stroke (N=809), heart failure (HF; N=1,592) or lung 
cancer (N=433), and those who underwent a cardiac revascularization procedure (N=1,340) 
during follow-up.  Among disease-free participants and across time, there was a trend for 
lowest mean SRH among persons living in low nINC areas and highest mean SRH among 
persons living in high nINC areas.  Factors contributing to the decline in SRH over time 
included advanced age, lower educational attainment, smoking and obesity.  Addressing 
factors related to poor SRH trajectories among patients pre- and post-incident disease may 
favorably affect health outcomes among patients regardless of type of disease. 
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B. INTRODUCTION 
Self-rated health (SRH) is a commonly used measure of general health status, which is 
thought to reflect both mental and physical health domains (Singh-Manoux et al., 2006).  
SRH is typically obtained by asking individuals to objectively describe their health status on 
a four- to eight-point Likert scale (e.g., excellent, good, fair or poor)(Singh-Manoux et al., 
2007).  SRH is generally stable until age 50 years (McCullough & Laurenceau, 2004), and 
then declines with increasing age (McFadden et al., 2008).  Low SRH is associated with 
adverse health outcomes, such as repeated hospitalizations (Kennedy et al., 2001) and 
mortality (Bardage, Isacson, & Pedersen, 2001; Wolinsky et al., 2008).  Thus, it is 
hypothesized that low SRH may be able to predict a wide range of adverse health outcomes 
(Bardage et al., 2001).   
Cross-sectional analyses of elderly persons demonstrate that living in disadvantaged 
neighborhoods, having low education and low household wealth is associated with self-
reported poor health (Daponte-Codina et al., 2008; Kunst et al., 2005; Power et al., 1998; 
Wight et al., 2008).  Furthermore, the association between neighborhood-level 
socioeconomic status (SES) and SRH remains after taking other individual-level measures - 
including measures of income, education and occupation - into account (Wight et al., 2008).  
Hypothesized mechanisms linking low SES with poor SRH may include an increase in 
allostatic load due to the stressors of low SES, and the availability of fewer resources in low 
SES areas to effectively manage such stress (Wight et al., 2008).    
While many studies have investigated factors associated with current SRH (Daponte-
Codina et al., 2008; McFadden et al., 2008; Wight et al., 2008) or a change in SRH (e.g., 
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from baseline) (Wolinsky et al., 2008), few studies have reported the trajectory of repeated 
measures of SRH across a specified time period (P. Diehr et al., 2001).  To our knowledge, 
research quantifying the trajectory of repeated measures of SRH among patients with 
incident disease by SES has not been undertaken, and may provide additional insight into the 
study of disease progression.  Information regarding SRH trajectories that differ by SES 
could be used to develop interventions which prevent the loss of well-being associated with 
an incident disease diagnosis, with interventions tailored to address issues pertinent to the 
specific disease diagnosis.  
C. METHODS  
The participants of the Atherosclerosis Risk in Communities (ARIC) cohort were 
enrolled from four U.S. communities (Washington County, Maryland; Forsyth County, North 
Carolina; Jackson, Mississippi; and eight suburbs of Minneapolis, Minnesota) beginning in 
1987 (White et al., 1996).   ARIC study staff conducts annual follow-up by telephone to 
update address and contact information, and to assess overnight hospitalizations and changes 
in health status occurring since the last annual contact.    
SRH was measured among 15,792 black and white men and women at baseline and at 
each annual follow-up (1987-2006) for a median of 17.6 (range 1-19) years using the 
question, "Over the past year, compared to other people your age, would you say that your 
health has been excellent, good, fair or poor?"   SRH data are simple to collect (McFadden et 
al., 2008), yet may be difficult to interpret, since the SRH scale is not precisely ordinal and is 
based on a subjective opinion of one’s health status.  Thus, Diehr et al (2003) proposed a 
transformation based on data from the Cardiovascular Health Study to a scale from 100 
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(perfect health) to 0 (death).  Diehr's transformation represents the probability of being 
healthy in the future, conditional on the current value of SRH (Paula Diehr & Patrick, 2003).   
Thus, we transformed SRH accordingly: 95 for excellent, 80 for good, 30 for fair, 15 for 
poor, and 0 for death. 
Participants' baseline place of residence (1987-1989) was geocoded to the level of the 
census tract by a vendor with demonstrated accuracy, as described elsewhere (Whitsel et al., 
2004).  Neighborhood-level median household income (nINC) was obtained from the 1990 
US Census and averaged across all ARIC study communities.  Participants were assigned a 
tertile of nINC [low (<$24,777), medium ($24,777≤-<36,071) or high (≥$36,071)] based 
upon their address at baseline. 
There were 276,200 total SRH observations for members of the cohort; 9,552 (3.4%) 
were missing.  If an observation was missing, and there were complete SRH values for both 
the previous and subsequent year of follow-up, we imputed the missing observation by 
averaging the values from the previous and subsequent years.  As a result, over half 
(N=5,140) of the missing observations were imputed.  We assigned a zero for the missing 
value if it occurred during the year in which the cohort member died.  In order to capture the 
SRH of the entire cohort across time, and not just that of the survivors, we included 
observations through contact year 19 for members lost to follow-up or who were deceased, 
and assigned a zero for each follow-up year which occurred after the cohort members' death.   
Of the original 15,792 cohort members, 754 were excluded due to missing nINC 
(N=13,030 SRH observations), resulting in 263,170 SRH observations available for these 
analyses.  We analyzed mean SRH at discrete time points and trajectories of SRH across time 
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among participants who were free of the selected diseases of interest as described below 
(“disease-free”) at baseline and disease-free throughout follow-up (N=11,188), as well as 
among those disease-free at baseline and receiving a diagnosis of incident myocardial 
infarction (MI; N=1,071), stroke (N=809), heart failure (HF; N=1,592) or lung cancer 
(N=433), and those undergoing cardiac revascularization procedures (N=1,340) during 
follow-up.  We assessed SRH data through the end of 2006, and incident events through the 
end of 2005, in order to give each cohort member at least one year of follow-up post-event.       
For comparison purposes, each member of the disease-free group was assigned a random 
“event” date (P. Diehr et al., 2001).  As a result, the pre-event and post-event trajectories 
from the incident disease groups could be compared to those of the group which remained 
healthy throughout follow-up, to determine if the SRH trajectories among the diseased differ 
from the trajectory of SRH that would be expected due to disease-free aging.  With regard to 
differences by incident disease status, HF survival has been shown to be worse than other 
cardiovascular diseases and cancers, with the exception of lung cancer (Simon Stewart et al., 
2001), and it remains unknown if SRH trajectories show similar trends.    
Factors influencing pre- and post-event trajectories were of interest, as well as covariates 
which played a role in the decline of SRH over the follow-up period.  Age (centered at 65 
years) and age squared at the time of the annual follow-up contact were included in statistical 
models.  Gender and race/study community were the additional demographic variables of 
interest.  Health status and behavior variables assessed at baseline included body mass index 
(BMI), classified into normal (referent, <25 kg/m2), overweight (25-<29.9 kg/m2) or obese 
(≥29.9 kg/m2); hypertension, present if systolic blood pressure ≥140 mmHg, diastolic blood 
pressure ≥90 mmHg, or if taking hypertensive medication within the previous two weeks; 
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current drinker and current smoker.  Educational attainment was assessed at baseline and 
categorized as less than 11 years, high school graduate, and greater than high school 
(referent).  We accounted for period effects [1987-1992 (referent), 1993-1999 and 2000-
2006] at each annual follow-up contact in order to capture secular trends (Rice et al., 2010) 
which may influence the nINC-SRH relationship, such as changes in health behaviors and 
disease treatments occurring in the ARIC communities over time.  We used an indicator 
variable, accounting for the presence of disease (yes/no) at each annual follow-up, which 
represented the change in SRH from pre- to post-disease, while an interaction term 
(time*indicator variable) reflected the change in slope pre- to post-disease.      
We regressed incident disease-specific SRH at each time point of interest (e.g., baseline; 
three, two, and one year prior to the event; event year; and one, two, three, four and five 
years post-event) on study covariates to generate estimated adjusted SRH values and standard 
errors (PROC GLM, SAS 9.1.3, Cary, NC).  We used the change in adjusted SRH between 
the year of event and one year later to calculate how much of the decline in SRH post-event 
was due to death for each incident disease group.  For example, we calculated the mean 
adjusted decline in SRH among participants who were alive one-year post event and divided 
that value by the mean adjusted decline in SRH among all participants (regardless of vital 
status).  The proportion of decline in SRH post-event due to deaths was then one minus the 
aforementioned value. 
If a relationship between nINC and SRH exists, it is feasible that nINC may influence 
the slope of decline in SRH over time depending on the type of incident health condition.  
Thus, we fit individual quadratic growth models separately to data by incident disease group, 
accounting for repeated measures of SRH (PROC MIXED, SAS 9.1.3, Cary, NC).  Effect 
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measure modification of the nINC-SRH relationship was assessed (disease-free: 
pinteraction<0.01; other disease: pinteraction<0.05) by demographic, medical history and health 
behavior variables. 
D. RESULTS 
Disease-free participants were more likely to reside in high nINC areas (36.1%) at 
baseline (Table 6.1), be female (59.2%) and have greater than a high school education 
(37.7%).  Among participants who were not disease-free over the course of follow-up, 
participants receiving a cardiac revascularization procedure were more likely to be male 
(67.3%).  Stroke patients were more likely to be living in low nINC areas (43.8%) and heart 
failure patients were most likely to have less than a high school education (39.2%).  Figure 
6.1 shows the relationship between nINC and SRH at each contact year, adjusted for age, 
race/study community and gender.  SRH declined over time and overall by nINC, and there 
was a stepwise association between nINC and mean SRH, such that participants living in 
high nINC areas at baseline consistently reported higher SRH values, followed by those 
living in medium nINC areas, while participants living in low nINC areas at baseline rated 
their health as the lowest across the entire study period (Figure 6.1). 
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Table 6.1. Baseline characteristics of participants by incident disease status, The ARIC 
study (1987-2005) 
 Disease- 
free 
N=11,188 
Cardiac 
Revascularization 
Procedure 
N=1,340 
Myocardial 
Infarction 
N=1,071 
Lung 
Cancer 
N=433 
Stroke 
N=809 
Heart 
Failure 
N=1,592 
Age, mean 54.2 55.7 56.0 57.5 54.7 57.1 
nINC       
     Low 29.5 21.8 25.8 31.6 43.8 42.6 
     Medium 34.4 44.5 40.0 40.2 29.0 33.3 
     High 36.1 33.7 34.2 28.2 27.2 24.1 
Female 59.2 32.7 43.0 36.7 55.3 46.8 
Race/Study Community       
Black/NC 3.1 2.7 2.8 3.2 3.6 3.3 
Black/MS 22.7 10.6 24.4 19.2 39.9 31.0 
White/NC 22.4 29.2 24.3 26.1 17.1 19.8 
White/MN 27.4 27.5 21.9 24.5 17.2 17.6 
White/MD 24.4 30.0 26.6 27.0 22.2 28.3 
Hypertensive 31.2 40.2 48.6 37.9 42.3 54.0 
Overweight or obese 65.0 65.9 74.8 55.9 70.2 78.1 
Current smoker 23.0 30.5 37.4 65.8 28.1 37.0 
Current drinker 57.3 57.1 49.6 64.0 48.7 45.4 
Educational Attainment       
     Less than HS 21.0 23.5 32.6 33.5 27.9 39.2 
     HS or equivalent 41.1 42.7 37.9 43.0 42.4 36.9 
     Greater than HS 37.7 33.7 29.4 23.5 29.4 23.6 
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Figure 6.1. The relationship between nINC and SRH across all contact years of follow 
up for the entire cohort, The ARIC study (1987-2006) 
 
 Adjusted for age, race/study community and gender 
  
Each type of incident disease was treated separately, thus it was possible for cohort 
participants to belong to more than one incident disease group, with the exception of disease-
free participants.  The largest overlap occurred between incident MI and cardiac 
revascularization procedure, which shared 12% of participants.  All other types of incident 
disease co-occurred at either a rate of 5% (e.g., HF and cardiac revascularization procedure, 
and HF and MI) or ≤1% (data not shown).  Figure 6.2 shows the impact of baseline age on 
the trajectory of mean SRH across all contact years by incident disease status.  Participants 
aged 60-64 years at baseline tended to report lower SRH and demonstrate a steeper decline in 
SRH across study follow-up as compared to participants aged 45-49 years at baseline, 
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regardless of incident disease status (Figure 6.2).  Those with lung cancer had the lowest 
SRH across all age groups, followed by those with HF. 
 116
Figure 6.2. Mean SRH by incident disease status among age groups at baseline, The ARIC study (1987-2006) 
45-49 years 50-54 years 
  
 
55-59 years 60-64 years 
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At baseline, 33.2% of participants reported excellent, 46.8% good, 16.6% fair and 3.4% 
poor SRH.  The internal validity of the SRH measure in this cohort was high, as participants 
reporting excellent health at baseline were least likely (and those reporting poor health at 
baseline were most likely) to be hypertensive, overweight/obese or to be deceased by the end 
of follow-up (Table 6.2). 
Table 6.2. Percentage of participants reporting a given SRH at baseline who had 
existing comorbid disease or had died by the end of follow-up: The ARIC Study (1987-
2005) 
SRH at baseline Hypertensive Overweight or obese 
Deceased by the end of 
follow-up 
     Excellent 33.2 18.7 58.3 11.2 
     Good 46.8 36.7 68.8 18.9 
     Fair 16.6 54.7 77.8 34.7 
     Poor 3.4 66.1 75.2 55.8 
 
 
Adjusting for age, race/study community, gender, hypertensive status, BMI, current 
smoking, current drinking, educational attainment and period effects, mean SRH was highest 
at baseline, pre-event, post-event and across entire follow-up for disease-free participants.  
Among disease-free participants and across time points, there was a trend for lowest mean 
SRH among persons living in low nINC areas and highest mean SRH among persons living 
in high nINC areas (Table 6.3).  This trend did not hold for all five incident disease types 
across all time points.  Among participants with a cardiac revascularization procedure during 
follow-up, low nINC was associated with the lowest mean SRH pre-event, post-event and 
overall, but not at baseline.  Low nINC was also associated with low mean SRH across the 
entire follow-up (overall) for MI and lung cancer, but not for stroke or HF.   
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Table 6.3. Mean SRH at selected time points during follow-up by incident disease 
status, The ARIC study (1987-2006) 
 nINC Baseline Pre-disease Post-disease Overall 
Low 75.3 (74.4-76.3) 71.6 (71.2-72.0) 70.2 (69.7-70.7) 68.6 (68.3-68.9) 
Medium 76.7 (75.9-77.4) 74.2 (73.9-74.5) 71.8 (71.4-72.1) 70.6 (70.4-70.8) Disease- free High 77.6 (76.8-78.3) 75.4 (75.1-75.8) 73.5 (73.2-73.9) 72.5 (72.2-72.7) 
Low 74.5 (71.5-77.6) 70.5 (69.5-71.5) 50.1 (48.6-51.6) 61.3 (60.4-62.2) 
Medium 75.4 (73.5-77.2) 75.2 (74.6-75.8) 55.5 (54.5-56.4) 67.0 (66.4-67.5) 
Cardiac 
Revascularization 
Procedure High 75.3 (73.0-77.5) 74.3 (73.6-75.0) 58.3 (57.2-59.5) 67.7 (67.0-68.3) 
Low 68.1 (64.7-71.4) 66.1 (65.0-67.3) 39.4 (37.8-40.9) 52.1 (51.1-53.1) 
Medium 70.7 (68.1-73.4) 69.6 (68.8-70.5) 48.0 (46.8-49.2) 60.0 (59.2-60.7) Myocardial Infarction High 68.0 (64.6-71.4) 67.6 (66.4-68.7) 47.1 (45.5-48.7) 58.4 (57.4-59.4) 
Low 67.9 (62.6-73.2) 67.1 (65.4-68.9)   8.1 (6.5-9.8) 40.8 (39.0-42.6) 
Medium 69.3 (65.2-73.4) 69.0 (67.7-70.2)   9.9 (8.5-11.3) 44.8 (43.4-46.2) Lung Cancer 
High 69.1 (63.9-74.3) 67.7 (66.0-69.3) 15.6 (13.9-17.4) 44.4 (42.6-46.2) 
Low 72.9 (69.6-76.2) 61.8 (60.6-63.1) 65.4 (63.9-66.9) 63.1 (62.2-64.1) 
Medium 66.9 (63.1-70.5) 67.4 (66.1-68.8) 53.2 (51.5-54.8) 61.5 (60.4-62.5) Stroke 
High 68.7 (64.9-72.5) 64.4 (62.9-65.9) 58.3 (56.6-59.9) 61.7 (60.6-62.8) 
Low 62.6 (60.0-65.1) 61.8 (60.9-62.6) 24.6 (23.6-25.7) 45.5 (44.7-46.3) 
Medium 63.1 (60.5-65.6) 61.9 (61.1-62.7) 26.0 (24.9-27.1) 47.4 (46.7-48.2) Heart Failure 
High 60.9 (57.7-64.1) 61.5 (60.5-62.5) 23.8 (22.5-25.2) 45.7 (44.8-46.7) 
Adjusted for age, race/study community, gender, hypertensive status, body mass index, current smoking, 
current drinking, educational attainment and period effects 
 
 
Figure 6.3 shows mean SRH by type of incident disease pre- and post-event, adjusting 
for age, race/study community, gender, hypertensive status, BMI, current smoking, current 
drinking, educational attainment and period effects.  Average SRH three years prior to the 
incident event was highest among disease-free participants (73.9) and lowest among those 
developing HF (59.2).  Between three years pre-event and the event year, the smallest 
average decline in SRH occurred among disease-free individuals (-1.4), while the largest 
average decline occurred among those developing HF (-8.2).  Large declines in SRH were 
seen during the one year following the event among MI, cardiac revascularization procedure, 
lung cancer and HF patients.  The percent of the decline in SRH due to death among these 
patients was 16%, 8%, 24% and 32%, respectively.  A gradual increase in SRH post-event 
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was seen among participants surviving events that did not have as high of a burden of 
mortality as HF and lung cancer (Figure 6.3). 
Figure 6.3. Trajectory of SRH pre- and post-event, The ARIC study (1987-2006) 
 
Adjusted for nINC, age, race/study community, gender, hypertensive status, body mass index, current 
smoking, current drinking, educational attainment and period effects 
 
After fitting individual quadratic growth models separately to data by incident disease 
group, and controlling for all available covariates, advancing age, lower educational 
attainment, current smoking and obesity were predictors of the decline in SRH over time 
regardless of type of incident disease (Table 6.4).  For all incident disease types except lung 
cancer, being hypertensive contributed to significant declines in SRH over time.  Among 
disease-free participants, as well as participants undergoing cardiac revascularization 
procedures or with MI, living in low nINC areas at baseline was a predictor of SRH decline.  
Notable among disease-free participants was a significant interaction between nINC and 
educational attainment, indicating that the combination of low nINC and lower educational 
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attainment conferred a statistically significant excess risk of an additional decrease in the 
trajectory of SRH over time.  Statistically significant declines in SRH occurred among 
participants pre- and post- event, except among those experiencing a stroke.  Meanwhile, 
statistically significant changes in slope pre- and post- event occurred for all incident disease 
types. 
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Table 6.4. Predictors of declines in SRH over time by incident disease status: The ARIC Study (1987-2006) 
 Disease- 
free 
N=11,188 
Cardiac 
Revascularization 
Procedure 
N=1,340 
Myocardial 
Infarction 
N=1,071 
Lung 
Cancer 
N=433 
Stroke 
N=809 
Heart 
Failure 
N=1,592 
Intercept 87.7 (0.8)* 84.8 (2.2)* 78.5 (2.9)* 79.7 (4.6)* 81.3 (3.4)* 71.2 (2.5)*
Age, centered at 65 -0.5 (0.04)* -0.3 (0.1)* -0.6 (0.1)* -0.3 (0.2) -0.9 (0.1)* -0.3 (0.1)*
Age2 -0.03 (0.002)* -0.02 (0.004)* -0.03 (0.005)* -0.02 (0.01)* -0.03 (0.01)* -0.03 (0.005)*
nINC (vs. High) 
  Low  -2.3 (0.8)* -5.2 (1.7)* -5.0 (2.3)* 2.0 (5.0) 1.8 (2.1) -0.04 (1.6)
  Medium -1.2 (0.6)* -0.9 (1.3) 1.2 (1.9) 6.2 (3.8) -0.6 (1.9) 0.5 (1.4)
Female (vs. male) -1.0 (0.3)* -3.7 (1.0)* -1.9 (1.2) -0.6 (1.7) 1.7 (1.3) 0.01 (1.0)
Race/Study Community (vs. White/MD) 
  Black/NC -6.5 (0.9)* -1.3 (2.8) -7.4 (3.5)* -6.1 (5.3) -9.1 (3.7)* -8.0 (2.8)*
  Black/MS -8.7 (0.6)* -3.7 (1.8)* -6.1 (2.0)* -5.5 (2.9) -10.7 (2.2)* -7.5 (1.6)*
  White/NC -0.8 (0.4) -0.6 (1.1) 0.1 (1.6) 1.9 (2.2) -2.1 (2.1) -3.6 (1.4)*
  White/MN 0.1 (0.5) 2.1 (1.3) 4.6 (1.8)* 1.6 (2.6) 2.6 (2.2) 2.4 (1.6)
Hypertensive -4.9 (0.3)* -4.4 (0.9)* -5.6 (1.2)* -2.4 (1.8) -7.9 (1.4)* -4.2 (1.0)*
BMI (vs. Normal) 
  Obese -4.8 (0.4)* -6.8 (1.2)* -5.8 (1.5)* -5.4 (2.1)* -7.1 (1.7)* -2.8 (1.3)*
  Overweight -0.7 (0.3)* -2.8 (1.1)* -1.3 (1.4) -1.1 (1.9) -3.6 (1.6)* 0.9 (1.3)
Current smoker -4.0 (0.4)* -3.8 (1.0)* -4.2 (1.2)* -4.7 (1.8)* -7.8 (1.4)* -3.8 (1.0)*
Current drinker 1.6 (0.3)* 3.6 (0.9)* 3.4 (1.2)* 0.9 (1.8) 2.5 (1.4) 2.8 (1.0)*
Educational Attainment (vs. Greater than HS) 
  Less than HS -9.5 (1.0)* -9.7 (1.3)* -10.3 (1.5)* -11.5 (5.2)* -12.9 (1.7)* -9.5 (1.3)*
  HS or equivalent -3.2 (0.5)* -3.4 (1.0)* -5.0 (1.3)* 4.7 (3.2) -6.0 (1.5)* -3.9 (1.2)*
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 Disease- 
free 
N=11,188 
Cardiac 
Revascularization 
Procedure 
N=1,340 
Myocardial 
Infarction 
N=1,071 
Lung 
Cancer 
N=433 
Stroke 
N=809 
Heart 
Failure 
N=1,592 
Contact year -0.3 (0.04)* -0.2 (0.1) 0.1 (0.1) -0.6 (0.2)* 0.1 (0.2) -0.4 (0.1)* 
Disease status -1.7 (0.3)* -14.9 (1.1)* -19.5 (1.2)* -44.7 (2.4)* -4.8 (1.3)* -26.3 (1.2)*
1987-1992 (vs. 2000-2006) -0.6 (0.4) 0.9 (1.1) 1.4 (1.5) -1.3 (2.1) 3.0 (1.3)* 5.0 (1.0)*
1993-1999 (vs. 2000-2006) -0.01 (0.2) 0.04 (0.7) -0.03 (1.0) -0.8 (1.3) 2.3 (0.7)* 3.2 (0.6)*
Age, centered at 65*1987-1992 -0.1 (0.05)* NS NS NS 0.03 (0.2) NS
Age, centered at 65*1993-1999 0.05 (0.03) NS NS NS 0.3 (0.1)* NS
Low nINC*Less than HS -3.9 (1.2)* NS NS 1.9 (6.8) NS NS
Low nINC*HS or equivalent -2.7 (0.8)* NS NS -12.4 (5.6)* NS NS
Medium nINC*Less than HS -1.5 (1.2) NS NS -4.6 (6.3) NS NS
Medium nINC*HS or equivalent -0.3 (0.8) NS NS -8.2 (4.6) NS NS
Low nINC*1987-1992 2.0 (0.4)* 1.8 (1.3) 3.3 (1.6)* NS NS NS
Low nINC*1993-1999 0.6 (0.3) -0.3 (1.0) 2.1 (1.2) NS NS NS
Medium nINC*1987-1992 0.4 (0.4) 0.5 (1.1) -0.6 (1.6) NS NS NS
Medium nINC*1993-1999 0.3 (0.3) 1.5 (0.8)* 1.0 (1.2) NS NS NS
Contact year*Disease status 0.2 (0.03)* 0.4 (0.1)* -0.6 (0.1)* 0.6 (0.2)* 0.2 (0.1) 0.8 (0.1)*
Significant predictors (p<0.05) are indicated with an (*) 
NS = Interaction Not Significant for this model 
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E. DISCUSSION 
To our knowledge, this is the first study to characterize trajectories of change in SRH 
status in assessing chronic disease burden pre- and post- incident disease diagnosis.  Values 
of SRH tended to be lower at baseline and declined at a greater rate prior to the disease 
occurrence among participants who were disease-free at baseline but developed a disease 
over the course of follow-up compared to healthy members of the cohort.  The largest pre-
event decline occurred in the HF group.  A positive stepwise assocation between nINC and 
SRH persisted across 19 years of followup of the entire cohort, regardless of incident disease 
status.  While nINC contributed to the decline in SRH among members of the cohort with 
selected types of incident disease, it was not a contributing factor to SRH decline over time 
for all participants, unlike age, educational attainment, current smoking and obesity.  With 
exception of lung cancer, being hypertensive contributed to significant declines in SRH over 
time. 
In order to get an accurate picture of the trajectory of SRH among members of a cohort, 
it was important to account for death in the analyses.  For example, if only live participants 
are considered during follow-up, SRH may have been shown to improve after a sentinel 
health event, since the sickest patients (i.e. those with fair or poor SRH) have 
disproportionately died (Paula Diehr & Patrick, 2003).  Similarly, had we attributed a zero to 
the participants' year of death, but counted SRH values as missing thereafter, we would have 
tracked the post-event SRH trajectories of the disease survivors, and ignored the experience 
of the entire cohort. 
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Trends in SRH differ for different types of incident disease.  Previous studies have 
shown a decline in health status pre-event for diseases such as cancer, MI and HF, as well as 
a relationship between health-related quality of life and the risk of hospital readmission or 
death post-event (P. Diehr et al., 2001; Rodriguez-Artalejo et al., 2005).  The steep decline in 
SRH post-event, followed by a leveling-off period, has been noted in other studies (P. Diehr 
et al., 2001).  This phenomenon is at least in part due to the fact that all participants 
experiencing an incident event had to be alive prior to the event, after which they could die.  
As described in the results section, the percent of decline during the first year post-event 
varied by type of incident disease, with a high proportion of deaths affecting the lung cancer 
and HF groups the most and cardiac revascularization and MI patients the least.   
Strengths of our study include a large number of SRH observations, due to nearly 20 
years of annual cohort follow-up.  We imputed SRH values if there were SRH values 
immediately prior to or following the missing value, allowing for a more complete picture of 
SRH across time.  In addition, due to the thorough medical history obtained at baseline, we 
excluded participants with prevalent disease from study, thus restricting our analysis to 
incident events only.  Our incident disease-specific results are consistent with an Israeli study 
which reported poor income, low education and obesity as independent predictors of a 
decline in SRH among MI patients (Gerber, Benyamini, Goldbourt, Drory, & for the Israel 
Study Group on First Acute Myocardial, 2009). 
SRH is a good indicator of overall health status, however, multiple measurements of 
other subjective health indicators were not collected annually from participants.  Thus, the 
extent to which a poor SRH rating was associated with poor physical health, mental health, 
functional status or a combination of these or other measures, such as positive or negative 
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affect (Winter, Lawton, Langston, Ruckdeschel, & Sando, 2007), cannot be ascertained from 
these data.  Better functional status, for example, may improve one’s ability to perform 
disease self-management techniques, which has been shown to have a positive impact on 
health status of HF patients (Suwanno, Petpichetchian, Riegel, & Issaramalai, 2009).   In 
addition, there is evidence that different pathways may link SES to distinct domains of health 
status (Barbareschi, Sanderman, Kempen, & Ranchor, 2009). 
Repeated measures data provide additional insight into the study of disease progression.  
In this study, significant predictors of the decline in SRH over a nearly 20-year period 
included age, educational attainment, current smoking and obesity.  As SRH is associated 
with subsequent risk of morbidity and mortality, addressing factors related to poor SRH 
trajectories among patients pre- and post-incident disease may favorably affect health 
outcomes among patients regardless of type of incident disease. 
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VII. CONCLUSIONS AND PUBLIC HEALTH IMPLICATIONS  
Rehospitalization and Mortality 
In this study, incident HF hospitalizations were more common among ARIC cohort 
participants of low and medium nINC compared to those living in high nINC areas at 
baseline.  Further, low nINC participants with an elevated comorbidity index score at the 
time of the incident hospitalized HF event were rehospitalized at a higher rate than high 
nINC participants in the same comorbidity category.  These findings were consistent with a 
review concluding that hospital admission rates increase with increased social deprivation 
(Blair et al., 2002).  In addition, we found that participants had an increased hazard of 
rehospitalization, death and rehospitalization or death if they lived in a low nINC area at 
baseline and had a higher burden of comorbidity, compared to participants living in high 
nINC areas at baseline with a similar level of comorbidity.   
Patients with limited neighborhood socioeconomic resources may not have adequate 
social support or access to primary care facilities necessary to manage HF out-of-hospital.  
Persons living in economically deprived areas may be less likely to have a primary care 
physician, and thus may seek care in-hospital for conditions commonly managed out-of-
hospital.  McAlister (2004) reported follow-up rates with primary care physicians were 
lowest among patients with high neighborhood socioeconomic deprivation (F. A. McAlister 
et al., 2004).  Fewer primary care visits may be an indication of higher hospital utilization 
rates among patients of lower nINC.  A limitation of our study is that we are unable to take 
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into account out-of-hospital management of HF, as outpatient records were not available for 
the time period under study.  Future investigations in ARIC will, however, attempt to 
monitor the outpatient events related to HF. 
Medicaid recipients without a high burden of comorbidity tended to have a higher hazard 
of first rehospitalization, and were rehospitalized more often than participants not receiving 
Medicaid.  It is possible that the Medicaid recipients in this study with greater comorbidity 
were more likely to seek or be referred to care for symptom managment out-of-hospital and 
as a result did not require more frequent hospitalizations than non-Medicaid recipients with a 
high comorbidity burden.  Conversely, the Medicaid recipients with fewer comorbidities in 
this study may not have been as aggressively managed in- or out-of- hospital, leading to a 
higher hazard of first rehospitalization following the index HF hospitalization. 
Shorter median times from the index event to readmission among those living in low 
nINC areas appeared to be a strong influence on the combined rehospitalization/mortality 
endpoint, as low nINC was not a predictor for HF survival across levels of comorbidity in the 
ARIC study population.  In particular, rehospitalization occurs more often and more quickly 
among participants living in low nINC areas, especially among those with more 
comorbidities identified during the incident hospitalized event.  In general, patients with 
more comorbidity may require a greater number of treatments because they are sicker, more 
susceptible to severe HF, or experience acute exacerbations of the disease.  Requiring more 
medical attention due to a high burden of comorbidity may serve to highlight the limited 
resources available in low nINC areas, either for adequate self-care (Booth & Hux, 2003) or 
out-of-hospital management of disease.   
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Strengths of this study include a racially diverse population of men and women who 
were free of HF at baseline and followed from 1987 to 2004 in order to capture an incident 
HF hospitalization, subsequent hospitalizations and fatal events.  Longer follow-up more 
adequately depicts the survival experience and clinical course of HF progression for the 
majority of patients diagnosed with this chronic disease.  The index HF hospitalization was 
defined as the first mention of a 428 ICD-9 discharge code in the medical record, a technique 
used in extant studies of HF (Loehr et al., 2008).  We acknowledge limitations inherent to 
this method of event identification, such as an inability to distinguish between acute and 
chronic HF events as well as not being able to determine the etiology of the incident 
hospitalized event.  Although the identification of incident events via ICD-9 discharge codes 
does not capture outpatient events that may have occurred prior the incident hospitalized 
event, the distribution of hospitalizations among ARIC participants with incident hospitalized 
HF were similar to a recently published community-based report which ascertained incident 
HF cases from both outpatient and inpatient records (Dunlay et al., 2009).   
In the context of increasing hospital discharges for HF and a consistently high rate of 
mortality from the syndrome, it is critical to identify social and economic neighborhood 
forces which impact HF rehospitalization or death in the presence of individual 
socioeconomic, demographic and comorbid factors.   Differences by nINC in survival free 
from readmission or death post-incident HF hospitalization may have important implications 
for the management and treatment of HF patients (Chaix et al., 2007; Stjarne et al., 2006).  It 
is likely that nINC in part determines the availability of health care resources in a 
community, such as the proximity of neighborhood health clinics.  Outpatient care is critical 
to the out-of-hospital monitoring of HF patients, and if less available in low nINC areas, may 
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adversely affect the progression of HF among patients in these communities (G. Lee & 
Carrington, 2007).  In this study, Medicaid recipients with a low burden of comorbidity were 
more likely to be admitted to the hospital following an incident hospitalized HF event.  
Whether or not these patients are adequately monitored on an outpatient basis remains 
unclear.  Regardless, comorbidity burden appears to influence the association between nINC, 
Medicaid status and rehospitalization and death among HF patients. 
There are concerns regarding the validity of using discharge diagnosis codes in 
diagnosing HF.  The true number of HF cases or hospitalizations can be underestimated, for 
example, if cases are identified by only using primary, not secondary, discharge diagnosis 
criteria.  In contrast, the absolute number of HF hospitalizations can be overestimated if the 
target diagnosis code is carried over from the incident hospitalization even if subsequent 
hospitalizations are not due to HF decompensation.  As a result, it is suggested that hospital 
discharge data is not adequate to confirm the accuracy of a HF diagnosis, and may not be 
sufficient to verify the existence of comorbid illnesses (J.G.F Cleland et al., 2003).   
Despite the aforementioned concerns, it is a common approach for epidemiologic 
researchers to use ICD-9-CM codes to identify HF cases.  From a review of studies which 
incorporated hospitalized HF events, ICD-9-CM code 428 was the most consistently used 
code to identify hospitalized HF events (Table 7.1).  The validity of using discharge 
diagnosis codes to identify HF hospitalizations is addressed by measures of sensitivity, 
specificity, as well as positive and negative predictive values.  In assessing the validity of HF 
diagnosis codes in the primary or secondary position, Goff et al. (2000) found that the net 
effect of HF event misclassification resulted in an underestimation of hospitalizations 
attributable to acute HF (Goff et al., 2000).  The authors investigated three different 
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algorithms for diagnosing HF in the Corpus Christi Heart Project, using a gold standard 
comprised of physician-diagnosed acute congestive HF or radiographic evidence of 
pulmonary edema for validation of HF.  Three ICD-9-CM code-based algorithms were 
compared: (1) 428.x only, (2) 428.x or 402.x and (3) any HF-related ICD-9-CM code.  
Results showed the sensitivity of ICD-9-CM codes associated with HF ranged from 
approximately 63% to 67%, which indicated that nearly one-third of the patients studied who 
met criteria for a HF diagnosis were not appropriately diagnosed as having HF.  Specificity 
was consistently greater than 92%, and positive predictive values ranged from 77% to nearly 
84%, and the negative predictive value averaged 88%.   
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Table 7.1. Discharge codes commonly used in epidemiologic studies to identify heart 
failure 
ICD-9-CM Codes Study Population Author 
402.x1 
404.x3 
428.xx 
5% sample of Medicare beneficiaries 
(n=622,789, 1994-2003) Curtis LH (Curtis et al., 2008) 
402.x 
404.x 
428.x 
National Hospital Discharge Survey 
(1979-2004) Fang J (Fang et al., 2008) 
402.x 
404.x 
428.x 
ADHERE (2001-2003, n=85,617) and 
update (2001-2004, n=105,388) 
Galvao M (M. Galvao & 
ADHERE Scientific Advisory 
Committee (SAC) Investigators, 
2005; Marie Galvao et al., 2006) 
398.91 
402.01, 402.11, 402.91 
428.x 
ANCHOR (1996-2002, n=59,772) Go AS (Go et al., 2006) 
428.x Death certificates in state vital statistics offices (1980-1995) Haldeman GA (CDC, 1998) 
428.x Canadian Institute for Health Information (n=38,702, 1994-1997) Jong P (Jong et al., 2002) 
402.9 
428.0, 428.1, 428.9 
Scotland national database linked with 
discharge and mortality data (n=12,640, 
1992)  
Khand AU (Khand et al., 2001) 
425.4, 425.5, 425.9 
428.0, 428.1, 428.9 Scotland (n=547, 1986-1995) 
MacIntyre K (MacIntyre et al., 
2000) 
428.x Rochester, MN (n=6,076, 1987-2001) Owan TE (Owan et al., 2006) 
402.01, 402.11, 402.91 
404.01, 404.03, 404.11, 
404.13, 404.91, 404.93 
428.0, 428.1, 428.9 
New York State (n=42,731, 1995) Philbin EF (Philbin et al., 2001; Philbin & DiSalvo, 1999) 
402.01, 402.11, 402.91 
404.01, 404.91 
428.x 
National Heart Failure Project, Medicare 
sample (n=30,996, 1998-1999) and 
(n=53,640, 1998-1999 and 2000-2001) 
Rathore SS (Rathore et al., 2005; 
Rathore et al., 2006) 
Smith GL (Smith et al., 2005) 
398.91 
402.01, 402.11, 402.91 
425.x 
428.x 
997.1 
Cardiovascular Health Study (n=5,888, 
1989-2000) 
Schellenbaum GD (Schellenbaum 
et al., 2006) 
 
 
Further, it is reported that the majority of HF diagnoses are made in the hospital 
(Blackledge et al., 2003; Cowie et al., 2002).  A community-based cohort study carried out in 
Olmsted County, Minnesota suggests that as hospitalization rates stabilize, the hospitalized 
burden of HF cases may shift to its management in the outpatient setting.  Roger et al. 
reported 42% of HF cases were diagnosed in the outpatient setting in Olmsted County, 
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Minnesota.  While nearly three-fourths of the cases diagnosed out-of-hospital were 
hospitalized within 1.7 years, 26% were never hospitalized (Roger et al., 2004). 
Self-Rated Health 
To our knowledge, this is the first study to characterize trajectories of change in SRH 
status in assessing chronic disease burden pre- and post- incident disease diagnosis.  Values 
of SRH tended to be lower at baseline and declined at a greater rate prior to the disease 
occurrence among participants who were disease-free at baseline but developed a disease 
over the course of follow-up compared to healthy members of the cohort.  The largest pre-
event decline occurred in the HF group.  A positive stepwise assocation between nINC and 
SRH persisted across 19 years of followup of the entire cohort, regardless of incident disease 
status.  While nINC contributed to the decline in SRH among members of the cohort with 
selected types of incident disease, it was not a contributing factor to SRH decline over time 
for all participants, unlike age, educational attainment, current smoking and obesity.  With 
exception of lung cancer, being hypertensive contributed to significant declines in SRH over 
time. 
In order to get an accurate picture of the trajectory of SRH among members of a cohort, 
it was important to account for death in the analyses.  For example, if only live participants 
are considered during follow-up, SRH may have been shown to improve after a sentinel 
health event, since the sickest patients (i.e. those with fair or poor SRH) have 
disproportionately died (Paula Diehr & Patrick, 2003).  Similarly, had we attributed a zero to 
the participants' year of death, but counted SRH values as missing thereafter, we would have 
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tracked the post-event SRH trajectories of the disease survivors, and ignored the experience 
of the entire cohort. 
Trends in SRH differ for different types of incident disease.  Previous studies have 
shown a decline in health status pre-event for diseases such as cancer, MI and HF, as well as 
a relationship between health-related quality of life and the risk of hospital readmission or 
death post-event (P. Diehr et al., 2001; Rodriguez-Artalejo et al., 2005).  The steep decline in 
SRH post-event, followed by a leveling-off period, has been noted in other studies (P. Diehr 
et al., 2001).  This phenomenon is at least in part due to the fact that all participants 
experiencing an incident event had to be alive prior to the event, after which they could die.  
As described in the results section, the percent of decline during the first year post-event 
varied by type of incident disease, with a high proportion of deaths affecting the lung cancer 
and HF groups the most and cardiac revascularization and MI patients the least.   
Strengths of our study include a large number of SRH observations, due to nearly 20 
years of annual cohort follow-up.  We imputed SRH values if there were SRH values 
immediately prior to or following the missing value, allowing for a more complete picture of 
SRH across time.  In addition, due to the thorough medical history obtained at baseline, we 
excluded participants with prevalent disease from study, thus restricting our analysis to 
incident events only.  Our incident disease-specific results are consistent with an Israeli study 
which reported poor income, low education and obesity as independent predictors of a 
decline in SRH among MI patients (Gerber et al., 2009). 
SRH is a good indicator of overall health status, however, multiple measurements of 
other subjective health indicators were not collected annually from participants.  Thus, the 
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extent to which a poor SRH rating was associated with poor physical health, mental health, 
functional status or a combination of these or other measures, such as positive or negative 
affect (Winter et al., 2007), cannot be ascertained from these data.  Better functional status, 
for example, may improve one’s ability to perform disease self-management techniques, 
which has been shown to have a positive impact on health status of HF patients (Suwanno et 
al., 2009).   In addition, there is evidence that different pathways may link SES to distinct 
domains of health status (Barbareschi et al., 2009). 
Repeated measures data provide additional insight into the study of disease progression.  
In this study, significant predictors of the decline in SRH over a nearly 20-year period 
included age, educational attainment, current smoking and obesity.  As SRH is associated 
with subsequent risk of morbidity and mortality, addressing factors related to poor SRH 
trajectories among patients pre- and post-incident disease may favorably affect health 
outcomes among patients regardless of type of incident disease. 
Public Health Implications 
Extant studies of the social determinants of CHD conclude that low SES results in a 
higher incidence of HF compared to high SES.  The current work implicates neighborhood-
level SES in the progression of HF, as defined as rehospitalization and mortality.  
Specifically, patients with a high burden of comorbidity living in low nINC areas have a 
higher risk of rehospitalization and death compared to patients with a high burden of 
comorbidity living in high nINC areas.  As a result, primary prevention efforts targeting HF 
incidence and comorbid conditions in low nINC areas are warranted, as are secondary 
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prevention efforts which are focused on effective outpatient management of HF patients 
living in low nINC areas. 
 It is likely that repeat hospitalizations and early mortality among HF patients from 
lower SES neighborhoods is in part due to inadequate outpatient management of HF.  
Primary prevention efforts in low nINC areas may serve to create an awareness of risk 
factors for CHD and to promote healthy behaviors in communities.  Secondary prevention 
efforts, including providing access to outpatient management of HF in poor communities, 
may help alleviate patient suffering and the rising costs of inpatient visits due to HF and the 
associated comorbid illnesses. 
Meanwhile, the current study found a more rapid decline in SRH among HF and lung 
cancer patients compared to patients with other types of incident disease.  Influential factors 
in the decline in SRH among HF patients included low educational attainment, advanced age, 
hypertension, smoking and obesity.  In the presence of these factors, low nINC did not exert 
a negative influence on the progression of SRH among HF patients.  Given that poor SRH is 
predictive of future adverse health outcomes, such as rehospitalization and death, factors 
influencing significant declines in SRH, such as hypertension, smoking and obesity, should 
be addressed with primary and secondary prevention efforts in order to slow the decline of 
SRH.  It remains unknown how low educational attainment adversely affects SRH.  One 
hypothesis is that having a low educational status may cause an individual to perceive their 
health status differently in terms of how optimistic they may be in light of potential health 
problems.  An alternative hypothesis is that persons with a low educational status may not 
have the social or environmental resources, nor understand, how to manage their disease 
symptoms, resulting in an increased disease burden and lower SRH. 
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This dissertation brings to attention several areas for future research in cardiovascular 
disease epidemiology.  The first is a need to better understand the relationship of 
socioeconomic status and the progression of heart failure in terms of its out-of-hospital 
management.  The second is to explore the mechanisms underlying the relationship between 
poor socioeconomic status and increased mortality.  Lastly, interventions can be tested to 
help understand how to improve SRH, and the resulting health outcomes, among aging 
adults.
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VIII. APPENDICES 
Appendix A.  Prevalence of Charlson index components during the incident heart 
failure hospitalization, Overall and by nINC: The ARIC study, 1987-2004. 
  Median Household Income (nINC) 
 Overall 
N=1,342 
Low 
N=553 
Medium   
N=454 
High  
N=335 
 N % N % N % N % 
Myocardial Infarction Yes 
No 
170 
1,172 
12.7 
87.3 
57 
496 
10.3 
89.7 
74 
380 
16.3 
83.7 
39 
296 
11.6 
88.4 
Peripheral Vascular Disease Yes 
No 
105 
1,237 
7.8 
92.2 
38 
515 
6.9 
93.1 
36 
418 
7.9 
92.1 
31 
304 
9.3 
90.7 
Cerebrovascular Disease Yes 
No 
121 
1,221 
9.0 
91.0 
55 
498 
10.0 
90.0 
38 
416 
8.4 
91.6 
28 
307 
8.4 
91.6 
Dementia Yes 
No 
8 
1,334 
0.6 
99.4 
0 
553 
- 
100 
5 
449 
1.1 
98.9 
3 
332 
0.9 
99.1 
Chronic Pulmonary Disease Yes 
No 
368 
974 
27.4 
72.6 
124 
429 
22.4 
77.6 
153 
301 
33.7 
66.3 
91 
244 
27.2 
72.8 
Rheumatologic Disease Yes 
No 
33 
1,309 
2.5 
97.5 
11 
542 
2.0 
98.0 
13 
441 
2.9 
97.1 
9 
326 
2.7 
97.3 
Mild Liver Disease Yes 
No 
11 
1,331 
0.8 
99.2 
4 
549 
0.7 
99.3 
4 
450 
0.9 
99.1 
3 
332 
0.9 
99.1 
Moderate or Severe Liver Disease Yes 
No 
6 
1,336 
0.6 
99.4 
4 
549 
0.7 
99.3 
0 
454 
- 
100 
2 
333 
0.6 
99.4 
Diabetes Mellitus Yes 
No 
293 
1,049 
21.8 
78.2 
137 
416 
24.7 
75.3 
91 
363 
20.1 
79.9 
65 
270 
19.5 
80.5 
Diabetes with Chronic Complications Yes 
No 
55 
1,287 
4.1 
95.9 
20 
533 
3.6 
96.4 
16 
438 
3.5 
96.5 
19 
316 
5.7 
94.3 
Hemiplegia or Paraplegia Yes 
No 
20 
1,322 
1.5 
98.5 
9 
544 
1.6 
98.4 
11 
443 
2.4 
97.6 
0 
335 
- 
100 
Renal Disease Yes 
No 
37 
1,305 
2.8 
97.2 
22 
531 
4.0 
96.0 
8 
446 
1.8 
98.2 
7 
328 
2.1 
97.9 
Charlson Index Score 0 
1 
2 
3 
4 
5 
6 
474 
554 
215 
47 
39 
12 
1 
35.3 
41.3 
16.0 
3.5 
2.9 
0.9 
0.1 
187 
218 
97 
25 
17 
9 
- 
33.8 
39.4 
17.6 
4.5 
3.0 
1.7 
- 
167 
188 
69 
15 
11 
3 
1 
36.8 
41.5 
15.2 
3.2 
2.5 
0.6 
0.2 
120 
148 
49 
7 
11 
- 
- 
35.8 
44.2 
14.6 
0.2 
3.2 
- 
- 
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Appendix B.  Percent of participants who had died, were rehospitalized, or who had 
died or were rehospitalized following an incident hospitalized heart failure event: The 
ARIC study (1987-2004) 
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Appendix C. Distribution of rehospitalizations by type among participants with an 
incident hospitalized heart failure event, The ARIC study (1987-2004) 
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Appendix D.  Rehospitalization status and characteristics of participants with incident 
hospitalized heart failure, overall and by nINC: The ARIC Study (1987-2004) 
  Median Household Income (nINC) 
 Overall 
N=1,342 
Low 
N=553 
Medium   
N=454 
High  
N=335 
 N % N % N % N % 
Rehospitalized at least once 1087 81.0 458 82.8 369 81.3 260 77.6 
30-day 246 18.3 81 14.6 112 24.7 53 15.8 
90-day 447 33.3 174 31.5 186 41.0 87 26.0 
6-month 614 45.8 240 43.4 236 52.0 138 41.2 
1-year 759 56.6 306 55.3 279 61.5 174 51.9 
5-year 1028 76.6 430 77.8 351 77.3 247 73.7 
Mean follow-up, years 1.4 1.4 1.3 1.6 
Characteristics at Baseline     
Median Household Income (USD), mean 28,293 16,519 31,799 42,979 
Gender                                                         Female
Male
610 
732 
45.5 
54.5 
309 
244 
55.9 
44.1 
173 
281 
38.1 
61.9 
128 
207 
38.2 
61.8 
Race/Study Community                   Black/Forsyth
Black/Jackson
White/Forsyth County
White/Washington County
White/Minneapolis
45 
397 
273 
383 
244 
3.4 
29.6 
20.3 
28.5 
18.2 
26 
369 
42 
103 
13 
4.7 
66.7 
7.6 
18.6 
2.4 
17 
6 
141 
232 
58 
3.7 
1.3 
31.1 
51.1 
12.8 
2 
22 
90 
48 
173 
0.6 
6.6 
26.9 
14.3 
51.6 
Hypertensivea        
                                                     Yes
No
Missing
710 
621 
11 
52.9 
46.3 
0.8 
349 
200 
4 
63.1 
36.2 
0.7 
200 
251 
3 
44.1 
55.3 
0.7 
161 
170 
4 
48.1 
50.8 
1.1 
Body Mass Index (BMI)b                                  Obese
Overweight
Normal
Missing
578 
484 
278 
2 
43.1 
36.1 
20.7 
0.2 
273 
186 
93 
1 
49.4 
33.6 
16.8 
0.2 
172 
173 
109 
- 
37.9 
38.1 
24.0 
- 
133 
125 
76 
1 
39.7 
37.3 
22.7 
0.3 
Current Drinker                                                Yes
No
621 
721 
46.3 
53.7 
168 
385 
30.4 
69.6 
237 
217 
52.2 
47.8 
216 
119 
64.5 
35.5 
Current Smoker                                                Yes
No
473 
869 
35.3 
64.7 
204 
349 
36.9 
63.1 
161 
293 
35.5 
64.5 
108 
227 
32.2 
67.8 
Educational Attainment, years                      17-21
12-16
 ≤11
Missing
319 
498 
521 
4 
23.8 
37.1 
38.8 
0.3 
79 
169 
302 
3 
14.3 
30.6 
54.6 
0.5 
106 
190 
157 
1 
23.4 
41.9 
34.5 
0.2 
134 
139 
62 
- 
40.0 
41.5 
18.5 
- 
Characteristics at Index Hospitalization      
Age, mean (SD) 67.0 (6.8) 66.0 (6.8) 67.9 (6.6) 67.5 (6.9) 
Charlson Comorbidity Index Score2                  ≥2
<2
314 
1,028 
23.4 
76.6 
148 
405 
26.8 
74.2 
99 
355 
21.8 
79.2 
67 
268 
20.0 
80.0 
Medicaid Recipientd                                          Yes
No
135 
1,207 
10.1 
89.9 
111 
442 
20.1 
79.9 
15 
439 
3.3 
96.7 
9 
326 
2.7 
97.3 
aSystolic blood pressure ≥140mmHg or diastolic blood pressure ≥90mmHg, or blood pressure medication in the 
last two weeks. 
bNormal BMI: <25kg/m2; overweight: 25-<29.5kg/m2; and obese: ≥29.5kg/m2 
2Adapted for use with ICD-9-CM discharge codes 
dAs indicated in medical record 
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Appendix E.  Odds ratios and 95% confidence intervals for rehospitalization among 
participants with an incident hospitalized heart failure event, The ARIC study (1987-
2004) 
 
 Charlson Index Score ≥2 Charlson Index Score <2 
 Model 1a Model 2b Model 1a Model 2b 
30-day     
nINC     
     Low  2.07 (0.69, 6.15) 2.68 (0.80, 9.00) 1.33 (0.75, 2.33) 1.25 (0.70, 2.22) 
     Medium 1.28 (0.50, 3.30) 1.51 (0.57, 4.05) 2.04 (1.31, 3.18) 1.99 (1.25, 3.17) 
     High 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
Medicaid Recipient      
     Yes 1.37 (0.54, 3.51) 1.27 (0.49, 3.29) 0.77 (0.37, 1.59) 0.69 (0.34, 1.42) 
     No 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
3-month     
nINC     
     Low  2.30 (1.04, 5.08) 2.40 (1.05, 5.52) 1.64 (1.08, 2.50) 1.64 (1.04, 2.61) 
     Medium 1.98 (0.94, 4.15) 1.98 (0.92, 4.26) 2.08 (1.47, 2.95) 2.12 (1.44, 3.12) 
     High 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
Medicaid Recipient      
     Yes 2.00 (0.89, 4.50) 1.90 (0.84, 4.32) 1.08 (0.70, 1.67) 1.03 (0.66, 1.62) 
     No 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
6-month     
nINC     
     Low  1.64 (0.81, 3.35) 2.05 (0.96, 4.38) 1.19 (0.81, 1.75) 1.19 (0.79, 1.78) 
     Medium 1.84 (0.98, 3.48) 2.30 (1.23, 4.32) 1.55 (1.11, 2.15) 1.57 (1.11, 2.24) 
     High 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
Medicaid Recipient      
     Yes 1.35 (0.62, 2.96) 1.18 (0.54, 2.57) 1.17 (0.77, 1.78) 1.16 (0.74, 1.81) 
     No 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
1-year     
nINC     
     Low  1.87 (0.86, 4.10) 2.35 (1.05, 5.26) 1.25 (0.87, 1.78) 1.27 (0.87, 1.84) 
     Medium 2.01 (1.00, 4.04) 2.52 (1.24, 5.13) 1.54 (1.14, 2.08) 1.58 (1.14, 2.20) 
     High 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
Medicaid Recipient      
     Yes 1.00 (0.47, 2.14) 0.89 (0.41, 1.94) 1.37 (0.93, 2.01) 1.37 (0.91, 2.07) 
     No 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
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 Charlson Index Score ≥2 Charlson Index Score <2 
 Model 1a Model 2b Model 1a Model 2b 
5-year     
nINC     
     Low  1.03 (0.33, 3.21) 1.42 (0.44, 4.59) 1.23 (0.83, 1.81) 1.27 (0.85, 1.89) 
     Medium 1.18 (0.38, 3.61) 1.59 (0.48, 5.31) 1.25 (0.93, 1.68) 1.29 (0.95, 1.75) 
     High 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
Medicaid Recipient      
     Yes 0.63 (0.28, 1.46) 0.58 (0.26, 1.32) 1.03 (0.65, 1.65) 0.99 (0.61, 1.58) 
     No 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
anINC and Medicaid status plus race/study community, gender and age at index event 
bModel 1 plus hypertension, body mass index, current smoker, current drinker and educational attainment 
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Appendix F. Mortality status and characteristics of participants with incident 
hospitalized heart failure, overall and by nINC: The ARIC Study (1987-2004) 
  Median Household Income (nINC) 
 Overall 
N=1,342 
Low 
N=553 
Medium   
N=454 
High  
N=335 
 N % N % N % N % 
Mortality Status Post-Index Hospitalization         
30-day 55 4.1 19 3.4 20 4.4 16 4.8 
90-day 119 8.9 49 8.9 36 7.9 34 10.2 
6-month 167 12.4 69 12.5 52 11.5 46 13.7 
1-year 231 17.2 98 17.7 74 16.3 59 17.6 
5-year 483 36.0 219 39.6 151 33.3 113 33.7 
Mean follow-up, years 4.1 3.9 4.2 4.1 
Characteristics at Baseline     
Median Household Income (USD), mean 28,293 16,519 31,799 42,979 
Gender                                                         Female
Male
610 
732 
45.5 
54.5 
309 
244 
55.9 
44.1 
173 
281 
38.1 
61.9 
128 
207 
38.2 
61.8 
Race/Study Community                   Black/Forsyth
Black/Jackson
White/Forsyth County
White/Washington County
White/Minneapolis
45 
397 
273 
383 
244 
3.4 
29.6 
20.3 
28.5 
18.2 
26 
369 
42 
103 
13 
4.7 
66.7 
7.6 
18.6 
2.4 
17 
6 
141 
232 
58 
3.7 
1.3 
31.1 
51.1 
12.8 
2 
22 
90 
48 
173 
0.6 
6.6 
26.9 
14.3 
51.6 
Hypertensivea                                                                             Yes
No
Missing
710 
621 
11 
52.9 
46.3 
0.8 
349 
200 
4 
63.1 
36.2 
0.7 
200 
251 
3 
44.1 
55.3 
0.7 
161 
170 
4 
48.1 
50.8 
1.1 
Body Mass Index (BMI)b                              
Obese 
Overweight
Normal
Missing
578 
484 
278 
2 
43.1 
36.1 
20.7 
0.2 
273 
186 
93 
1 
49.4 
33.6 
16.8 
0.2 
172 
173 
109 
- 
37.9 
38.1 
24.0 
- 
133 
125 
76 
1 
39.7 
37.3 
22.7 
0.3 
Current Drinker                                                Yes
No
621 
721 
46.3 
53.7 
168 
385 
30.4 
69.6 
237 
217 
52.2 
47.8 
216 
119 
64.5 
35.5 
Current Smoker                                                Yes
No
473 
869 
35.3 
64.7 
204 
349 
36.9 
63.1 
161 
293 
35.5 
64.5 
108 
227 
32.2 
67.8 
Educational Attainment, years                      17-21
  12-16
 ≤11
Missing
319 
498 
521 
4 
23.8 
37.1 
38.8 
0.3 
79 
169 
302 
3 
14.3 
30.6 
54.6 
0.5 
106 
190 
157 
1 
23.4 
41.9 
34.5 
0.2 
134 
139 
62 
- 
40.0 
41.5 
18.5 
- 
Characteristics at Index Hospitalization      
Age, mean (SD) 67.0 (6.8) 66.0 (6.8) 67.9 (6.6) 67.5 (6.9) 
Charlson Comorbidity Index Scorec                   ≥2
<2
314 
1,028 
23.4 
76.6 
148 
405 
26.8 
74.2 
99 
355 
21.8 
79.2 
67 
268 
20.0 
80.0 
Medicaid Recipientd                                          Yes
No
135 
1,207 
10.1 
89.9 
111 
442 
20.1 
79.9 
15 
439 
3.3 
96.7 
9 
326 
2.7 
97.3 
aSystolic blood pressure ≥140mmHg or diastolic blood pressure ≥90mmHg, or blood pressure medication in the 
last two weeks. 
bNormal BMI: <25kg/m2; overweight: 25-<29.5kg/m2; and obese: ≥29.5kg/m2 
2Adapted for use with ICD-9-CM discharge codes 
dAs indicated in medical record 
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Appendix G.  Odds ratios and 95% confidence intervals for death among participants 
with an incident hospitalized heart failure event, The ARIC study (1987-2004) 
 
 Charlson Index Score ≥2 Charlson Index Score <2 
 Model 1a Model 2b Model 1a Model 2b 
30-day     
nINC     
     Low  Not estimable Not estimable 0.66 (0.25, 1.78) Not estimable 
     Medium Not estimable Not estimable 0.68 (0.32, 1.43) Not estimable 
     High 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
Medicaid Recipient      
     Yes Not estimable 1.12 (0.89, 1.40) 1.82 (0.66, 5.05) 1.18 (1.04, 1.34) 
     No 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
3-month     
nINC     
     Low  1.12 (0.33, 3.81) 1.15 (0.26, 5.17) 0.92 (0.52, 1.65) 0.89 (0.50, 1.58) 
     Medium 0.44 (0.12, 1.62) 0.45 (0.09, 2.27) 0.77 (0.46, 1.31) 0.72 (0.42, 1.23) 
     High 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
Medicaid Recipient      
     Yes 0.91 (0.25, 3.25) 0.93 (0.25, 3.40) 1.33 (0.62, 2.85) 1.33 (0.58, 3.06) 
     No 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
6-month     
nINC     
     Low  1.58 (0.53, 4.75) 1.91 (0.51, 7.23) 0.68 (0.38, 1.20) 0.63 (0.35, 1.16) 
     Medium 0.71 (0.24, 2.13) 0.79 (0.21, 2.90) 0.73 (0.45, 1.18) 0.67 (0.40, 1.12) 
     High 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
Medicaid Recipient      
     Yes 1.19 (0.46, 3.03) 1.20 (0.47, 3.06) 1.21 (0.63, 2.30) 1.08 (0.53, 2.22) 
     No 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
1-year     
nINC     
     Low  2.21 (0.79, 6.21) 2.44 (0.77, 7.79) 0.89 (0.56, 1.41) 0.87 (0.53, 1.43) 
     Medium 1.39 (0.56, 3.43) 1.45 (0.52, 4.05) 0.81 (0.55, 1.21) 0.77 (0.51, 1.18) 
     High 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
Medicaid Recipient      
     Yes 1.20 (0.49, 2.96) 1.15 (0.47, 2.80) 0.86 (0.47, 1.59) 0.79 (0.41, 1.51) 
     No 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
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 Charlson Index Score ≥2 Charlson Index Score <2 
 Model 1a Model 2b Model 1a Model 2b 
5-year     
nINC     
     Low  1.55 (0.74, 3.29) 1.65 (0.75, 3.63) 1.25 (0.88, 1.76) 1.17 (0.82, 1.68) 
     Medium 1.13 (0.60, 2.11) 1.13 (0.58, 2.18) 0.95 (0.67, 1.34) 0.93 (0.66, 1.32) 
     High 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
Medicaid Recipient      
     Yes 0.90 (0.41, 1.99) 0.88 (0.39, 1.99) 0.83 (0.53, 1.30) 0.75 (0.46, 1.21) 
     No 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
anINC and Medicaid status plus race/study community, gender and age at index event 
bModel 1 plus hypertension, body mass index, current smoker, current drinker and educational attainment 
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Appendix H. Rehospitalization or mortality status and characteristics of 
participants with incident hospitalized heart failure, overall and by nINC: The 
ARIC Study (1987-2004) 
  Median Household Income (nINC) 
 Overall 
N=1,342 
Low 
N=553 
Medium   
N=454 
High  
N=335 
 N % N % N % N % 
Rehospitalized or Died 1171 87.3 491 88.8 394 86.8 286 85.4 
30-day 273 20.3 92 16.6 119 26.2 62 18.5 
90-day 490 36.5 191 34.5 198 43.6 101 30.2 
6-month 666 49.6 262 47.4 250 55.1 154 46.0 
1-year 822 61.3 332 60.0 295 65.0 195 58.2 
5-year 1108 82.6 462 83.5 374 82.4 272 81.2 
Mean follow-up, years 1.4 1.4 1.3 1.6 
Characteristics at Baseline     
Median Household Income (USD), mean 28,293 16,519 31,799 42,979 
Gender                                                         Female
Male
610 
732 
45.5 
54.5 
309 
244 
55.9 
44.1 
173 
281 
38.1 
61.9 
128 
207 
38.2 
61.8 
Race/Study Community                   Black/Forsyth
Black/Jackson
White/Forsyth County
White/Washington County
White/Minneapolis
45 
397 
273 
383 
244 
3.4 
29.6 
20.3 
28.5 
18.2 
26 
369 
42 
103 
13 
4.7 
66.7 
7.6 
18.6 
2.4 
17 
6 
141 
232 
58 
3.7 
1.3 
31.1 
51.1 
12.8 
2 
22 
90 
48 
173 
0.6 
6.6 
26.9 
14.3 
51.6 
Hypertensivea                                                    
Yes 
No
Missing
710 
621 
11 
52.9 
46.3 
0.8 
349 
200 
4 
63.1 
36.2 
0.7 
200 
251 
3 
44.1 
55.3 
0.7 
161 
170 
4 
48.1 
50.8 
1.1 
Body Mass Index (BMI)b                                  Obese
Overweight
Normal
Missing
578 
484 
278 
2 
43.1 
36.1 
20.7 
0.2 
273 
186 
93 
1 
49.4 
33.6 
16.8 
0.2 
172 
173 
109 
- 
37.9 
38.1 
24.0 
- 
133 
125 
76 
1 
39.7 
37.3 
22.7 
0.3 
Current Drinker                                                Yes
No
621 
721 
46.3 
53.7 
168 
385 
30.4 
69.6 
237 
217 
52.2 
47.8 
216 
119 
64.5 
35.5 
Current Smoker                                                Yes
No
473 
869 
35.3 
64.7 
204 
349 
36.9 
63.1 
161 
293 
35.5 
64.5 
108 
227 
32.2 
67.8 
Educational Attainment, years                      17-21
12-16
 ≤11
Missing
319 
498 
521 
4 
23.8 
37.1 
38.8 
0.3 
79 
169 
302 
3 
14.3 
30.6 
54.6 
0.5 
106 
190 
157 
1 
23.4 
41.9 
34.5 
0.2 
134 
139 
62 
- 
40.0 
41.5 
18.5 
- 
Characteristics at Index Hospitalization      
Age, mean (SD) 67.0 (6.8) 66.0 (6.8) 67.9 (6.6) 67.5 (6.9) 
Charlson Comorbidity Index Score2                   ≥2
<2
314 
1,028 
23.4 
76.6 
148 
405 
26.8 
74.2 
99 
355 
21.8 
79.2 
67 
268 
20.0 
80.0 
Medicaid Recipientd                                         Yes
No
135 
1,207 
10.1 
89.9 
111 
442 
20.1 
79.9 
15 
439 
3.3 
96.7 
9 
326 
2.7 
97.3 
aSystolic blood pressure ≥140mmHg or diastolic blood pressure ≥90mmHg, or blood pressure medication in the 
last two weeks. 
bNormal BMI: <25kg/m2; overweight: 25-<29.5kg/m2; and obese: ≥29.5kg/m2 
2Adapted for use with ICD-9-CM discharge codes 
dAs indicated in medical record 
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Appendix I.  Odds ratios and 95% confidence intervals for rehospitalization or death 
among participants with an incident hospitalized heart failure event, The ARIC study 
(1987-2004) 
 
 Charlson Index Score ≥2 Charlson Index Score <2 
 Model 1 Model 2 Model 1 Model 2 
30-day     
nINC     
     Low  1.99 (0.69,5.70) 2.33 (0.73, 7.46) 1.19 (0.72, 1.98) 1.13 (0.68, 1.88) 
     Medium  1.01 (0.41, 2.48) 1.13 (0.44, 2.93) 1.79 (1.19, 2.69) 1.74 (1.14, 2.66) 
     High  1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
Medicaid Recipient     
     Yes 1.78 (0.75, 4.27) 1.67 (0.67, 4.12) 0.85 (0.42, 1.71) 0.77 (0.38, 1.57) 
     No 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
3-month     
nINC     
     Low  2.18 (0.94, 5.08) 2.16 (0.89, 5.21) 1.41 (0.95, 2.10) 1.43 (0.94, 2.19) 
     Medium  1.39 (0.67, 2.89) 1.34 (0.63, 2.87) 1.89 (1.34, 2.66) 1.92 (1.32, 2.79) 
     High  1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
Medicaid Recipient     
     Yes 2.63 (1.19, 5.83) 2.43 (1.07, 5.53) 1.17 (0.75, 1.83) 1.15 (0.72, 1.84) 
     No 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
6-month     
nINC     
     Low  1.78 (0.91, 3.47) 2.06 (1.01, 4.19) Not estimable 1.09 (0.75, 1.59) 
     Medium  1.48 (0.85, 2.58) 1.75 (0.99, 3.08) Not estimable 1.48 (1.07, 2.02) 
     High  1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
Medicaid Recipient     
     Yes 1.72 (0.76, 3.89) 1.47 (0.64, 3.37) Not estimable 1.16 (0.72, 1.86) 
     No 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
1-year     
nINC     
     Low  2.11 (0.94, 4.72) 2.46 (1.13, 5.34) 1.12 (0.79, 1.57) 1.17 (0.82, 1.68) 
     Medium  1.52 (0.80, 2.92) 1.85 (0.96, 3.57) 1.41 (1.06, 1.86) 1.45 (1.07, 1.96) 
     High  1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
Medicaid Recipient     
     Yes 1.25 (0.53, 2.95) 1.08 (0.44, 2.65) 1.41 (0.89, 2.22) 1.47 (0.91, 2.35) 
     No 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
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 Charlson Index Score ≥2 Charlson Index Score <2 
 Model 1 Model 2 Model 1 Model 2 
5-year     
nINC     
     Low  1.11 (0.23, 5.35) 1.47 (0.31, 6.96) 1.01 (0.68, 1.50) 1.08 (0.72, 1.62) 
     Medium  0.72 (0.18, 2.91) 0.97 (0.21, 4.39) 1.09 (0.81, 1.47) 1.14 (0.84, 1.55) 
     High  1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
Medicaid Recipient     
     Yes 0.71 (0.29, 1.75) 0.56 (0.23, 1.39) 1.19 (0.65, 2.15) 1.19 (0.65, 2.16) 
     No 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
anINC and Medicaid status plus race/study community, gender and age at index event 
bModel 1 plus hypertension, body mass index, current smoker, current drinker and educational attainment 
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Appendix J.  Rate ratios and 95% confidence intervals for rehospitalization or death 
among participants with an incident hospitalized heart failure event: Negative binomial 
regression, The ARIC study (1987-2004) 
 Charlson Index Score ≥2 Charlson Index Score <2 
 Model 1a Model 2b Model 1a Model 2b 
All-cause 
Rehospitalization 
    
nINC     
     Low  1.58 (0.98, 2.56) 1.84 (1.07, 3.18) 1.22 (0.94, 1.58) 1.16 (0.89, 1.52) 
     Medium 1.33 (0.89, 1.98) 1.50 (0.95, 2.37) 1.14 (0.94, 1.38) 1.12 (0.92, 1.37) 
     High 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
Medicaid Recipient      
     Yes 0.80 (0.60, 1.07) 0.77 (0.58, 1.02) 1.47 (1.14, 1.90) 1.41 (1.09, 1.82) 
     No 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
CVD-related 
Rehospitalization 
    
nINC     
     Low  1.70 (1.06, 2.71) 2.00 (1.17, 3.41) 1.16 (0.89, 1.50) 1.09 (0.83, 1.43) 
     Medium 1.31 (0.86, 2.01) 1.51 (0.92, 2.46) 1.15 (0.94, 1.41) 1.13 (0.91, 1.39) 
     High 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
Medicaid Recipient      
     Yes 0.91 (0.67, 1.25) 0.88 (0.65, 1.19) 1.68 (1.30, 2.18) 1.61 (1.24, 2.09) 
     No 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
HF-related 
Rehospitalization 
    
nINC     
     Low  1.58 (0.82, 3.06) 2.04 (0.93, 4.51) 1.16 (0.83, 1.63) 1.06 (0.74, 1.50) 
     Medium 1.47 (0.82, 2.66) 1.90 (0.97, 3.69) 1.15 (0.88, 1.51) 1.13 (0.85, 1.50) 
     High 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
Medicaid Recipient      
     Yes 0.92 (0.59, 1.44) 0.84 (0.55, 1.29) 1.79 (1.28, 2.50) 1.65 (1.19, 2.27) 
     No 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
anINC and Medicaid status plus race/study community, gender and age at index event 
bModel 1 plus hypertension, body mass index, current smoker, current drinker and educational attainment 
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Appendix K. Self-rated health among all participants, by contact year (CY) and nINC, 
The ARIC study (1987-2004)  
  Self-Rated Health (SRH), Mean 
CY N* Overall Low nINC Medium nINC High nINC 
1 15,038 74.5 64.4 76.9 81.3 
2 14,955 76.7 68.2 78.3 82.7 
3 14,909 75.6 66.9 77.4 81.6 
4 14,813 74.9 66.0 76.7 81.0 
5 14,687 74.4 65.0 75.8 80.5 
6 14,539 73.2 64.0 75.0 79.5 
7 14,372 72.7 63.0 75.0 79.0 
8 14,161 72.6 63.3 74.6 78.7 
9 13,951 71.9 63.0 73.4 78.3 
10 13,730 72.0 62.3 74.0 78.4 
11 13,548 71.4 62.5 73.3 77.2 
12 13,309 70.6 61.3 72.0 77.2 
13 13,078 70.4 61.1 72.2 76.4 
14 12,804 69.9 60.4 71.5 76.4 
15 12,548 69.5 60.8 71.0 75.4 
16 12,270 69.0 60.5 70.5 74.7 
17 11,771 68.5 59.8 69.9 74.3 
*Number of participants (of 15,038) who contributed non-missing SRH data for each CY 
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